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Abstract  
Introduction 
Production employees within the UK fragrance industry are exposed to large 
quantities of chemical substances and mixtures over working shifts. Occupational 
respiratory exposure within this industry is managed in line with relevant legislation 
and guidelines. There is a lack, however, of published literature studying the effects 
of respiratory exposure to chemicals on fragrance production employees.  
A multi-site cross-sectional study was conducted using employees from the UK 
fragrance industry. The primary aim was to answer the research question: 
In fragrance industry employees, is occupational respiratory exposure to 
chemicals linked to a statistically significant change in lung function as 
measured using spirometry? 
The secondary aim was to use the data acquired to develop a weighted 
questionnaire that is predictive for potential lung function problems, for use as a pre-
placement occupational health tool within the fragrance industry.  
Methods 
A cross-sectional study was designed, using an exposed group (fragrance 
production and associated functions, n = 60) and a control group (non-exposed 
fragrance industry employees, e.g. office staff, n = 52). 5 UK companies took part, 
giving a total of 112 participants. This was calculated as sufficient to achieve 80% 
power and 5% significance.  
Spirometric measurements (FEV1, FVC and PEF*) were taken pre-shift and post-
shift. Information was provided by participants for information on potential 
confounding factors (smoking, personal or family history of respiratory problems, 
body mass index). Post-shift measurements were compared between groups, using 
analysis of covariance (ANCOVA) to adjust for the baseline pre-shift measurements. 
* FEV1 = forced expiratory volume in 1 second; FVC = forced vital capacity; PEF = peak expiratory 
flow 
A pilot questionnaire was developed. The weightings for each of the questions 
contained within the questionnaire were found by performing simple and multiple 
linear regression on the spirometric and demographic data. The unstandardised 
coefficient (B) was used as a measure of effect size in order to calculate a weighted 
score for each question response. 
 
Results  
Adjusted mean difference in post-shift measurements between groups (exposed vs. 
control) for each outcome measure was NOT observed to be statistically significant. 
Adjusted p-values for FEV1, FVC and PEF were 0.722, 0.883, and 0.676, 
respectively.  
Internal validation checks showed that the weighted questionnaire scores correlated 
with FEV1 measurements, with a high score correlating with a reduced FEV1 
performance. Further validation is necessary to determine a threshold score 
corresponding to FEV1 of <80%predicted, the lower limit of normal for FEV1 
performance. 
 
Conclusions 
The present study showed no significant effects of occupational respiratory exposure 
on the spirometric performance of the study population,  
On first inspection the present findings support the suggestion that protective 
measures in place in the fragrance industry are sufficient in minimising occupational 
risk to respiratory health. Further validation of airway hypersensitivity measurement 
methods used in spirometry and the questions asked in the questionnaire is vital in 
order to determine a threshold score corresponding to FEV1 of <80%predicted, the 
lower limit of normal for FEV1 performance.  
 
The pre-placement occupational health questionnaire has potential to be employed 
as a predictive tool for potential lung functionality in fragrance industry employees, 
subject to further development.  
Subsequent external validation in future studies will be required before the 
questionnaire can be released for widespread use. 
In conclusion, this work is the first step in a novel area of research, and the industry 
would benefit from the follow-up or expansion of this research. 
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Chapter 1 Background and context 
The aim of this first chapter is to outline the background underlying the research 
study which forms the core of this thesis. This will be achieved by:  
● giving background information on the industry which provides the setting and 
context for the research;  
● providing justification for the research by identifying a gap in the literature;  
● defining the formal aims and objectives relating to the research study. 
 
1.1 Background 
The creation and development of fragrances has progressed from simple beginnings 
into a global, commercialised industry which has successfully married the artisan 
skills of the perfumer with the profit-driven aims of the business world. 
The origins of the fragrance industry lie in pre-historical Asia, and the chance 
discovery that certain plants would give off a fragrant smoke when burned as fuel. 
This discovery led to the burning of fragrant materials as religious offerings, and the 
manufacture of the first perfumery material – incense – for this purpose, dated to 
approximately 1500BCE in India (Curtis & Williams, 2001, p.425). Subsequent 
technological advances such as solvent extraction (Curtis & Williams, 2001, p.427) 
led to more efficient manufacturing and processing, and so fragrances gradually 
became available to a wider populace – from deity offerings and anointing royalty 
through the nobility and the wealthy, and finally to the general population. The rapid 
development of large fragrance houses such as Guerlain in the 1800s and Coty in 
the early 1900s established fragrance as a fashionable, trend-based consumable, 
and also cemented the idea of fragrances as a part of ordinary, everyday life 
(Hockey, 2011). 
Today, it is a global industry, with creation and development centres and 
manufacturing sites spread around the world. The market size of the fragrance 
industry globally was reported as greater than US$43 billion in 2011 (Wray, 2012). 
Approximately 150,000 people are directly employed within the industry globally 
(with 2,500 of those employed in the UK [personal communication, September 25, 
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2012]), with many more employed by other parties along the supply chain, such as 
raw material producers and retailers; contribution to the UK’s gross national product 
(GNP) is estimated at 0.1% (personal communication, September 25, 2012). The 
fragrance manufacturer, however, typically does not produce the final product as 
purchased by the consumer, and this sector is therefore the invisible arm of the 
industry, with the majority of consumers unaware of its existence – it is the brand of 
the final product that achieves consumer recognition.  
What is produced and sold by the fragrance manufacturer is the fragrance 
component of the product, briefed, designed and safety-assessed for inclusion in a 
specific application or range at a defined usage level. The purpose of the fragrance 
component is to ensure the final product emits a pleasing odour when used by the 
consumer, and sometimes to also mask undesirable odours. A wide variety of 
consumer products are fragranced in this way, and so the fragrance industry is an 
integral, if unnoticed, part of everyday life in the developed world. 
Applications can be divided into three broad categories: fine fragrance, 
cosmetics/personal care, and air care/household. Examples of applications in each 
category are given in table 1.1. Safety assessments are carried out by fragrance 
industry regulatory personnel, based on the application and usage level of the 
fragrance in the final product. 
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Table 1.1: Examples of fragranced product applications* 
Category Application 
Fine fragrance Hydroalcoholic products applied to recently shaved skin (eau de 
toilette for men) 
Hydroalcoholic products applied to unshaved skin (eau de toilette 
for women) 
Cosmetics / 
personal care 
Deodorant and antiperspirant products (roll-on, underarm and body) 
Facial creams and balms 
Bath gels, foams, mousses, salts, oils and other products added to 
bathwater 
Air care / 
household 
Hard surface cleaners of all types (bathroom and kitchen cleansers, 
furniture polish) 
Machine wash laundry detergents 
Air fresheners of all types (plug-ins, ambient, electrical) 
*RIFM Expert Panel, 2011 
 
The fragrance manufacturing process uses a variety of chemicals as raw material 
constituents. These may be natural materials extracted directly from botanical 
sources, or synthetic materials. Each chemical is assessed for its intrinsic hazards 
and usage restrictions in potential final product applications, and this information is 
collated and used to determine the permitted usage levels of the fragrance. 
Table 1.2 shows examples of commonly-used raw materials and their associated 
hazards. 
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Table 1.2: Examples of fragrance raw materials and associated hazards 
Name Chemical / 
Botanical 
name 
Origin Label(s)* Risk phrases (R-phrases)* 
Dipropylene 
glycol 
1,1’-
Oxydipropan-
1-ol 
Synthetic None 
required 
None required 
Cedarwood 
Oil, Chinese 
Cupressus 
funebris 
Natural 
  
 
 
R50/53 Very toxic to aquatic 
organisms, may cause long-term 
adverse effects in the aquatic 
environment. 
R65 Harmful: may cause lung 
damage if swallowed. 
Clary Sage 
Oil, Russian 
Salvia 
sclarea 
Natural 
  
R38 Irritating to skin. 
R43 May cause sensitisation by skin 
contact. 
R52/53 Harmful to aquatic 
organisms, may cause long-term 
adverse effects in the aquatic 
environment. 
*Home Office, 2009 
 
The fragrance manufacturer keeps a palette of these raw materials for use in 
fragrance production; limiting the size of the palette ensures that safety and physical 
data can be effectively kept up-to-date and accurate. Taking the researcher’s 
workplace, CPL Aromas, as an example, the palette is maintained in the region of 
1500-1600 raw materials. Each fragrance compounded in the production facility may 
be comprised of 5-10 raw materials for a simple base fragrance, or >200 raw 
materials for a complex fragrance (personal communication, May 02, 2012). It is 
impractical to risk-assess production of each compound when an average of 60 
fragrances are compounded every day (personal communication, March 23, 2012), 
and the formula database of even a small-to-medium fragrance company consists of 
approximately 78,000 formulas, any of which may be selected for production 
(personal communication, May 02, 2012). Given these figures, the usage levels and 
combinations of chemicals vary greatly each day, and thus personal respiratory 
exposure on a given day is unpredictable. 
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The fragrance industry is regulated by the International Fragrance Association 
(IFRA). IFRA are responsible for establishing standards for maximum levels for 
substances in final consumer products, and also prohibiting substances where 
necessary (IFRA, 2011a). Member companies of IFRA are bound by IFRA limits, and 
cannot supply fragrances for use in a given application at levels greater than those 
stipulated by IFRA. IFRA ensures adherence to these limits via its conditions of 
membership, regular cross-company collaboration and information exchange, and 
the IFRA compliance programme, whereby random consumer products are selected 
and tested for compliance with defined fragrance usage levels (IFRA 2011b). 
IFRA work in conjunction with the Research Institute for Fragrance Materials (RIFM), 
an independent testing organisation which carries out the testing and evaluation on 
raw materials which underlies the restrictions imposed by IFRA. These restrictions 
have historically been revised and updated annually (now biannually), and released 
to the industry as the IFRA Standards, currently on the 46th amendment (RIFM 
Expert Panel, 2011). 
In addition to the IFRA standards, designed for consumer protection, legislation is in 
place intended to provide protection for the employee. The Health and Safety at 
Work Act 1974 (Home Office, 1974) provides general guidelines on workplace 
safety, such as using and maintaining the correct protective wear and equipment, 
and the correct reporting of incidents. The Control of Substances Hazardous to 
Health Regulations 2002 (Home Office, 2002) gives more specific guidance on 
handling and using potentially hazardous chemicals, and implementing health 
surveillance of employees where appropriate. 
Figure 1.1 shows the legislation and regulatory bodies relevant to the fragrance 
industry. 
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*Home Office, 2009 
 
1.2 Context 
Individuals employed as compounders and associated functions within the fragrance 
industry work with large quantities of chemicals as a regular part of their jobs, and so 
experience regular inhalation exposure over considerable periods of time. Legislation 
exists to specify the measures necessary to minimise this exposure (Home Office, 
2002), and safety information to be passed on to users (Home Office, 2009), while 
industry regulation is intended to protect the consumer at the fragranced product’s 
end-point (IFRA 2011a). 
Legislation such as COSHH (Home Office, 2002), however, refers to single 
chemicals and basic polymers, and does not take into account the complexity of the 
fragrance compound, which may contain dozens or even hundreds of basic chemical 
components.  
Figure 1.1: History of industry regulation and relevant legislation 
Consumer products tested at random to ensure 
compliance with IFRA Standards 
1966: Research Institute for Fragrance Materials (RIFM) formed 
1973: International Fragrance Association (IFRA) formed 
1973: first release of IFRA Code of Practice / IFRA Standards 
2006-7: IFRA Compliance Programme begins 
1974: Health & Safety At Work Act 
2002: Control of Substances Hazardous to Health (COSHH) 
Regulations 
2002: Chemicals Hazard Information and Packaging for Supply 
Regulations (CHIP)* 
Specific protective measures for substances: 
health surveillance/monitoring, risk 
assessment, exposure control 
General workplace protective measures 
Specifies fragrance materials subject to 
restriction or prohibition 
Labelling of final consumer product, and 
transport labelling: hazard symbols, risk 
phrases, safety phrases 
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There is therefore a need for additional measures to ensure employees are 
monitored for respiratory changes. COSHH recommends a health surveillance 
system to monitor employees’ health in such a situation (Home Office, 2002, 
Regulation 11), and this has been established at the researcher’s workplace as part 
of the occupational health service. Employees undergo periodic spirometry 
assessments to monitor their lung function; any reduction in lung function can then 
be observed, investigated, and any necessary action taken. 
As in any industry involving occupational respiratory exposure, there is a conceivable 
risk of irritation or damage to the lungs. A literature search was conducted to explore 
the available research on occupational respiratory exposure in all industries, and 
showed a distinct lack of recent research investigating the respiratory effects of 
chemical exposure on fragrance industry employees. Research has been 
undertaken in other industries where respiratory exposure is a concern, such as 
metalworking (Kezunovic, 2008; Musk et al., 2000) and woodworking (Baran & Teul, 
2007; Osman & Pala, 2009). Within the fragrance industry, however, published work 
consists mainly of commentaries and editorial-style articles (Bridges, 2002; Cadby, 
Troy, Middleton & Vey, 2002), and research investigating the effects of the final 
fragranced product on the consumer (Kumar et al., 1995). Fragrance industry-
specific research focussing on occupational exposure was not, therefore, retrieved in 
this search. Only two specific examples of employee exposure within the fragrance 
industry were found (Galperina, Perekrest & Preobrazkenskii, 1986; Xuev, 1964), but 
these articles were too old to be of any current relevance. Both articles pre-date the 
COSHH Regulations, and the article by Xuev (1964) also pre-dates the Health and 
Safety at Work Act (1974). Also, the fragrance industry has updated its standards for 
inclusion levels and prohibitions annually, often resulting in dramatic restrictions. 
Research published in 1986, for example, will bear no relevance to chemical usage 
levels – and thus exposure and effects – today. These articles were also published in 
the Russian language. 
The articles retrieved are considered below. A consideration of the available relevant 
literature is necessary in order to examine the nature, quality and quantity of studies 
investigating occupational respiratory exposure and to provide justification for similar 
research to be undertaken within the fragrance industry. 
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Literature review 
A review of published literature investigating occupational respiratory 
problems in different industries 
 
Respiratory exposure is a significant issue within a variety of occupational settings. 
The aim of this review was to collate the available research on occupational 
respiratory exposure and therefore demonstrate the variety of occupations in which 
this research has been conducted.  
 
Methods 
Data collection 
Search strategy 
Databases used for the literature search are given in table 1.3, along with refined 
search terminology and number of results. Only articles published from 2000 
onwards are considered relevant, to ensure a focus on recent research. 
Table 1.3: Search strategy, showing databases and search terms used, 
alongside initial and refined results 
Database Refined search terms Initial 
results 
Relevant 
results 
SSCI  
(Social Sciences 
Citation Index) 
lung function AND workplace OR 
occupational AND chemical AND 
respiratory in TOPIC, 2000-2012 
380 18 
PubMed 
 
lung function AND occupational OR 
workplace AND chemical AND 
respiratory in TITLE/ABSTRACT, 
2000-2012 
95 6 
CINAHL  
(Cumulative Index to 
Nursing and Allied 
Health Literature) 
lung function AND workplace OR 
occupational AND chemical in 
ABSTRACT, 2000-2012 
182 5 
Google Scholar lung function AND workplace OR 
occupational in TITLE, 2000-2012 
43 4 
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Selection 
The following inclusion criteria were used to select relevant articles from initial 
results: 
• must be written in the English language; 
• must investigate respiratory exposure within the workplace; 
• the exposure must be to a clearly defined substance, material or group of related 
substances; 
• quality of study design was appraised using appraisal checklists developed by the 
Critical Appraisal Skills Programme (CASP) (Public Health Resource Unit, 2004a; 
Public Health Resource Unit, 2004b); studies considered to be poorly-designed were 
excluded (CASP checklists are included as appendix entries 1 and 2). 
The total number of relevant articles included in this review was 33. 
 
Data analysis 
Selected articles were organised into groups based on the occupation being 
investigated. Each group was then considered in turn. 
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Results 
Tables 1.4a-1.4e show the summaries of studies for the articles retrieved and 
organised by industry, followed by a brief commentary. 
Table 1.4a: Summary of studies, investigations of occupational respiratory 
exposure 
Industry Type of study Sample 
size 
Measure 
(exposure) 
Measure 
(outcome) 
Results / 
significance 
Wood-working Cross-sectional with 
controls (Osman & 
Pala, 2009) 
n=656 Measured for 
1 employee, 
extrapolated 
FEV1, FVC Significant 
decline (p = 
<0.001) 
 
Cohort (Kogevinas 
et al, 2007) 
n=6837 Interview Relative risk 
(RR) of 
occupational 
asthma (OA) 
RR = 2.22 
(95%CI 0.69-
7.17), non-
significant 
 
Cohort (Baran & 
Teul, 2009) 
n=1100 Measured Incidence of 
lung cancer 
No incidence 
found 
Agriculture Case-report (Hoy, 
Pretto, van 
Gelderen & 
McDonald, 2007) 
n=2 Occupational 
history 
Hyper-
sensitivity 
pneumonitis 
(HP) 
HP diagnosed 
 
Cross-sectional with 
controls (Rylander 
& Carvalheiro, 
2006) 
n=82 Measured FEV1  Significant 
decline (p = 
0.003) 
 
Cohort (Venier et al, 
2006) 
n=265 Self-reported FEV1, FVC Significant 
decline, FEV1  
(p = <0.05); FVC 
(p = <0.01) 
 
Cross-sectional 
(Faria, Facchini, 
Fassa & 
McDonald,2005) 
n=1379 Interview Symptom 
prevalence 
Odds ratio (OR) 
for pesticide 
spreading = 
2.54 (95%CI 
1.36-4.72) 
 
Case-report (van 
Heemst et al, 2009) 
n=1 Measured HP HP diagnosed 
 
Wood-dust exposure in the furniture manufacturing industries was investigated in 
three studies. A cross-sectional study (Osman & Pala, 2009) found that FEV1 (forced 
expiratory volume in one second) and FVC (forced vital capacity) were significantly 
lower in furniture workers than in controls (p = <0.001). The authors state that they 
were unable to measure exposure levels for each worker, and one measurement 
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was assumed to be representative. A large population-based study investigating 
multiple industries across Europe (Kogevinas et al., 2007) for risk of occupational 
asthma (OA) found wood-working to have a relative risk (RR) of 2.22 (95% CI 0.69 – 
7.17), but this was not significant due to the confidence intervals crossing 1.0. The 
carcinogenic properties of wood-dust were also investigated (Baran & Teul, 2007). 
The authors found no incidence of lung cancer, and also were unable to attribute any 
cases of occupational respiratory disease to wood-dust exposure in the 1100 
subjects.  
Five articles investigated exposure within the agricultural industry. A case-report 
(Hoy, Pretto, van Gelderen & McDonald, 2007) describes two cases of 
hypersensitivity pneumonitis (HP) following exposure to organic dust resulting from 
mushroom farming (referred to here as ‘mushroom worker’s lung’, also known as 
‘farmer’s lung’). Airways inflammation was also reported following exposure to 
poultry-house dust (Rylander & Carvalheiro, 2006), with a significant reduction in 
FEV1 in poultry-house workers compared to controls (p = 0.003). FEV1 following 
methacholine challenge was further reduced in workers compared to controls (p = 
<0.001), suggesting airways hyperreactivity resulting from exposure to bacterial 
endotoxins, a significant component of this type of organic dust. A cohort study 
investigated the effects on respiratory function of the general modernisation of dairy 
farms (Venier et al., 2006), postulating that advanced methods and improved 
ventilation may result in significantly improved spirometric values. The authors cite 
micro-organisms within stored hay as the significant exposure for small dairy 
farmers. FEV1 and VC (vital capacity) were reduced in traditional farm workers in 
comparison to those using modern techniques and equipment (p = <0.05 and <0.01, 
respectively). Pesticides exposure among farmers was investigated for its 
relationship to prevalence of respiratory symptoms in a cross-sectional study (Faria, 
Facchini, Fassa & Tomasi, 2005). A greater than twofold risk was shown for 
development of asthma symptoms following pesticide exposure. For example, 
adjusted OR for pesticide spreading >2 days per month was 2.54 (95% CI 1.36 – 
4.72). The enzyme phytase – used in animal feed – was described as a novel 
allergen in a case-report describing a case of hypersensitivity pneumonitis in an 
agricultural foodstuff production worker (van Heemst et al., 2009). Spirometric 
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testing, workplace exposure rechallenge and positive response to steroids 
contributed to the diagnosis.  
Table 1.5b: Summary of studies, investigations of occupational respiratory 
exposure 
Industry Type of study Sample 
size 
Measure 
(exposure) 
Measure 
(outcome) 
Results / 
significance 
Construction & 
associated 
Cross-sectional 
(Ghasemkhani 
et al, 2006) 
n=880 Self-reported Symptom 
prevalence 
Prevalence 
chest tightness 
37.5% (p = 
<0.009); nasal 
irritation 30.8% 
(p = <0.0001) 
 
Cross-sectional 
(Moshammer, 
Hochgatterer, 
Angerschmid & 
Hutter, 2007) 
n=994 Occupational 
history 
MEF50  Significant 
decline (p = 
0.002) 
 
Cohort (Burstyn 
et al, 2003) 
n=58962 Estimated RR RR of mortality 
from obstructive 
lung disease = 
4.06 (95%CI 
1.35-12.19) 
Health-care Cross-sectional 
(Delclos et al, 
2007) 
n=3650 Self-reported OA 
prevalence 
OR = 2.07 
(95%CI 1.29-
3.33, p = 0.03) 
 
Cohort 
(Kogevinas et al, 
2007) 
n=6837 Interviews RR of OA RR = 1.80 
(95%CI 1.01-
3.18) 
 
Case-report 
(Ong, Tan, Lee 
& Eng, 2004) 
n=1 Occupational 
history 
OA OA diagnosed 
 
Cross-sectional 
(Liss et al, 2003) 
n=2633 Self-reported OA incidence OR = 5.3 
(95%CI 1.4-
20.2) for males, 
non-significant 
for females 
 
In a study comparing respiratory symptoms across a number of occupationally-
hazardous industries (Ghasemkhani et al., 2006), the construction industry had the 
highest prevalence for chest tightness (37.5%, p = <0.009) and nasal irritation 
(30.8%, p = <0.0001); the construction industry is named here as one of the two 
most significant industries in this study, along with the textile industry. Quartz dust 
exposure from stone-working (Moshammer, Hochgatterer, Angerschmid & Hutter, 
2007) was shown to be associated with a significant decrease in MEF50 (maximal 
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expiratory flow with 50% of FVC remaining) (p = 0.02). The control group used, 
however, consisted of other workers exposed to other/mixed sources of dust. The 
lack of an effective control group is questionable, as the selection of an unexposed 
control group would potentially have increased the significance of results; the 
authors do not state why such a group was not selected. A large cohort study of 
respiratory mortality in asphalt workers (Burstyn et al., 2003) showed that in the 
group with highest exposure, relative risk (RR) of mortality from obstructive lung 
diseases was 4.06 (95% CI 1.35 – 12.19), a four-fold risk in comparison to the 
unexposed.  
A cross-sectional study of prevalence in health-care workers (Delclos et al., 2007) 
found an OR of 2.07 (95% CI 1.29 – 3.33, p = 0.003) for occupational asthma in 
those responsible for medical instrument cleaning. A large multi-industry study 
(Kogevinas et al., 2007) also found RR of 1.80 (95% CI 1.01 – 3.18) for occupational 
asthma resulting from use of cleaning products in the health-care industry. OA was 
also attributed to use of glutaraldehyde (a chemical commonly used for cleaning 
medical equipment) in a case-report describing a medical technician’s symptoms 
and diagnosis (Ong, Tan, Lee & Eng, 2004), confirmed with a specific inhalational 
challenge (SIC) and subsequent 25% drop from baseline FEV1. Glutaraldehyde was 
cited alongside another aldehyde used for this purpose – formaldehyde – in a study 
of asthma prevalence among medical radiation technologists (MRTs) (Liss et al., 
2003). Using a non-exposed control group (physiotherapists), the odds ratio for new-
onset asthma in MRTs was not significant for females, but was 5.3 (95% CI 1.4 – 
20.2) for males, a five-fold risk.  
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Table 1.4c: Summary of studies, investigations of occupational respiratory 
exposure 
Industry Type of study Sample 
size 
Measure 
(exposure) 
Measure 
(outcome) 
Results / 
significance 
Metalworking 
& associated 
Cross-sectional 
with controls 
(Johnsen, 
Kongerud, 
Hetland, Benth & 
Soyseth, 2008) 
n=3294 Occupational 
history 
FEV1  Significant 
decline in never-
smokers (p = 
0.03) 
 
Case series 
(Gupta & 
Rosenman, 2006) 
n=7 Measured HP HP diagnosed 
 
Case report 
(Beckett, Kallay, 
Sood, Zuo & 
Milton, 2005) 
n=1 Measured HP HP diagnosed 
 
Case report (Di 
Stefano, 
Giampaolo, Verna 
& Gioacchino, 
2007) 
n=1 Occupational 
history 
Occupational 
eosinophilic 
bronchitis 
(OEB) 
OEB diagnosed 
 
Cross-sectional 
with controls 
(Kezunovic, 2008) 
n=296 Occupational 
history 
FEV1, FVC, 
PEF 
Significant 
decline, FEV1  
(p = 0.04); FVC 
(p = 0.03); PEF 
(p = <0.01) 
 
Cross-sectional 
with controls 
(Musk et al, 2000) 
n=2639 Self-reported FEV1, FVC, 
FEV1/FVC 
Significant 
decline, FVC    
(p = 0.03); 
FEV1/FVC        
(p = <0.001); 
FEV1 non-
significant 
 
Cross-sectional 
with controls 
(Fishwick 
Bradshaw, Slater, 
Curran & Pearce, 
2004) 
n=75 Measured FEV1  OR for reduction 
of FEV1 of ≥5%, 
aluminium 
exposure = 5.8 
(95%CI 1.7-
20.6) 
OR for 
respiratory 
symptoms, 
nickel exposure 
= 7.0 (95%CI 
1.3-36.6) 
 
Cross-sectional 
with controls 
(Jakubowski, 
Abramowska-
Guzik, Szymczak 
& Trzcinka-
Ochocka, 2004) 
n=238 Measured FEV1, PEF Significant 
decline (highest 
vs. lowest 
exposure), FEV1 
(p = 0.0208); 
PEF (p = 
0.0488) 
Page | 15  
 
Occupational exposure to dust in the smelting industry (Johnsen, Kongerud, Hetland, 
Benth & Soyseth, 2008) was significantly associated with a reduction in FEV1 when 
compared to non-exposed workers (p = 0.001). Further analysis to examine the 
confounding effect of smoking showed that a significant difference in FEV1 between 
exposed and non-exposed was only seen in those workers who had never smoked 
(p = 0.03). 
Metalworking fluids (MWFs) were associated with hypersensitivity pneumonitis (HP) 
in a case-series reporting outbreaks of HP (Gupta & Rosenman, 2006). The authors 
suggest that mycobacterial contamination of MWFs was responsible for the 
condition. This is further supported by another case-report of an individual 
developing HP following MWF exposure (Beckett, Kallay, Sood, Zuo & Milton, 2005), 
where the mycobacteria growing within five out of six MWF reservoirs in the 
workplace were cultured and identified as Mycobacterium immunogenum, an 
organism previously associated with HP (Suuronen, Henriks-Eckerman, Riala & 
Tuomi, 2008; Khan, Selvaraju & Yadav, 2005; Shelton, Flanders & Morris, 1999; 
Wallace, Zhang, Wilson, Mann & Rossmoore, 2002). Occupational eosinophilic 
bronchitis (OEB) – a non-asthmatic respiratory condition – was diagnosed in a 
foundry worker (Di Stefano, Giampaolo, Verna & Gioacchino, 2007). The OEB case 
was diagnosed via induced sputum testing, as spirometry is not typically a useful 
diagnostic tool in such cases. 
Aluminium exposure was investigated in three studies (Kezunovic, 2008; Musk et al., 
2000; Fishwick, Bradshaw, Slater, Curran & Pearce, 2004). Prevalence of respiratory 
symptoms in an aluminium factory was found to be high (e.g. breathlessness 56.7%) 
in one study (Kezunovic, 2008), but no significant changes in spirometric results 
were found. Significant spirometric changes were found between working groups in 
an aluminium refinery (Musk et al., 2000), but the authors concluded that these were 
not consistent and were unlikely to be of clinical importance. High aluminium 
exposure from welding (Fishwick et al., 2004) was, however, found to have a greater 
than five-fold risk of a reduction in FEV1 of at least 5% (OR = 5.8 [95% CI 1.7 – 
20.6]). In the same study, high nickel exposure from welding was found to have a 
seven-fold risk of work-related respiratory symptoms (OR = 7.0 [95% CI 1.3 – 36.6]). 
A study of cadmium exposure in a cadmium battery plant (Jakubowski, 
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Abramowska-Guzik, Szymczak & Trzcinka-Ochocka, 2004) showed a significant 
decrease in spirometric values only in the highest exposure group compared to the 
lowest exposure group; for FEV1, p = 0.0208, and for PEF, p = 0.0488.  
Table 1.4d: Summary of studies, investigations of occupational respiratory 
exposure 
Industry Type of study Sample 
size 
Measure 
(exposure) 
Measure 
(outcome) 
Results / 
significance 
Bakers Case report (Di 
Stefano et al, 
2007) 
n=1 Occupational 
history 
OEB OEB diagnosed 
 
Retro cohort 
(Karjalainen, 
Kurppa, 
Virtanen, 
Keskinen & 
Nordman, 2000) 
n=2602 Occupational 
history 
OA incidence Incidence rate 
444 per 100 000 
(males) (95%CI 
362-540) 
Incidence rate 
408 per 100 000 
(males) (95%CI 
337-489) 
Textiles Cross-sectional 
(Ghasemkhani 
et al, 2006) 
n=880 Self-reported Symptom 
prevalence 
Prevalence of 
cough 30.8%   
(p = <0.035); 
phlegm 53.8% 
(p = <0.004); 
dyspnoea 65.0% 
(p = <0.002)  
 
Case report 
(Kim et al, 2001) 
n=1 Measured OA OA diagnosed, 
confirmed with 
specific 
inhalational 
challenge (SIC) 
Hairdressing Case control 
(Hashemi, 
Boskabady & 
Nazari, 2010) 
n=238 Occupational 
history 
FEV1, FVC, 
PEF 
Significant 
decline (p = 
<0.001) 
 
Cross-sectional 
(Munoz et al, 
2003) 
n=8 Occupational 
history 
OA OA diagnosed 
 
Occupational exposure to flour in a bakery was shown in a case report (Di Stefano et 
al., 2007) to be associated with respiratory symptoms corresponding to occupational 
eosinophilic bronchitis (OEB). OA was also shown to have the highest incidence rate 
in bakers in a study of various occupations (Karjalainen, Kurppa, Virtanen, Keskinen 
& Nordman, 2000); incidence rate was 444 per 100 000 (extrapolated from a 
population of 3248) for male bakers (95% CI 362 – 540) and 408 per 100 000 
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(extrapolated from a population of 4101) for female bakers (95% CI 337 – 489), 
almost double the rate of the next highest occupation.  
Formaldehyde exposure in the textiles industry was shown to be associated with OA 
in a case-report (Kim et al., 2001), confirmed with SIC. FEV1 was measured at 
36.3% of the predicted value, which rose to 81.9% of predicted following steroid 
treatment. The textiles industry was also shown to have the highest prevalence for 
cough (30.8%, p = <0.035), phlegm (53.8%, p = <0.004) and dyspnoea (65.0%, p = 
<0.002) in a multi-industry study (Ghasemkhani et al., 2006). 
A case-control study comparing spirometric values in hairdressers and matched 
controls (Hashemi, Boskabady & Nazari, 2010) found a significant reduction in FEV1, 
FVC and PEF (p = <0.001 for all). Persulfate salts, used in hair bleaching powder, 
were found to be the substance with the greatest level of respiratory irritation. 
Another study (Munoz et al., 2003) showed that persulfate salts caused occupational 
asthma in both the employees preparing bleaching powder in a factory and the 
hairdressers using the powder in salons. OA was confirmed with specific bronchial 
challenge tests (SBCT) in all seven individuals tested; work-related changes in serial 
PEF measurements were also observed. 
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Table 1.4e: Summary of studies, investigations of occupational respiratory 
exposure 
Industry Type of study Sample 
size 
Measure 
(exposure) 
Measure 
(outcome) 
Results / 
significance 
Working with 
coal-dust 
Cross-sectional 
with controls 
(Drivas et al, 
2007) 
 
n=165 Measured FEV1  Increased 
prevalence  
FEV1 <80%pred. 
(p = <0.05) 
Printing Cross-sectional 
with controls 
(Gioda & Neto, 
2007) 
n=135 Measured Symptom 
prevalence 
87% symptom 
prevalence vs. 
78% prevalence 
in controls 
Spray-painting Case report 
(Minov, 
Karadzinska-
Bislimovska, 
Vasilevska, 
Risteska-Kuc & 
Stoleski, 2008) 
n=2 Occupational 
history 
OA OA diagnosed 
Flavourings Cross-sectional 
with controls 
(van Rooy et al, 
2009) 
n=175 Estimated Symptom 
prevalence 
Prevalence ratio 
(PR), ever 
asthma attack = 
2.0 (95%CI 1.2-
3.4); PR asthma 
attack previous 
12 months = 4.7 
(95%CI 1.9-
11.4) 
Cleaning Case-control 
(Medina-Ramon 
et al, 2005) 
n=195 Measured Symptom 
prevalence 
OR, high 
frequency 
ammonia use = 
3.1 (95%CI 1.2-
8.0) 
OR, high 
frequency 
bleach use = 2.4 
(95%CI 1.0-6.1) 
Pharmaceutical 
production 
Case series 
(Klusackova et 
al, 2007) 
n=5 Occupational 
history 
OA OA diagnosed 
Paper recycling Case report 
(Tran, Francis, 
Hoyle & Niven, 
2009) 
n=2 Occupational 
history 
OA OA diagnosed 
 
Only one article was retrieved for each of the occupations listed in table 1.4e.  
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A cross-sectional study examining the effects of lignite dust (coal dust) respiratory 
symptoms and spirometric values in power station workers (Drivas et al., 2007) 
found an increased prevalence of FEV1 below 80% of predicted compared to non-
exposed workers (p = <0.05). A similar level of increase was also found, however, in 
smokers compared to non-smokers (p = <0.05). The difference in mean FEV1 values 
between exposed and non-exposed was not significant, whereas the same 
comparison between smokers and non-smokers was significant (p = <0.05), 
suggesting that smoking is a strong confounder here. The authors acknowledge this, 
and their calculation of odds ratios suggest a possible combinatory effect of both 
smoking and lignite dust exposure. Odds ratio (OR) for smoking as a predictor of 
chronic bronchitis symptoms was 3.47 (95% CI 1.45 – 8.33), and OR for lignite dust 
exposure as a predictor of chronic bronchitis symptoms was 3.48 (95% CI 1.46 – 
8.2). The OR for smoking and lignite exposure combined, however, was 5.4 (95% CI 
1.49 – 19.6), showing a five-fold risk for chronic bronchitis symptoms in exposed 
employees who smoke. 
Prevalence of respiratory symptoms was investigated in a printing facility (Gioda & 
Neto, 2007). Individuals working near solvents reported 87% prevalence of at least 
one respiratory symptom; the control group, however, reported a 78% prevalence. 
The authors do acknowledge that the control group (office workers) was poorly 
chosen, as air sampling was not performed in the office area. If, however, the control 
group was ineffective due to solvent air contamination of the office area, this is 
suggestive of the risk posed by solvent use without appropriate extraction. 
Occupational asthma was diagnosed in two employees exposed via car spray-
painting (Minov, Karadzinska-Bislimovska, Vasilevska, Risteska-Kuc & Stoleski, 
2008). Asthma was diagnosed via spirometry (PEF) and bronchoprovocation testing. 
The authors state that they were unable to perform a specific inhalational challenge 
that may have revealed the specific causative agent. 
A cross-sectional study within the flavourings industry compared exposed employees 
with a non-exposed group (van Rooy et al., 2009). The authors found a prevalence 
ratio (PR) of 2.0 (95% CI 1.2 – 3.4) for having ever suffered an asthma attack, and a 
PR of 4.7 (95% CI 1.9 – 11.4) for suffering an attack within the previous twelve 
months. 
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A case-control study conducted on occupational domestic cleaners (Medina-Ramon 
et al., 2005) found high frequency use of household bleach and ammonia to be 
associated with asthma/chronic bronchitis symptoms (OR for bleach = 2.4 [95% CI 
1.0 – 6.1]; OR for ammonia = 3.1 [95% CI 1.2 – 8.0]).  
Occupational asthma was diagnosed in a case-report describing five workers using 
lasamide as a pharmaceutical intermediate in the production of diuretic medicines 
(Klusackova et al., 2007). Specific bronchoprovocation testing confirmed OA due to 
lasamide exposure in three out of the five subjects. The authors describe the 
discovery of lasamide as a novel allergen. 
A case-report on two employees within the paper recycling industry described 
occupational asthma resulting from exposure to hydroxylamine, a potential 
replacement for glutaraldehyde (Tran, Francis, Hoyle & Niven, 2009) highlighting the 
difficulties of chemical substitution. OA was diagnosed in one individual following a 
positive response to SBCT with hydroxylamine, suggesting that in this case one 
sensitiser has been replaced with another, although the authors did propose that this 
was the first reported case of OA to hydroxylamine. 
 
Conclusions 
Occupational health and health surveillance strategies should take into account the 
frequency of identified respiratory problems relevant to their workplace exposure 
conditions. The benefits of modernisation of ventilatory equipment and personal 
protective equipment were observed (Venier et al., 2006) in terms of ensuring 
reasonable employee protection from occupational respiratory exposure. The 
potential hazards behind chemical substitution for health reasons was also observed 
(Tran et al., 2009). Evidence should be sought on the safety and/or sensitisation 
potential of possible replacements before a substitution is made. 
No articles investigating respiratory exposure within the fragrance industry were 
retrieved for review. This lack of previous research on industry employees is 
remarkable, considering that the consumer’s exposure to the fragrance component 
of a product may be orders of magnitude lower than the employee who compounded 
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that fragrance. A typical eau de toilette perfume may contain around 10% fragrance, 
and a body wash product around 1%, for example; the fragrance compounder, 
meanwhile, may be exposed to large quantities of that fragrance without dilution, and 
so the exposure is notably greater. The fragrance industry is therefore an unexplored 
area for occupational exposure studies, and there is strong justification for similar 
research in this area as described in the articles reviewed above. 
 
1.3 Defining the research question (part 1) 
As seen in section 1.2, extensive research has been carried out exploring 
occupational respiratory exposure in other industries. Similar research has not been 
undertaken in the fragrance industry, despite the hazard of respiratory exposure 
resulting from regular working procedures. Health surveillance (as recommended by 
COSHH [Home Office, 2002, Regulation 11]) using spirometry is useful in such a 
workplace environment in monitoring employees’ respiratory health over time, and 
such a system is in place at the researcher’s workplace, but there is a clear lack of 
published literature exploring the consequences of working in the industry.  
The primary aim of the research planned and undertaken for this thesis was formally 
organised into a research question using the PECO method (population, exposure, 
comparison, outcome) (Richardson, Wilson, Nishikawa and Hayward, 1995; Dewey 
et al., 2011). The PECO method was selected instead of PICO as the factor to be 
investigated is an exposure, rather than an intervention. 
Table 1.5 shows how the PECO method was used to define the research question. 
Table 1.5: Formalising the research question using PECO 
P Population fragrance industry employees 
E Exposure occupational respiratory exposure to chemicals 
C Comparison employees using chemicals compared to non-exposed control group 
O Outcome change in lung function (measured using spirometry) 
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Formal research question: 
In fragrance industry employees, is occupational respiratory exposure to chemicals 
linked to a statistically significant change in lung function as measured using 
spirometry? 
This research question gives the alternative and null hypotheses: 
Research/alternative hypothesis: In fragrance industry employees, occupational 
respiratory exposure to chemicals is linked to a statistically significant change in lung 
function as measured using spirometry. 
Null hypothesis: In fragrance industry employees, occupational respiratory exposure 
to chemicals is not linked to a statistically significant change in lung function as 
measured using spirometry. 
 
Designing, undertaking and reporting a research study that aims to answer this 
question will form the primary arm of the research, referred to as ‘part 1’ (part 2 
comprises questionnaire development, outlined in section 1.4 and detailed in 
chapters 4 and 5). Aims and objectives for both parts of the study will be outlined in 
section 1.5. Methodology of the research study will be covered in chapter 2. 
 
1.4 Questionnaire development (part 2) 
Part 2 of the study approaches the knowledge gap in the fragrance industry from the 
perspective of occupational health and pre-placement questionnaires and 
assessments. 
Many pre-placement examinations and assessment procedures used currently are 
ineffective in assessing employees’ fitness for work, and there is weak evidence to 
support their continued use (Madan & Williams, 2010; Madan & Williams, 2012; 
Mahmud et al., 2010; Hulshof, Verbeek, van Dijk, van der Weide & Braam, 1999). 
Within the fragrance industry, respiratory exposure is an occupational hazard, and 
health surveillance of employees is recommended (Home Office, 2002). This may 
take the form of periodic monitoring of employees’ lung function with spirometric 
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assessments. Knowledge of an employee’s lung health at the start of employment 
would inform the employer of the necessity of further measures for that employee, 
for example the use of face masks, or more frequent spirometric assessments. 
Due to the Equality Act 2010 Section 60 (Home Office, 2010), however, it is now 
illegal for an employer to request any health-related information from a prospective 
employee prior to a formal offer of employment. This Act has two consequences 
relevant here: 
1) ‘pre-employment’ questionnaires should now be referred to as ‘pre-placement’ 
questionnaires. Existing questionnaires considered later in this section were 
developed prior to the Act becoming law, and so these terms may be used 
interchangeably here. 
2) as health information can now only be sought following an employment offer, it is 
crucial that a pre-placement questionnaire functions as a worthwhile tool, and is able 
to correctly identify potential relevant issues that can then be addressed.  
 
The aim of part 2 of this research was to additionally use the spirometric data 
collected from participants, along with demographic and physical information 
collected on pre-assessment data collection sheets, to develop a pre-placement 
questionnaire that is predictive for lung function impairment. This questionnaire is 
intended to fulfil this function specifically within the fragrance industry, developed to 
be representative of its target population. 
The process behind the development of the data collection sheets will be detailed in 
chapter 4 (part 2 methodology), and subsequent construction of the final pre-
placement questionnaire will be covered in chapter 5 (part 2 results). 
 
1.5 Aims and objectives 
The production of fragrance mixtures for inclusion in perfumes and other fragranced 
products has developed from the simple burning of fragrant plant material to the 
industrial manufacturing processes and facilities used today. Production employees 
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in these modern facilities are exposed to the natural and synthetic chemicals used as 
fragrance ingredients, often in large quantities, and so this work falls within the scope 
of occupational health. What effect, if any, does respiratory exposure in this industry 
have on the health of the employee, and how can this be sensibly measured? This 
thesis is concerned with the investigation of this question, and has two overarching 
aims: 
Primary aim (part 1): to investigate the effects of occupational respiratory exposure 
to chemicals in the fragrance industry on lung function, by answering the research 
question: 
In fragrance industry employees, is occupational respiratory exposure to chemicals 
linked to a statistically significant change in lung function as measured using 
spirometry?  
Secondary aim (part 2): to develop a pre-placement occupational health 
questionnaire that is predictive of reduced lung function, for use within the fragrance 
industry. 
 
For clarification, the structure and terminology used to describe the work undertaken 
towards this thesis is shown in figure 1.2. 
 
 
 
 
 
 
 
 
 
PARTS 
AIMS 
OBJECTIVES 
PHASES 
Figure 1.2: General structure and organisation of the research 
The division of the overall work into 2 parts. 
Each part has an underlying aim. The aim 
describes both the purpose and the measure 
of success for each part. 
A list of steps which must be completed in 
order to fulfil each aim. Each objective is 
relevant to one or both aims. 
The division of a specific objective-related 
task into logical phases. 
OBJECTIVES 
PHASES 
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Figure 1.3 shows a process map of how parts 1 and 2 will be undertaken as part of 
one cohesive body of work. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: Process map showing parts 1 and 2 of the research 
PART 1 
Research question 
SPIROMETRIC DATA 
PART 2 
Questionnaire development 
AIM 
to investigate the effects of occupational 
respiratory exposure to chemicals in the 
fragrance industry on lung function 
AIM 
to develop a pre-placement occupational health 
questionnaire that is predictive of reduced lung 
function, for use within the fragrance industry 
DEMOGRAPHIC AND 
PHYSICAL DATA 
EXPLORE RESEARCH 
QUESTION 
RESULTS 
PREDICTIVE QUESTIONNAIRE 
DEVELOPMENT 
FINAL QUESTIONNAIRE 
DISCUSSION AND IMPLICATIONS 
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Table 1.6 shows the objectives for both study aims. 
Table 1.6: Objectives relating to parts 1 and 2 
Objective 
number 
Objective description 
1 Professional training and experience: 
To gain formal training in spirometric testing and interpretation, and experience 
at conducting spirometric testing in the workplace. 
2 To answer the research question: 
In fragrance industry employees, is occupational respiratory exposure to 
chemicals linked to a statistically significant change in lung function as 
measured using spirometry? 
3 Statistical analysis: 
To undertake statistical analysis on data collected to explore the relationship 
between chemical exposure and lung function. 
4 Predictive questionnaire:  
To develop a predictive pre-placement screening questionnaire using 
spirometric data obtained and demographic information from pre-assessment 
data collection sheets. 
Sub-objective:  
To critically evaluate existing evidence on factors potentially associated with 
reduction in lung function (to inform the development of pre-assessment data 
collection sheets). 
5 Dissemination: 
To disseminate results via industry seminars/presentations and reports, and 
preparation of article(s) for publication. 
6 Professional implications: 
To explore the implications of research findings for industry via: 
preparation of guidelines / recommendations as appropriate;  
making the predictive questionnaire available within the fragrance industry; 
suggestion of future research ideas arising from the research findings.  
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Objective 1 
Professional training and experience: 
To gain formal training in spirometric testing and interpretation, and experience at 
conducting spirometric testing in the workplace. 
 
The research outcome, a change in lung function, will be measured using 
spirometry. To ensure competence of lung function testing during data collection, 
both formal training and significant prior experience with conducting spirometric 
assessments are necessary (Miller et al., 2005a).  
I received formal training in spirometric assessments and interpretation of results in 
March 2010 at the Royal Brompton Hospital’s Lung Function Unit, London (appendix 
entry 3). Immediately following this training, a health surveillance programme was 
implemented in the workplace, involving spirometric testing at two-month intervals 
(appendix entry 4). I am responsible for all aspects of organising and conducting this 
programme. Data collection for research purposes was scheduled to take place 
during October and November 2011, giving over 18 months personal experience in 
regular spirometric testing. Standardisation of testing was achieved by ensuring that 
all spirometric tests were conducted by the same trained and experienced individual 
(myself). 
 
Objective 2 
To answer the research question: 
In fragrance industry employees, is occupational respiratory exposure to chemicals 
linked to a statistically significant change in lung function as measured using 
spirometry? 
 
Design and methodology of the research study planned to answer this question will 
be reported in chapter 2. 
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Objective 3 
Statistical analysis: 
To undertake statistical analysis on data collected to explore the relationship between 
chemical exposure and lung function. 
 
Statistical methods used in the analysis of the data will be detailed in chapter 2. 
 
Objective 4 
Predictive questionnaire: 
To develop a predictive pre-placement screening questionnaire using spirometric data 
obtained and demographic information from pre-assessment data collection sheets. 
Sub-objective: 
To critically evaluate existing evidence on factors potentially associated with reduction in 
lung function (to inform the development of pre-assessment data collection sheets). 
 
Chapter 4 contains the review of existing literature and examination of existing 
questionnaires. Information obtained through these processes was used to develop 
a data collection sheet (appendix entry 5). The methodology behind the development 
of a predictive pre-placement screening questionnaire to fulfil this objective will be 
covered in chapter 4. 
 
Objective 5 
Dissemination: 
To disseminate results via industry seminars/presentations and reports, and preparation of 
article(s) for publication. 
 
Disseminated material arising from the research was listed in the dissemination list 
(page xi). Future articles and presentations will be listed in chapter 5. 
The questionnaire developed for part 2 will be made available to other fragrance 
companies. As future work, a presentation will be prepared on the development and 
intended use of the questionnaire to aid its release into industry; there will be interest 
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from RIFM and IFRA United Kingdom to receive this presentation. The results of part 
2 will also be written up as an article and submitted for publication in a peer-reviewed 
journal. 
 
Objective 6 
Professional implications: 
To explore the implications of research findings for industry via: 
preparation of guidelines/recommendations as appropriate; 
suggestion of future research ideas arising from the research findings. 
 
Chapter 6 will explore the implications of the research findings. Considering the 
research question, the primary and immediate implication of the results will be: 
If the research hypothesis is supported: industry will be made aware of a potential 
problem that could affect the well-being of their staff, and will have the justification to 
budget for improvements to ventilation and protective measures, for example. 
If the null hypothesis is supported: existing measures used will have been shown to 
be sufficient. Industry will have justification for continuing to use existing measures.  
The potential benefits of the predictive questionnaire will also be explored in chapter 
6, along with specific ideas for future research leading on from and inspired by both 
parts of this research study. 
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Summary 
This chapter has provided the setting, context, and justification for the research 
study, and defined the formal research question and the aims and objectives 
underlying the research. 
Chapter 2 will follow the background, research question and objectives formalised in 
this chapter to give detailed methods and study design for part 1, followed by the 
reporting and discussion of the results in chapter 3. 
Chapter 4 will detail the methodology behind the development of the predictive pre-
placement questionnaire. Chapter 5 will report  the results of questionnaire 
development and link to the completed questionnaire and accompanying scoring 
guide in the appendix. 
Chapter 6 will then conclude by drawing together all elements of the research and 
results, the implications for industry, and future research possibilities arising from the 
study. 
Chapter 7 will be dedicated to personal and professional reflection, including an 
evaluation of my progress towards the professional doctorate and the significant 
developmental steps that have occurred throughout the process. 
The methodology for part 1, the primary aim of answering the research question, can 
now be detailed in chapter 2. 
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Chapter 2 Methodology, part 1 
The aim of this chapter is to provide the methodology used to investigate the effects 
of occupational respiratory exposure to chemicals in the fragrance industry on lung 
function, and so answer the research question:  
In fragrance industry employees, is occupational respiratory exposure to chemicals 
linked to a statistically significant change in lung function as measured using 
spirometry? 
This will be achieved by detailing all aspects of study design, planning and 
organisation. 
 
2.1 Study design 
The outcome(s) were measured using numerical spirometric data, therefore the 
study was designed using quantitative methodology. 
 
The type of study design used must provide the most appropriate and suitable 
method of answering the type of research question, and must also be feasible and 
practical in the intended setting. Using an inappropriate design not only wastes time 
and funding, but could also give misleading results and render the entire process 
meaningless (Petrie & Sabin, 2005, p.30). An understanding of the nature, benefits 
and disadvantages of each type of study is critical to the whole research process 
(Gordis, 2009, p.166), so consideration was given to each study type in turn. Three 
main types of study design can be used for quantitative research, as shown in table 
2.1. 
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Table 2.1: Types of quantitative study design 
Type of study Example 
Observational, descriptive Cross-sectional 
Case study / case report, case series 
Observational, analytical Case-control 
Cohort (prospective) 
Cohort (retrospective) 
Cross-sectional with controls 
Experimental Randomised controlled trial 
 
As this study will be looking at occupational exposure rather than an intervention, an 
experimental design such as a randomised controlled trial would be unsuitable, as it 
would be unethical to purposely expose individuals to a hazard (Petrie & Sabin, 
2005, p.30). The observational types of design will be considered in turn, enabling 
the selection of the most appropriate design (Crombie & Davies, 1996, pp.168-9). 
● Cross-sectional: carrying out a ‘snap-shot’ study gives rapid results and is 
inexpensive. Although useful in determining prevalence, the lack of a control group 
means that a causal relationship between the exposure and outcome(s) of interest 
cannot be investigated (Mann, 2003; Monson, 1990, pp.144-147), and so this type of 
design would not be effective in answering the research question. 
● Case studies / case series: while case studies are inexpensive and can give 
detailed information on the clinical progress of a disease or condition and response 
to treatment, this type of study is not suitable for investigating and answering formal 
research questions (Crombie & Davies, 1996, pp.79-84). 
● Case-control: usually retrospective, this type of study matches a case group (those 
with the outcome) and a control group (those without the outcome) and compares 
historical exposure to the variable of interest between groups (Mann, 2003; Gordis, 
2009, pp.177-178). This type of study is particularly effective when investigating rare 
diseases or conditions (Mann, 2003). A retrospective approach, however, can make 
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it difficult or impossible to control for confounding variables (Crombie & Davies, 
1996, p.152; Mann, 2003). Also, a case-control study designed to answer this 
research question would require the recruitment of a sufficient number of industry 
employees with either a reduced lung function or a specific respiratory condition 
such as asthma, and a similar number of control employees without the outcome, 
and acquiring historical exposure data. This approach was felt to be impractical to 
answer this specific question. 
● Cohort study: these studies typically require a large sample size and take place 
over a lengthy timescale, often several years (Gordis, 2009, p.169). While the idea of 
following a cohort of industry employees over many years to monitor lung function is 
an attractive one, it is not feasible given the time and budgetary constraints of this 
study.  
● Cohort study (retrospective): this approach modifies the standard cohort study to 
use historical data already collected for other purposes (Mann, 2003; Gordis, 2009, 
pp.170-171). This has the advantage of being more rapid and less expensive than a 
prospective cohort study, although controlling for confounding variables can be 
difficult or impossible (Mann, 2003). It would be possible to use historical spirometric 
data from the researcher’s workplace collected as part of the occupational health 
service; however, the limitation on demographic data would make controlling for 
confounding factors difficult. The main issue with this study type, however, would be 
population size; the population at a single fragrance production site would not be 
sufficient to conduct a viable study. 
● Cross-sectional with controls: modifying a cross-sectional study design to add a 
control group (Monson, 1990, pp.144-147) elevates the design from a descriptive 
study to an analytical methodology. In the context of answering this specific research 
question, this design has the benefit of a basic ‘case-control’ structure, with the 
statistical analysis options this gives, and also the shorter timescale offered by a 
cross-sectional study. This was the most appropriate study methodology.  
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The selected design was therefore a cross-sectional study with controls: 
• exposed group: employees using chemicals as part of their daily working routine 
(fragrance production employees such as compounders, and associated functions 
such as packers). 
• non-exposed group (controls): employees not using chemicals as part of their daily 
working routine (office-based staff, e.g. customer services, finance, human 
resources, for example). 
Recruiting a control group from within industry ensures that the study remains 
relevant to the fragrance industry, and that recruitment of a sufficient number of 
controls can realistically be achieved within the organisational requirements of the 
study. This also minimises potential selection bias resulting from the ‘healthy worker 
effect’ (Monson, 1990, p.114; Leonard, Kreckmann, Sakr & Symons, 2008; Shah, 
2009; Le Moual, Kauffmann, Eisen & Kennedy, 2008). 
 
2.2 Outcome measurements (spirometry) 
The spirometric measurements used were forced expiratory volume in one second 
(FEV1), forced vital capacity (FVC) and peak expiratory flow (PEF). These are 
standard measurements used when assessing and reporting on lung function (Berry, 
Bhagat, Ajelabi & Petrini, 2008; Downs et al., 2005; Jakubowski, Abramowska-
Guzik, Szymczak & Trzcinka-Ochocka, 2004; Kezunovic, 2008; Kumar et al., 1995; 
Marcon et al., 2009; Osman & Pala, 2009; Quanjer et al., 1993; Wang, Avashia & 
Petsonk, 2009).  
Measurements taken were converted to a percentage of the predicted values for 
each participant. The predicted values were taken from the European Community for 
Steel and Coal Working Party Report (Quanjer et al., 1993), these are the standards 
used in European spirometric assessments. Each participant’s age, height and 
gender can be factored in, and a predicted value given based on these variables. 
Each outcome measurement can then be expressed as percentage-of-predicted 
(%pred). This method ensures standardisation of measurements for all outcome 
measures, and also accounts for three potential confounding factors at the data 
collection stage (age, height and gender).  
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A further correction factor was applied to the predicted figures for FEV1 and FVC for 
participants of African ethnic origin, as recommended by Quanjer et al. (1993), to 
account for the proportionate difference in trunk length – and therefore lung size – 
relative to height in those individuals. An adjustment of 0.87 was made, i.e. predicted 
value x 0.87 to give a predicted value adjusted for ethnicity in addition to age, height 
and gender; this adjustment was made for 6 participants.  
The outcome sought using spirometric measurements was a change in spirometric 
performance over the course of a working shift. Such cross-shift change has been 
used as a measurement tool in many similar studies in other industries, often 
referred to as cross-shift decline or cross-shift decrement. The term ‘cross-shift 
change’ is preferred here, as the outcome sought was any significant change in 
spirometric measurements, whether that change is a decline or an increase. 
Reversible obstruction observed across a working shift in this context would be 
defined as work-related asthma. This may be an aggravation of a pre-existing 
condition (work-aggravated asthma), or directly induced by occupational exposure 
(occupational asthma) (Nicholson, Cullinan, Burge & Boyle, 2010, p.4; Vandenplas & 
Malo, 2003). If occupational asthma were to be observed in this study, it is unlikely to 
result from a sensitising reaction, as known respiratory sensitisers are not used in 
the production of fragrance compounds; if observed, this would almost certainly be 
irritant-induced. Distinguishing between the variant types of work-related asthma 
does not fall within the scope of this study, however, nor does clinical diagnosis. 
Although spirometry is often used in health surveillance, these measurements can 
have a low sensitivity in detecting reversible airway obstruction, leading to false 
negatives (Nicholson et al, 2010, p.18, p.21). Serial peak flow readings may be more 
effective in detecting such obstruction; the minimum criteria required to achieve 
optimal diagnostic accuracy, however, is ≥4 readings per day for a period of at least 
3 weeks (Nicholson et al, 2010, pp.21-22; Anees, Gannon, Huggins, Pantin & Burge, 
2004; Malo et al, 1993). This is not feasible within the organisational constraints of 
this study. Cross-shift change as measured using spirometry was selected for this 
study, as used in a number of similar occupational studies (Mandryk, Alwis & 
Hocking, 1999; Abramson et al., 2001; Park et al., 2007; Raulf-Heimsoth et al., 2007; 
Fell et al., 2011).  
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A further point regarding spirometry is the risk of false positives arising from poor 
subject technique (Nicholson et al, 2010, p.18; Kraw & Tarlo, 1999). This can be 
prevented by ensuring that data collection is carried out by an experienced 
competent individual, and by taking repeated measurements. Ensuring that all data 
collection is carried out by the same individual (the researcher) using the same 
equipment and protocol will also minimise measurement bias (Hartman et al., 2002; 
Crombie & Davies, 1996, pp.259-260; Monson, 1990, p.138). 
Measurements were taken from each participant by the same trained and competent 
individual (the researcher) to minimise measurement bias. The spirometry equipment 
used is detailed in table 2.2; this is the spirometer used by the researcher for 
occupational health assessments, selected for its ease of use, portability and its 
proven reliability (Dirksen, Madsen, Pedersen, Vedel, & Kok-Jensen, 1996; Otulana 
et al., 1990). The spirometer was returned to the manufacturer for calibration prior to 
data collection taking place, thus ensuring the reliability of the measurements taken. 
Table 2.2: Details of the MicroPlus spirometer used for spirometric data 
collection 
Model: MicroPlus 
Type: Flow spirometer – turbine 
Portable / fixed: Portable 
Manufacturer: Cardinal Health UK 232 Ltd., Quayside, Chatham Maritime, Kent, ME4 4QY 
Supplier: Williams Medical Supplies Ltd. 
Craiglas House, Maerdy Industrial Estate, Rhymney, Gwent, NP22 5PY 
Measurements 
taken: 
FEV1 - forced expiratory volume in one second (litres) 
FVC - forced vital capacity (litres) 
FEV1/FVC - ratio of FEV1 to FVC 
PEF - peak expiratory flow (litres/min) 
Calibration: Once annually, by manufacturer 
 
The procedure followed for spirometric data collection is as described in the 
spirometry measurement protocol used at the researcher’s workplace (appendix 
entry 6); Johns & Pierce, 2007; Miller et al, 2005b). 
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2.3 Bias 
Biases inherent to a study must be acknowledged and controlled in order for the 
study to produce valid results (Hartman, Forsen, Wallace & Neely, 2002; Crombie & 
Davies, 1996, pp.256-262; Monson, 1990, pp.34-37). 
The types of bias relevant to this study are summarised in table 2.3, along with 
measures taken to minimise their effects. 
Table 2.3: Types of bias 
Bias Measure(s) taken 
Sampling / 
selection bias 
Selection of the most appropriate study design to answer the research 
question (section 2.1) (Hartman et al., 2002) 
Clearly defined eligibility and exclusion criteria prior to recruitment 
(section 2.6) (Hartman et al., 2002; Monson, 1990, p.35) 
Recruitment of control group (non-exposed) from the same industry 
Measurement bias Data collection methods clearly defined in advance, as part of the study 
design (section 2.7) (Hartman et al., 2002) 
The same (trained and competent) individual was responsible for 
spirometric measurements; procedure used was identical for exposed 
and control groups (Hartman et al., 2002; Crombie & Davies, 1996, 
pp.259-260; Monson, 1990, p.138) 
Same equipment was used for measurements; reliable, maintained, 
calibrated (Crombie & Davies, 1996, pp.259-260) 
Recall bias Questions (e.g. on smoking habits) on data collection sheet were written 
to be easy to understand and sensible; the data collection sheet was 
piloted pre-study to ensure ease of completion 
Confounding Relevant information on potential confounding factors was acquired via 
data collection sheets and/or during assessments (section 2.7) 
(Monson, 1990, pp.34-35) 
Potential confounding factors were adjusted for using appropriate 
statistical analysis methods (section 2.8) 
Use of percentage-of-predicted values controlled for certain potential 
confounders (age, height, gender) (Quanjer et al., 1993) 
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2.4 Sample size 
The minimum sample size required for the study was calculated as shown in table 
2.4, below (also see appendix entry 7). 
 
Table 2.4: Minimum sample size required for study 
Power Significance Effect size Sample size 
80% 5% 7% or greater* 108 
80% 5% 6% or greater 126 
90% 5% 6% or greater 168 
*i.e. the cross-shift decline measured in an individual must be 7% or greater to be considered 
important. 
 
Sample size calculations were performed by University of Portsmouth statistician, Dr. 
Reuben Ogollah. The effect size of clinical significance for cross-shift change in 
spirometric measurements was set at ≥6%, to be greater than the 5% variance limit 
for acceptable repeatability criteria (Miller et al, 2005b; Quanjer et al, 1993). 
Minimum sample size for 80% power and 5% significance was calculated as 126. 
Recruitment gave an initial sample size of 125 (prior to subsequent withdrawals and 
exclusions, see section 2.6), so a post-hoc sample size calculation was performed 
by the statistician using an effect size of ≥7%, which gave a lower minimum sample 
size of 108. 
Sample sizes in similar cross-sectional respiratory studies in other industries ranged 
from 75 (Fishwick et al, 2004) to 2639 (Musk et al, 2000). Given the initial 
recruitment of 125 participants, a final sample size of ≥108 was an achievable target. 
Details of the phased recruitment strategy are given in section 2.6. 
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2.5 Ethics and governance 
Ethical review 
Ethical approval was sought from the Research Ethics and Peer Review Committee, 
School of Health Sciences and Social Work (SHSSW), University of Portsmouth. 
Formal approved was granted in July 2011 (appendix entry 8). 
Ethics 
Ethical issues to consider when planning this study were: 
● confidentiality: measures undertaken to ensure confidentiality (Department of 
Health, 2005, pp.30-32) are outlined below. 
- anonymisation: each participating company was allocated a reference 
number (site 1, site 2 etc.). Company names or other identifying 
characteristics such as location were not revealed to other parties, and are 
not stated in the presentation or dissemination of results. Participants were 
each allocated a reference number, and these numbers were used for 
electronic data entry. It is not possible to identify individuals from these 
numbers. 
- data storage (electronic): for the duration of the study, all electronic data 
acquired from study participants will be stored on a personal laptop 
computer that is password-protected. Following the completion, 
presentation, dissemination and defence of the study, all such electronic 
data will be deleted. 
- data storage (hard copy): for the duration of the study, all completed 
spirometry data-entry forms, data collection sheets and other material 
such as appointment schedules will be stored in a locked cabinet to which 
only the researcher has a key. No other individual shall have access to this 
material. Following the completion, presentation, dissemination and 
defence of the study, all such material will be either destroyed or returned 
to the participant, by individual preference. 
Figure 2.1 shows how confidentiality was maintained. 
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● ensuring free and informed consent: an information sheet (appendix entry 9) was 
prepared and given to suitable employees to allow informed consent. Individuals 
expressing an interest were then given a consent form (appendix entry 10) and data 
collection sheet (appendix entry 5). Both the employee information sheet and 
consent form clearly state that the participant may withdraw from the study at any 
time without giving a reason. Free consent was ensured at the beginning of the data 
collection appointment, when each participant was advised verbally that participation 
was voluntary and they were under no obligation (or pressure from their employer) to 
proceed further.  
● worrying employees: it was possible that some employees may have become 
worried by the implied risks resulting from their occupational exposure. Any queries 
of this nature were discussed confidentially during appointments; indeed, many 
participants were reassured by this novel research taking place within their industry, 
and understood that the research was beneficial to them as a workforce. 
Stored on personal laptop computer 
(password-protected) 
Each participating company 
allocated a numeric identifier 
Each participating individual 
allocated a reference number 
Completion, presentation, dissemination 
and defence of the study 
Data storage (electronic) 
DELETED Participant’s choice 
DESTROYED by the 
researcher 
Data storage (hard-copy) 
Stored in locked cabinet (to which only the 
researcher has a key) 
Completion, presentation, dissemination 
and defence of the study 
RETURNED to the 
participant 
Figure 2.1: Confidentiality process map 
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● worrying employers: it was also possible that employers may have been reluctant 
to participate due to a fear of the consequences of a negative relationship between 
exposure and lung function being found. A presentation was given by the researcher 
to a meeting of the International Fragrance Association, United Kingdom (IFRA-UK) 
Executive Committee, to provide information on the research prior to formal 
invitations. It was made clear that if a negative relationship was found, this would 
suggest that improvements were necessary, and those improvements would improve 
the health of the workforce and would show concrete evidence to enforcing bodies 
(e.g. Health and Safety Executive) that exposure was being investigated and acted 
upon. Ultimately, however, this may have been a factor in the decision of some of 
the invited companies not to participate. 
● conflict of interest: all material relating to the research study was given University 
of Portsmouth headers, and it was made clear to invited companies that for the 
purposes of the study, the researcher should be considered as a researcher affiliated 
with the university, rather than an employee of one particular company. A 
confidentiality agreement was also prepared (appendix entry 11), and was signed by 
a representative from each participating company. 
● dealing with an issue/referral: any spirometric results which suggested a restricted 
lung function would at first be discussed confidentially with the individual. A 
confidential letter would then be provided by the researcher summarising the results, 
for the individual to discuss with their general practitioner. The individual would also 
be offered confidential follow-up contact with the researcher to further discuss the 
issue. 
 
Governance 
Effective research governance requires that research is conducted according to 
general principles of good practice, ensuring the quality of the research and the 
safety of participants (Department of Health, 2005). The responsibilities of the 
researcher’s employer as the employing organisation and the sole funder of the 
study are outlined in table 2.5 (adapted from Department of Health, 2005, pp.23-24; 
text marked in italic are direct quotations). 
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Table 2.5: Responsibilities and actions of the researcher’s workplace towards 
research governance 
 Responsibility Action (individual) 
Employing 
organisation 
Ensuring researchers 
understand and discharge their 
responsibilities 
Regular discussions and 
progress updates with 
researcher (AC*, BW**) 
 
Ensuring studies are properly 
designed and submitted for 
independent review 
Checked that ethical review was 
sought and approved (AC) 
 
Ensuring studies are 
managed…as agreed 
Regular discussions and 
progress updates with 
researcher (AC, BW) 
Funder / 
sponsor 
Assessing the scientific quality 
of the research as proposed 
Discussions with researcher 
during planning stages (AC) 
 
Establishing the value for 
money of the research as 
proposed 
Assessing and approving 
funding and expenses requests 
(AC, GE***) 
 
Considering the suitability of 
the research environment 
Discussions with researcher 
during planning stages, following 
site visits (AC, BW) 
 
Confirming that everything is 
ready for the research to begin 
Progress updates, providing 
funds for equipment and 
sundries, confirming travel 
arrangements etc. (AC, GE) 
*Anne Connet, Regulatory Manager, CPL Aromas, Brixworth (workplace supervisor). 
**Brian White, Q-SHE Manager, CPL Aromas, Brixworth (workplace supervisor). 
***George Ewen, Production Director, CPL Aromas, Brixworth (head of establishment). 
 
2.6 Recruitment 
The study population was employees working within the fragrance industry, so all 
fragrance companies with a production site in the UK were invited to participate. 
Individual recruitment then took place in those companies agreeing to take part. 
Conducting a multi-site study ensured that a sufficient sample size could be 
achieved, and also ensured that the population was representative of the UK 
fragrance industry as a whole.  
Page | 43  
 
Recruitment of participants was achieved via a phased process, as shown in figure 
2.2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*International Fragrance Association, United Kingdom 
Company willing to participate 
PHASE 3: RECRUITMENT OF INDIVIDUALS 
Company contact distributes information sheets to suitable employees (Aug/Sep 2011) 
PHASE 2: RECRUITMENT OF COMPANIES 
Site visit with company contact to discuss requirements and individual recruitment. 
Collect signed acceptance form and confidentiality agreement (Jul/Aug 2011) 
Figure 2.2: Phased recruitment strategy 
Company declines 
Employee willing to participate Employee declines 
Company contact distributes consent forms and data collection sheets (Sep/Oct 2011) 
PHASE 4: EXCLUSIONS / WITHDRAWALS 
Site visits for data collection appointments (Oct/Nov 2011) 
PHASE 1: AWARENESS 
Presentation to IFRA-UK* (Mar 2011) 
Invitation packs sent to employers (May 2011) 
Follow-up contact via telephone and email (Jun/Aug 2011) 
 
5 companies agree to take part; 
Total population = 398 
n = 125 
Employee willing to 
participate 
Employee no longer 
willing to participate WITHDRAWN = 10 
1
st
 appointment, beginning of shift: contraindications for spirometry checked 
No contraindications One or more 
contraindications 
EXCLUDED = 3 FINAL SAMPLE 
SIZE: 
n = 112 
n = 115 
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Recruitment phase 1: Awareness 
Phase 1 was intended to promote awareness of the aims, justification and 
methodology of the study in advance of formally inviting companies to participate. 
This involved: 
• giving a presentation to a meeting of the International Fragrance Association, 
United Kingdom (IFRA-UK) Executive Committee 
• sending official invitation packs to suitable companies (appendix entry 12).  
 
Recruitment phase 2: Recruitment of companies 
The purpose of phase 2 was to acquire definitive signed agreements from 
participating companies. This involved: 
• repeated follow-up of invitations via telephone and email 
• establishing contact with an individual from each company to sign relevant forms 
and assist in individual recruitment 
• return of signed acceptance forms (appendix entry 13) and confidentiality 
agreements from participating companies. 
 
Recruitment phase 3: Recruitment of individuals 
The purpose of phase 3 was to finalise a list of participants from each site and 
arrange data collection appointments. This involved: 
• arranging site visits with the contact at each company to discuss requirements and 
individual recruitment 
• instructing the company contacts to distribute employee information sheets 
(appendix entry 9) to all suitable employees 
• instructing the company contacts to distribute informed consent form (appendix 
entry 10) and data collection sheets (see section 2.7) to individuals expressing an 
interest and giving initial agreement to participate 
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• liaising with company contacts to acquire participant lists and arrange an 
appointment schedule for data collection. 
 
Recruitment phase 4: Exclusions and withdrawals 
Withdrawals: of the total number of individuals who were initially willing to take part 
(125), 10 subsequently decided to withdraw from the study prior to assessments 
taking place.  
Exclusions on medical grounds: contraindications for performing the spirometric 
procedure were used as exclusion criteria. Examples of such contraindications are 
recent surgery, pneumothorax, heart attack, stroke, aneurysm, or glaucoma (Cooper, 
2011; Miller et al, 2005a). Each participant was asked about these prior to the first 
(pre-shift) spirometric assessment being performed, and any giving a positive 
response to at least one contraindication were excluded. Three individuals were 
excluded from the study in this manner. 
Ten companies were identified as suitable for participation and approached to take 
part in the study. Of these, five companies agreed to participate. Individual 
recruitment over the five sites as described above gave a final sample size of 112. 
 
The comparison of response rates between groups (Table 2.6) shows that the 
response rate was higher in the exposed group but the difference did not reach the 
standard level of statistical significance (p = 0.066). 
Table 2.6: Cross-tabulation showing comparison of response rate between 
groups 
 Response rate Pearson Chi-square 
 Participants Non-
participants 
Total Value df p-value 
Group Exposed 60 (32.6%) 124 184 3.38 1 0.066 
Control 52 (24.3%) 162 214    
Total 112 (28.1%) 286 398    
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2.7 Data collection 
Spirometry 
Spirometric assessments were conducted on each participant prior to beginning a 
working shift and at the end of a working shift, with such a shift consisting of ≥6 
hours. A cross-shift change was then calculated from the pre-shift and post-shift 
measurement.  
 
Figure 2.3 shows the spirometric data collection process.  
 
 
 
 
 
 
 
 
 
All assessments were conducted by the researcher over a six week period of site 
visits during October and November 2011. This was as narrow a time window as 
could be arranged for organisational reasons, as the researcher was required to be 
personally present to conduct the assessments during each site visit. 
 
Potential confounding factors 
Potential confounding factors (table 2.6) were selected using the following criteria: 
● potentially associated with the outcome (change in lung function), and either: 
CONTROLS 
(fragrance industry employees 
NOT using chemicals, n=52) 
EXPOSED  
(fragrance industry employees 
using chemicals, n=60) 
%pred (pre-shift) 
%pred (post-shift) 
%pred (pre-shift) 
%pred (post-shift) 
∆%pred 
∆%pred 
Figure 2.3: Spirometric data collection process 
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● physical data – a physical factor that can be measured rapidly and non-invasively 
by the researcher during data collection appointments, or: 
● demographic data – lifestyle or historical information that can be recorded by a 
participant on a questionnaire or form. 
 
Table 2.7: Potential confounding factors 
Factor Information acquired Literature 
Smoking Questionnaire/form* Vollmer et al., 2000; Downs et al., 
2005; Urrutia et al., 2005; Clennell et 
al., 2008 
Personal history 
of respiratory 
problems 
Questionnaire/form* Hersh et al., 2011; McCloskey et al., 
2001; Sly, 2011; Tennant, Gibson & 
Pearce, 2008 
 Family history of 
respiratory 
problems 
Questionnaire/form* 
Body mass index 
(BMI) 
Measured during 
appointment+ 
Wood, Attia, McElduff, McEvoy & 
Gibson, 2010; Thyagarajan et al., 
2008; Eisner et al., 2007 
*information provided by participants on data collection sheets 
+calculated by the researcher from physical data recorded during assessments 
 
Physical data 
Physical data was measured and recorded by the researcher during the pre-shift 
spirometric appointments. Height was measured using a stadiometer; participants 
were asked to remove shoes and caps. Weight was measured using a digital scale; 
participants were asked to remove shoes and protective clothing such as high-
visibility vests and jackets. Body mass index (BMI) was calculated from standing 
height and weight (BMI = weight[kg] / height[m]2[National Heart, Lung and Blood 
Institute, 1998]). 
Spirometric data and physical data were recorded on a results form, which the 
participant was asked to sign (appendix entry 14). 
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2.8 Statistical analysis 
The statistical package Predictive Analytics SoftWare Statistics (PASW [Predictive 
Analytics SoftWare] Statistics version 18.0 for Windows, release 18.0.0 [July 30, 
2009]) was used for all statistical calculations. An electronic PASW data file was 
created containing spirometric data and data on potential confounding factors. 
Analysis of covariance (ANCOVA) was used to compare each outcome measure 
between the exposed and control groups. The ANCOVA model was fitted as 
described in table 2.24 below, following the advice of University of Portsmouth 
statistician, Dr. Reuben Ogollah. Modelling the analysis in this way – using the post-
shift measurement as the response variable and the pre-shift measurement as a 
covariate – accounts for variability in the baseline measurement (Robins et al., 1997; 
Christiani et al., 1994; personal communication, March 02, 2012). Further analysis 
can be conducted using the potential confounding factors identified earlier as 
additional covariates. 
Table 2.8: Modelling the statistical analysis 
Analysis: ANCOVA (unadjusted) 
Response variable: FEV1* post-shift %predicted 
Fixed factor: Case or control 
Covariate: FEV1* baseline (pre-shift) %predicted 
Analysis: ANCOVA (adjusted) 
Response variable: FEV1* post-shift %predicted 
Fixed factor: Case or control 
Covariates: FEV1* baseline (pre-shift) %predicted 
Smoking 
Personal history of respiratory problems 
Family history of respiratory problems 
Body mass index 
*FEV1 is used as an example here; the same procedure was carried out for the other outcome 
measures, FVC and PEF. 
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Summary 
This chapter has detailed all aspects of the research methodology used to answer 
the research question formalised in chapter 1. The results of the research study 
conducted in accordance with this methodology are reported in the next chapter, 
chapter 3. 
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Chapter 3 Results and discussion, part 1 
The aim of this chapter is to answer the research question defined in chapter 1. 
Research question: In fragrance industry employees, is occupational respiratory 
exposure to chemicals linked to a statistically significant change in lung function as 
measured using spirometry?  
This will be achieved by: 
● exploring the demographics of the study participants;  
● performing analysis of covariance (ANCOVA) using the spirometric data; 
● discussing the findings in relation to the research question. 
 
3.1 Demographics 
Demographics – results  
Gender of the exposed group was almost exclusively male (96.7% male vs. 3.3% 
female), while in the control group gender was close to equal distribution (51.9% 
male vs. 48.1% female) (table 3.1). 
Age of the participants was well-matched across the study groups, with a mean age 
of 43.6 (range 21-65) for the exposed group and 43.9 (range 22-66) for the controls 
(table 3.1), with a total mean age of 43.7 years (range 21-66) for the whole study 
population. The difference in means between groups was not significant. 
The exposed group were significantly taller than the controls, with mean heights of 
1.76m (SD 0.06) and 1.71m (SD 0.09), respectively (p = 0.004) (table 3.1). 
There was no significant difference in weight and body mass index between groups. 
Mean weight was 81.5kg (SD 13.2) for exposed and 81.6kg (SD 17.2) for controls. 
Mean body mass index was 26.5 (SD 4.5) for exposed and 27.7 (SD 4.9) for 
controls. 
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Table 3.1: Characteristics of the study participants 
 Exposed Control 
Subjects, n 60 52 
Gender Male, n (%) 58 (96.7) 27 (51.9) 
Female, n (%) 2 (3.3) 25 (48.1) 
Mean age, years* (SD) 43.6 (10.4) 43.9 (11.9) 
Height, m+ (SD) 1.76 (0.06) 1.71 (0.09) 
Weight, kg* (SD) 81.5 (13.2) 81.6 (17.2) 
Body mass index, weight(kg)/height(m)2* (SD) 26.5 (4.5) 27.7 (4.9) 
Smoking status Non-smoker, n (%) 23 (38.3) 26 (50.0) 
Former smoker, n (%) 15 (25.0) 15 (28.8) 
Smoker, n (%) 22 (36.7) 11 (21.2) 
Personal history of respiratory problems, n (%) 13 (21.7) 14 (26.9) 
Family history of respiratory problems, n (%) 20 (33.3) 15 (28.8) 
*non-significant (p=>0.05) 
+p = 0.004 
 
Demographics – discussion  
The gender distribution in the exposed group is a population characteristic of the 
exposed population as a whole, as few women were observed to be working in the 
factory (exposed) areas of the participating companies. 
This unequal gender distribution is likely to be the cause of the significant difference 
in mean heights between groups, with the exposed group being significantly taller (p 
= 0.004). This difference in height has in turn affected the difference in mean body 
mass index between groups (as body mass index is calculated from height and 
weight), although this was not significant. Both group means were within the same 
category, ‘overweight’ (body mass index score of 25.0-29.9 [National Heart, Lung 
and Blood Institute, 1998]).  
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Using percentage-of-predicted (%pred) values for the spirometric outcome measures 
prevented the introduction of bias resulting from the significant difference in height 
between groups, as these %pred values account for age, height and gender. The 
unequal gender distribution between groups is therefore also accounted for. 
 
3.2 Statistical analysis 
Statistical analysis – results (cross-shift change and ANCOVA) 
The research question requires comparison of spirometric measurements between 
the exposed and control groups. Table 3.2 shows the unadjusted mean cross-shift 
change (%predicted) for each outcome measurement and the differences between 
groups.  
Table 3.2: Mean cross-shift change for spirometric outcome measurements, 
comparison between groups 
 Exposed Control Difference (95%CI) 
Mean cross-shift change,        
FEV1 %predicted* (SD) 
0.22 (4.58) -0.16 
(4.00) 
0.38 (-1.24 – 2.00)+ 
Mean cross-shift change,         
FVC %predicted* (SD) 
-1.13 (6.66) -0.60 
(4.67) 
-0.53 (-2.72 – 1.66)+ 
Mean cross-shift change,         
PEF %predicted* (SD) 
1.43 (8.45) 0.44 
(8.76) 
0.99 (-2.24 – 4.21)+ 
*Unadjusted 
+
non-significant (p=>0.05) 
 
These differences were not seen to be significant; it should be noted, however, that 
in analysing mean cross-shift change no adjustment has been made for the pre-shift 
baseline measurements. There was variance, albeit non-significant, in these initial 
baseline measurements, and so they must be adjusted for in the same manner as 
the defined potential confounding factors. (Differences between mean baseline 
measurements were not significant, although the difference in PEF approached 
significance [p = 0.064].)  
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Further detailed analysis using analysis of covariance (ANVOCA) allowed for the 
appropriate adjustments to be made, initially for the baseline measurements only, 
and then in conjunction with the additional potential confounding factors. 
 
Table 3.3 shows ANCOVA results for each outcome measure, comparing mean 
post-shift measurements between groups. (Note that values in the ‘unadjusted’ 
column have been adjusted only for the baseline pre-shift measurements.) 
Table 3.3: Analysis of covariance (ANCOVA) results, comparison between 
groups 
Outcome 
variable 
Mean post-shift 
measurement, 
%pred (SD) 
Unadjusted* Adjusted+ 
F value (df) P-value F value (df) P-value 
FEV1 cross-shift change 
Control, 
n=52 
99.0 (12.9) 0.080 
(1,109) 
0.778 0.127 
(1,105) 
0.722 
Exposed, 
n=60 
98.0 (14.5)     
FVC cross-shift change 
Control, 
n=52 
107.8 (14.3) 0.019 
(1,109) 
0.890 0.022 
(1,105) 
0.883 
Exposed, 
n=60 
105.9 (14.2)     
PEF cross-shift change 
Control, 
n=52 
103.4 (15.6) 0.014 
(1,109) 
0.906 0.176 
(1,105) 
0.676 
Exposed, 
n=60 
98.6 (16.8)     
*Adjusted for the pre-shift (baseline) measurements only 
+Adjusted for the pre-shift (baseline) measurements as well as BMI, smoking status, personal history 
of respiratory problems and family history of respiratory problems 
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Potential confounding factors – results  
The potential confounding factors selected for the study were smoking status, 
personal history and family history of respiratory problems, and body mass index. 
None of the potential confounding factors were seen to have a significant effect on 
the outcome measures (table 3.4).  
The effect of personal history of respiratory problems on FVC measurements was 
the closest to, but did not reach, statistical significance (p = 0.097). 
Table 3.4: Effects of potential confounding factors on each outcome measure* 
Potential 
confounding 
factor 
FEV1 cross-shift 
change 
FVC cross-shift 
change 
PEF cross-shift 
change 
Smoking status 
 
p = 0.648 p = 0.257 p = 0.361 
Personal history of 
respiratory 
problems 
p = 0.445 p = 0.097 p = 0.400 
Family history of 
respiratory 
problems 
p = 0.415 p = 0.227 p = 0.208 
Body mass index 
(BMI) 
p = 0.514 p = 0.964 p = 0.448 
*p-values taken from adjusted ANCOVA results 
 
With smoking status, there were differences between groups in current smokers 
(36.7% in exposed vs. 21.2% in controls) and non-smokers (38.3% in exposed vs. 
50.0% in controls). There was a smaller difference in former smokers (25.0% in 
exposed vs. 28.8% in controls). Chi-square (Pearson) of 3.30 (p = 0.192) indicated 
that the difference in smoking status between groups was not significant (table 3.5). 
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Table 3.5: Cross-tabulation showing comparison of smoking status between 
groups 
 Smoking status Pearson Chi-square 
 Non-
smoker 
Former 
smoker 
Smoker Total Value df p-value 
Group Exposed 23 15 22 60 3.30 2 0.192 
Control 26 15 11 52    
Total 49 30 33 112    
 
A greater proportion of the control group (26.9%, vs. 21.7% of exposed) declared a 
personal history of respiratory problems. The reverse was the case with declaration 
of a family history of respiratory problems (33.3% of exposed, vs. 28.8% of controls). 
These differences were not significant: Chi-square (Pearson) statistic for personal 
history was 0.42 (p = 0.517), and 0.26 (p = 0.609) for family history (table 3.6). 
Table 3.6: Cross-tabulation showing comparison of history of respiratory 
problems between groups 
 Personal history Pearson Chi-square 
 Personal 
history 
No personal 
history 
Total Value df p-value 
Group Exposed 13 (21.7%) 47 60 0.42 1 0.517 
Control 14 (26.9%) 38 52    
Total 27 85 112    
 Family history Pearson Chi-square 
 Family 
history 
No personal 
history 
Total Value df p-value 
Group Exposed 20 (33.3%) 40 60 0.26 1 0.609 
Control 15 (28.8%) 37 52    
Total 35 77 112    
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Statistical analysis – discussion (including potential confounding factors) 
 
Forced expiratory volume in 1 second (FEV1) cross-shift change 
Mean post-shift measurements were marginally lower for the exposed group 
(98.0%predicted against 99.0%predicted for controls). Adjusting for the baseline 
measurements showed that this difference was not statistically significant 
(unadjusted p = 0.778); further adjustment for potential confounding factors gave an 
adjusted p-value of 0.722. 
 
Forced vital capacity (FVC) cross-shift change 
Mean post-shift measurements were marginally lower for the exposed group 
(105.9%predicted against 107.8%predicted for controls). Adjusting for the baseline 
measurements showed that this difference was not statistically significant 
(unadjusted p = 0.890); further adjustment for potential confounding factors gave an 
adjusted p-value of 0.883. 
 
Peak expiratory flow (PEF) cross-shift change 
Mean post-shift measurements were lower for the exposed group (98.6%predicted 
against 103.4%predicted for controls). This difference between means was the 
largest of the three outcome measures. This is accounted for by the difference in 
baseline PEF measurements, which approached significance (p = 0.064). Adjusting 
for the baseline measurements showed that this difference was not statistically 
significant (unadjusted p = 0.906); further adjustment for potential confounding 
factors gave an adjusted p-value of 0.676. 
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Statistical analysis of the data acquired for the study has shown no significant effects 
of occupational respiratory exposure on the spirometric performance of the study 
population.  
ANCOVA analysis showed no significant effects in all spirometric outcome measures 
used. This is in direct contrast to the results of similar studies in other industries with 
occupational respiratory exposure, as seen in the literature review included in 
chapter 1. Significant reductions in spirometric measurements were observed in the 
wood-working industry (Osman & Pala, 2009), farming and agriculture (Rylander & 
Carvalheiro, 2006), metalworking and smelting (Fishwick et al., 2004; Johnsen et al., 
2008) and in hairdressers (Hashemi et al., 2010). Sample size (n = 112) may 
account for the lack of significant findings in comparison to other, larger studies (n = 
656, Osman & Pala, 2009; n = 3924, Johnsen et al., 2008). Many studies were, 
however, of a similar or smaller sample size (n = 100, Hashemi et al., 2010; n = 82, 
Rylander & Carvalheiro, 2006; n = 75, Fishwick et al., 2004). The lack of a significant 
effect in this study may instead be accounted for by the nature of the occupational 
hazards within the industry and the effectiveness of the protective measures in 
place. Such measures are clearly prescribed by law in the UK and subject to strict 
enforcement by a single body, the Health and Safety Executive (Home Office, 2002; 
Home Office, 1974), and so the measures are seen to be standardised in principle 
across the industry.  
The assumption cannot be made that a lack of effect signifies a lack of hazards. 
Although there is a strong argument that respiratory exposure from fragrance 
production carries far less risk than industries such as construction (Ghasemkhani et 
al., 2006; Moshammer et al., 2007), welding (Fishwick et al., 2004) or even hospital 
cleaning (Kogevinas et al., 2007; Bello et al., 2009), many fragrance chemicals do 
pose a known risk to health in the absence of any protective measures. Table 3.7 
shows the risk phrases relevant to respiratory health and the number of fragrance 
chemicals each risk phrase applies to. 
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Table 3.7: Hazard classifications relating to respiratory exposure 
Risk phrases (R-phrases)* Number of applicable chemical 
substances used at CPL Aromas+ 
R37 Irritating to respiratory system 49 
R20 Harmful by inhalation 31 
R23 Toxic by inhalation 2 
R26 Very toxic by inhalation 0 
R42 May cause sensitisation by inhalation 0 
*Home Office, 2009 
+Used as example of a typical fragrance manufacturer 
 
Two substances are classified as ‘Toxic by inhalation’; the procedure for using one of 
these substances (cresylic acid) is included in the appendix (appendix entry 15) to 
demonstrate the strict control measures in place where appropriate. 
The lack of a significant effect in this study may suggest that protective measures in 
place in fragrance manufacturing workplaces – such as the example above – are 
sufficient in preventing reduction of employees’ lung function during working hours. 
To further explore this, a multi-industry study directly comparing relative risk between 
fragrance production and other industries, similar to that conducted by Kogevinas et 
al. (2007), would be of great interest. 
A degree of unavoidable selection bias may have theoretically influenced the results, 
and must be acknowledged. Employees suffering a current episode of airways 
obstruction may have been absent from work and so not available to participate in 
the study, resulting in sampling bias due to a healthy worker effect. Furthermore, it is 
reasonable to assume that any individuals who suffer any respiratory condition may 
have previously left the industry, or chosen a different occupation altogether, and this 
may have led to survivorship bias. These selection biases may have resulted in the 
study population being biased towards those without any known respiratory 
conditions. Potential non-response bias resulting from a varying response rate was 
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not seen to be important, as the difference in response rate between groups was not 
statistically significant (Chi-square [Pearson] of 3.38, p = 0.066; see table 2.6, 
section 2.6). 
 
Potential confounding factors had no significant effect on outcome measures, in 
contrast to previous research. Smoking has been shown to significantly affect lung 
function in many previously published studies (Vollmer et al., 2000; Downs et al., 
2005; Urrutia et al., 2005; Clennell et al., 2008); the lack of a significant effect here is 
of interest, and may suggest an area for potential future research. A larger study, or 
one focussed specifically on smoking as the variable of interest, may provide further 
explanation as to why smoking was not seen to affect the outcome, as might 
reasonably be expected from previous findings. This may be a result of the 
population size; the study population here was sufficient to investigate a binary 
variable (i.e. exposed vs. non-exposed), but not to investigate smoking as the 
primary variable of interest, as the allocation of three categories (current, former and 
non-smoker) may not leave a sufficient number in each group. A larger population 
size would allow the further exploration of the effects of smoking. For example, the 
above studies used considerably larger sample sizes than this study, from n = 1792 
(Downs et al., 2005) to n = 3387 (Clennell et al., 2008). The study by Vollmer et al. 
(2000) was particularly large as this was a meta-analysis pooling the results of 8 
cross-sectional studies (total n = 40,733); a reduction in FEV1 due to smoking was 
observed, although no control groups were used.  
Body mass index (BMI) has been shown to affect lung function in previous studies 
(Wood, Attia, McElduff, McEvoy & Gibson, 2010; Thyagarajan et al., 2008), but was 
not seen to have a significant effect here. This may be due to the population size not 
allowing a large enough variance of the BMI measure to reveal any significant 
effects, although there was a reasonable spread along the range of values, with the 
only category not represented being ‘underweight’. Alternatively, it may be the case 
that BMI is not the most useful physical factor in terms of its effects on lung function, 
and an alternative such as sitting height may be more appropriate. 
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Personal and family history of respiratory problems did not have a significant effect 
on the outcome measures. Of all the potential confounding factors, the factor which 
came closest to achieving significance was personal history of respiratory problems 
and its effect on FVC (p = 0.097). Personal history of childhood lower respiratory 
tract infections was previously observed to have a negative impact on adult lung 
function (Tennant, Gibson & Pearce, 2008) and childhood asthma prevalence (Sly, 
2011). The lack of significance in this study may be due to sample size; the study by 
Tennant et al. (2008) used a sample size of n = 412, for example. Alternatively, a 
degree of recall bias is unavoidable when requesting historical information from 
participants, and this may have been a factor. 
An additional potential confounder was the length of time each participant had spent 
working in the industry. Participants remaining in the industry for longer periods of 
time may be less likely to suffer from respiratory conditions due to survivorship bias, 
or alternatively, may be more likely to suffer the effects of increasing years of 
exposure. The results may have been confounded if the length of employment 
showed a statistically significant difference between groups. 
Table 3.8 shows the comparison of means between groups. The difference was not 
statistically significant (p = 0.273). 
Table 3.8: Mean time working in fragrance industry (years), comparison 
between groups 
 Exposed Control P-value 
Mean length of time working in 
fragrance industry (years) (SD) 
13.7 (9.8) 15.8 (10.1) 0.273 
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Summary 
Point summary (part 1) 
● Using statistical analysis to answer the research question, no significant effects of 
occupational respiratory exposure were observed on the spirometric performance of 
the study population. The alternative hypothesis must be rejected, and the null 
hypothesis must be accepted: 
In fragrance industry employees, occupational respiratory exposure to chemicals is 
not linked to a statistically significant change in lung function as measured using 
spirometry. 
● Smoking status, body mass index, personal and family history of respiratory 
problems were not observed to significantly affect the outcome measurements. The 
effect of personal history on FVC was the closest to – but did not reach – a 
statistically significant effect size.   
● Acceptance of the null hypothesis suggests that protective measures in place in 
fragrance manufacturing workplaces are sufficient in minimising occupational risk to 
respiratory health, and so are effective in preventing reduction of employees’ lung 
function during working hours.  
 
This chapter has reported the results of the study designed to answer the research 
question, and shown that the null hypothesis must be accepted. Chapters 4 and 5 
will report the methodology and results of the second part of this body of work, the 
development of the predictive pre-placement questionnaire. The results of both parts 
will be further discussed and summarised in chapter 6. 
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Chapter 4 Methodology, part 2 (questionnaire development) 
The aim of this chapter is to provide the methodology behind the development of a 
pre-placement predictive questionnaire. This will be achieved by:  
● describing the phased process of creating a data collection sheet (informed by 
published literature and existing questionnaires) to acquire information towards the 
development of a predictive questionnaire;  
● describing the process used to develop the predictive questionnaire from the 
spirometric and demographic information acquired. 
 
4.1 Rationale 
The aim of part 2 of this research is to additionally use the spirometric data collected 
from participants, along with demographic and physical data, to develop a pre-
placement questionnaire that is predictive for lung function impairment. This 
questionnaire is intended to fulfil this function specifically within the fragrance 
industry, developed to be representative of its target population. 
The pre-placement questionnaire was developed by exploring spirometric data 
alongside demographic and physical data collected from the participants and using 
these to select questions for inclusion on the final questionnaire and develop an 
appropriate weighting system. A phased approach was used in the development of 
the pre-placement questionnaire (figure 4.1). 
FEV1 pre-shift measurements collected for part 1 were used as the spirometric data 
for questionnaire development. The collection of demographic and physical data for 
use towards questionnaire development required the construction of data collection 
sheets, informed by published literature and existing questionnaires. The phased 
methodology used to develop the final pre-placement questionnaire is outlined in 
subsequent sections. 
 
 
 
Page | 63  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Literature review Existing questionnaires 
Data collection sheets 
Factors selected / excluded 
Physical data measured 
Participants complete data collection sheets 
Figure 4.1: Phased strategy for questionnaire development 
Pilot data collection sheets 
Analysis of factors and spirometric data 
Spirometric data measured 
Final questionnaire assembled 
Factors thematically organised 
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4.2 Data collection sheets (questionnaire development phase 1) 
The purpose of phase 1 (figure 4.1) was to construct data collection sheets in order 
to collect demographic data from study participants. A literature review was 
conducted to inform development of the sheets by critically evaluating existing 
research and identifying factors which were observed to influence lung function. 
 
Literature review 
Factors with an observed or potential influence on lung function: a review of 
the literature 
Methods 
Data collection 
Search strategy 
A systematic search was conducted using relevant keywords combined into search 
strings as shown in table 4.1. 
Table 4.1: Keywords and search strings used in systematic search 
Keywords: factor / factors cause trigger 
Search string: factor* OR cause OR trigger 
Purpose: synonyms for underlying causal factor being investigated 
Keywords: Influence impact affect effect 
Search string: Influence OR impact OR affect OR effect 
Purpose: Synonyms for effect of the causal factor being investigated 
Key-words: lung function spirometry spirometric FEV+ 
Search string: “lung function” OR spirometr* OR fev* 
Purpose: measurements used in assessing respiratory effects 
+forced expiratory volume. Commonly measured and expressed as FEV1, (forced expiratory volume in 
one second), alternatives such as FEV0.4 are occasionally used. 
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Search strings were combined using the Boolean operators AND and/or OR in order 
to broaden or narrow the search as necessary. The search terms above were used 
for an initial search, with subsequent refinements as necessary to give sufficient yet 
manageable results. Table 4.2 shows the databases used for the literature search, 
refined search terminology and the number of results retrieved. 
Table 4.2: Search strategy, showing databases and search terms used, 
alongside initial and relevant results 
Database Refined search terms Initial 
results 
Relevant 
results 
SSCI  
(Social Sciences 
Citation Index) 
(factor* OR cause OR trigger) in 
Topic AND (influence OR impact 
OR affect OR effect) in Topic AND 
(“lung function” OR spirometr* OR 
fev) in Title 
323 19 
PubMed (influence OR affect OR effect) 
AND “lung function” in Title 
428 10 
CINAHL  
(Cumulative Index to 
Nursing and Allied 
Health Literature) 
(factor* OR cause OR trigger) AND 
(influence OR impact OR affect OR 
effect) AND (“lung function” OR 
spirometr* OR fev) in Abstract 
180 
 
7 
Cochrane 
Reviews 
(factor* OR cause OR trigger) AND 
(influence OR impact OR affect OR 
effect) in Title, Abstract or 
Keywords, AND (“lung function” OR 
spirometr* OR fev) in Record Title 
121 3 
Science Direct (factor* OR cause OR trigger) AND 
(influence OR impact OR affect OR 
effect) AND (“lung function” OR 
spirometr* OR fev) in Abstract 
427 7 
(duplicates) 
 
Selection 
The following inclusion criteria were used to select relevant articles from initial 
results: 
• must be written in the English language; 
• must provide statistically significant evidence for a factor with an influence on lung 
function; 
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• the causal factor investigated must be either:  
- information that can be accurately recalled by a study participant (e.g. 
smoking habits, childhood illness), or: 
- data that can be non-invasively measured by a researcher (e.g. body 
mass index); 
• quality of study design was appraised using appraisal checklists developed by the 
Critical Appraisal Skills Programme (CASP) (Public Health Resource Unit, 2004a; 
Public Health Resource Unit, 2004b); studies considered to be poorly designed were 
excluded (CASP checklists are included as appendix entries 1 and 2). 
The total number of relevant articles included in this review was 39. 
 
Data analysis 
Factors identified from selected articles were organised into groups, to allow 
evidence for each factor to be evaluated concurrently. The grouping method used 
was taken and adapted from a thematic analysis process (Braun & Clarke, 2006). 
Although typically used for qualitative research analysis, this method was 
appropriate in this case, facilitating the organisation of identified substances into sub-
groups and larger overarching ‘theme’ groups. 
The factors identified from the selected articles were organised into four ‘theme’ 
groups, which will be considered in turn: lifestyle factors and lung function; 
environmental factors and lung function; occupation and lung function; and physical 
factors and lung function. 
 
Results 
1. Lifestyle factors and lung function 
Sub-category: smoking 
Table 4.3 summarises information on the factor(s) allocated to this sub-category. 
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Table 4.3: Summary of studies, smoking and lung function 
Exposure 
/ factor 
Type of study Sample 
size 
Measure  
(exposure) 
Measure 
(outcome) 
Results / significance 
Smoking & 
ethnicity 
Retro cohort (Berry, 
Bhagat, Ajelabi & Petrini, 
2008) 
n=216 Self-reported Lung function 
decline, FEV1, FVC 
No difference in results when ethnic reference equations 
used 
Pooling of cross-sectional 
analyses (Vollmer et al., 
2000) 
8 studies, 
total 
n=40733 
Self-reported Lung function 
decline, FEV1   
No difference between black and white smokers;                      
Difference between whites and Asians/Pacific Islanders 
(men), p = <0.05 
Smoking & 
gender 
Cohort (Downs et al., 
2005) 
n=1792 Self-reported Lung function 
decline, FEV1   
Both genders showed significant mean annual decline (p 
=<0.001), females showed greater decline; female quitters 
showed less mean annual decline than persistent 
smokers (p = 0.05), not sig. in males (p = 0.49) 
Smoking Cohort (Belousova, Haby, 
Xuan & Peat, 1997) 
n=1499 Self-reported Lung function 
decline, FEV1, 
PEFR, FEF25-75%   
FEV1 decline not significant (p = 0.53); PEFR sig. decline        
(p = <0.05); FEF25-75% sig. decline (p = <0.05) 
Cohort (Jaakkola, Ernst, 
Jaakkola, N’gan’ga & 
Becklake, 1991) 
n=391 Self-reported Lung function 
decline, FEV1 
Significant decline (p = 0.04) 
Retro cohort (Wang, 
Avashia & Petsonk, 2009) 
n=1884 Self-reported Lung function 
decline, FEV1 
Significant decline in males (p = <0.0001); no sig. decline 
in females 
Cohort (Clennell et al., 
2008 
n=3387 Self-reported Lung function 
decline, FEV1 
Decline significantly faster in current smokers vs. never 
smokers (8.4 mL/y faster, 95%CI -12.0 - -5.0) 
Cross-sectional (Urrutia et 
al., 2005) 
n=2647 Self-reported Lung function 
decline, FEV1 
Significant decline, p = 0.03 (10-20 cigarettes/day), p = 
<0.01 (>20 cigarettes/day) 
Initiation 
<15 years 
Cohort (Apostol et al., 
2002) 
n=3901 Self-reported Lung function 
decline, FEV1 
Significant decline (p = 0.01); not sig. after adjusting for 
current smoking 
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Smoking status was observed to have a negative influence on lung function in  
a number of studies (Vollmer et al., 2000; Downs et al., 2005; Belousova et al., 1997; 
Jaakkola et al., 1991; Wang et al., 2009; Clennell et al., 2008; Urrutia et al., 2005; 
Apostol et al., 2002).  
 
A small retrospective cohort study (n = 216) compared the effects of smoking on lung 
function between two ethnic groups (Berry et al., 2008). A difference between means 
of 0.39L for forced expiratory volume in one second (FEV1) (p = 0.002) and 0.59L for 
forced vital capacity (FVC) (p = 0.001) was found in African-American smokers vs. 
white smokers. There were, however, no statistically significant differences when the 
data were converted to percentage-of-predicted (%pred) values using equations that 
allow racial differences to be accounted for. This is in line with guidance for 
interpreting lung function results (Quanjer et al., 1993), advising that subjects of 
African ethnicity would be expected to give proportionally reduced data; the accepted 
range for this difference is 12-15% for FEV1 and FVC (Quanjer et al., 1993; Collen et 
al., 2010). Berry et al. (2008) assumed a difference of 15%, and found a difference of 
14.3% and 13.8% for FEV1 and FVC, respectively. Although such racial differences 
are generally accepted, another study (Vollmer et al., 2000) found no significant 
difference between black smokers and white smokers; a significant difference in 
smoking-related FEV1 decline was detected, however, between whites and 
Asians/Pacific Islanders (-10 mL/year ± 1.0 vs. -4 mL/year ± 2.0 for >10 
cigarettes/day, p = <0.05). It is important to note that all participants in both studies 
were current smokers; it is unfortunate that Berry et al. and Vollmer et al. did not 
include a non-smoking group in order to more thoroughly explore the difference 
between races in the effects of smoking. 
 
A large (n = 9651) 11-year cohort study (Downs et al., 2005) showed that female 
smokers experience a greater mean annual decline in FEV1 than men (-13.8mL vs. -
10.4mL per pack per day). Also, women who ceased smoking before the end of the 
study experienced less annual decline than persistent smokers (p = 0.05), an effect 
not seen in male participants (p = 0.49). The authors concluded that lung function 
recovers faster in women who cease smoking than men. 
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A study exploring factors affecting lung function (Belousova et al., 1997) found that 
current smoking (vs. non-smoking) adversely affected peak expiratory flow rate 
(PEFR) (p = <0.05) and forced expiratory flow between 25% and 75% of FVC 
(FEF25-75%) (p = <0.05) measurements. A decline was observed in FEV1, but not to a 
significant level (p = 0.053). The study population, however, was exclusively white 
Australians, so these results can only be generalised to the same ethnic group. 
Current smoking was found to negatively affect FEV1 in a number of studies 
(Jaakkola et al., 1991; Wang et al., 2009; Clennell et al., 2008; Urrutia et al., 2005; 
Apostol et al., 2002). The study by Wang et al. (2009) found a significant effect in 
men (n = 1721, p = <0.0001), but not in women (n = 163). The small proportion of 
women in the study may account for this gender difference. Urrutia et al. (2005) 
found that the degree of effect increased with the number of cigarettes smoked per 
day: 10-20/day corresponds to a change of -83mL FEV1 (p = 0.03), and >20/day a 
change of -177mL FEV1 (p = <0.01). Apostol et al. (2002) found that smoking 
initiation at less than 15 years of age appeared to be significant for greater decline in 
FEV1 (p = 0.01), but the decline did not remain significant after adjusting for current 
smoking. 
 
A common problem with these studies is that the data on smoking habits is self-
reported, thereby introducing the possibility of recall bias. None of the above authors 
comment on this bias, however a small number use reasonable steps to minimise it, 
such as interviewer-administered questionnaires (Downs et al., 2005; Jaakkola et al., 
1991), and providing clear definitions of categories of smoking habit (Downs et al., 
2005; Urrutia et al., 2005). 
 
 
Sub-category: weight 
Table 4.4 summarises information on the factor(s) allocated to this sub-category. 
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Table 4.4: Summary of studies, weight and lung function 
Exposure / 
factor 
Type of study Sample 
size 
Measure 
(exposure) 
Measure 
(outcome) 
Results / significance 
Weight-
related 
(weight gain) 
Retro cohort (Wang et 
al., 2009) 
n=1884 Measured Lung function 
decline, FEV1 
Significant decline, 5.43mL per pound gained (p = 
<0.0001) 
Cohort (Marcon et al., 
2009) 
n=638 Measured Lung function 
decline, FEV1 
Significant decline, 20mL/y (95% CI 10-30) (males) and 
7mL/y (95% CI 1-11) (females) per kg gained 
Weight-
related 
(weight loss) 
Randomized controlled 
study (Stenius-
Aarniala et al.,2000) 
n=38 Measured Lung function 
change in 
asthmatics, FEV1, 
FVC 
FEV1 improved by 7.2%predicted (p = 0.009); FVC 
improved by 8.6%predicted(p = <0.0001) 
Weight-
related (BMI 
& proportion 
of dietary fat 
intake) 
Cohort (Wood et al., 
2010) 
n=195 Measured, self-
reported 
Lung function 
decline, FEV1, FVC 
BMI associated with significant FVC decline in males                
(-3.9%pred, p = 0.05); proportion of dietary fat intake 
associated with sig. FEV1 decline in males (-4.8%pred,               
p = 0.05); no sig. decline in females 
Weight-
related 
(‘traditional’ 
diet) 
Cross-sectional 
(McKeever et al., 
2010) 
n=12648 Self-reported Lung function 
decline, FEV1  
Significant decline (-94.4mL, 95% CI –123.4 - -65.5mL,        
p = <0.001) 
Weight-
related 
(waist-hip 
ratio, WHR) 
Cross-sectional (Harik-
Khan, Wise & Fleg, 
2001a) 
n=1634 Measured Lung function 
decline, FEV1, FVC 
Significant FEV1 decline in males (p = 0.0001);     
significant FVC decline in males (p = 0.0005);               
significant FVC decline in females (p = 0.02) 
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Weight gain negatively affected FEV1 in two studies. A decline of 5.43mL per pound 
gained (p = <0.0001) was observed (Wang et al., 2009), while a study in asthmatics 
found that a gain of 1 kilogram was associated with a decline of 20mL/y and 7mL/y in 
men and women, respectively. (Marcon et al., 2009). Conversely, a reduction in 
weight (a loss of 14.5% body weight compared to 0.3% in controls) was associated 
with an increase in FEV1 of 7.2%pred (p = 0.009) and FVC of 8.6%pred (p = 
<0.0001) measurements in asthmatics (Stenius-Aarniala et al., 2000).  
A greater body mass index (BMI) and proportion of dietary fat intake were 
significantly associated with a reduction in FVC (-3.9%pred, p = 0.05) and FEV1       
(-4.8%pred, p = 0.05), respectively, in men but not in women (Wood et al., 2010). 
The consumption of a ‘traditional’ diet (defined as high intake of meat and potatoes 
and low intake of soy and cereal) was also associated with a reduction in FEV1 of 
94.4mL (95% CI –123.4 – -65.5mL, p = <0.001) (McKeever et al., 2010). Both these 
articles use self-reported data on food intake, however, introducing potential recall 
bias.  
Body-fat distribution, measured by waist-to-hip ratio (WHR), was inversely 
associated with FEV1 in men (p = 0.0001) but not women, and with FVC (p = 0.0005 
for men, p = 0.02 in women) (Harik-Khan et al., 2001a). Overall WHR is therefore a 
more important predictor of reduced lung function in men than women in this study. 
 
 
Sub-category: socio-economic status (SES) 
Table 4.5 summarises information on the factor(s) allocated to this sub-category. 
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Table 4.5: Summary of studies, socio-economic status (SES) and lung function 
Exposure / 
factor 
Type of study Sample 
size 
Measure 
(exposure) 
Measure 
(outcome) 
Results / significance 
Socio-
economic 
Cross-sectional 
(Adedoyin, Erhabor, 
Olajide & Anifowose, 
2010) 
n=1930 Self-reported Lung function 
decline, FEV1, 
FVC, PEF 
Significant FEV1 decline (0.23mL, p = <0.01); sig. FVC 
decline (0.25mL, p = <0.01); sig. PEF decline (25L/s, p = 
<0.01) 
Cross-sectional (Raju, 
Prasad, Ramana, 
Balakrishna & Murthy, 
2005) 
n=2616 Reported by 
parents of 
subjects 
Lung function 
decline (5-15 
years), FEV1, FVC 
Significant decline in FEV1 and FVC (p = 0.001 for both);                         
decline greater in males than females 
Cohort (Johannessen, 
Eagan, Omenaas, 
Bakke & Gulsvik, 
2010) 
n=1644 Self-reported Lung function 
decline, FEV1, FVC 
Significant decline associated with socioeconomic status 
in males; significant decline associated with marital 
status in females 
Socio-
economic 
(level of 
education) 
Cohort (Tabak, 
Spijkerman, 
Verschuren & Smit, 
2009) 
n=5705 Self-reported Lung function 
decline, FEV1 
Significant decline in females (p = <0.01), but not in 
males 
Cross-sectional 
(Trupin et al., 2010) 
n=176 Self-reported Lung function 
decline in 
asthmatics, FEV1 
Borderline significant decline (p = 0.05) 
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Socio-economic status (SES), as defined by a variety of criteria, was also shown to 
be associated with lung function. A study conducted on a population of Nigerians 
(Adedoyin et al., 2010) showed that SES assessed by occupation, educational level 
and family income was associated with a reduction of FEV1 (0.23L mean difference 
high SES vs. low SES, p = <0.01), FVC (0.25L mean difference high SES vs. low 
SES, p = <0.01), and peak expiratory flow (PEF) (25L/s mean difference high SES 
vs. low SES, p = <0.01). 
SES as assessed by family income in Indian children 5-15 years (Raju et al., 2005) 
showed a reduction in lung function measurements in the low income group 
compared to the high income group. In the oldest children, difference in FEV1 and 
FVC (high income group vs. low income group) was greater in boys (0.52L and 
0.56L, respectively) than in girls (0.27L and 0.35L, respectively). 
Two cohort studies found gender differences in the effects of SES (Johannessen et 
al., 2010; Tabak et al., 2009). Lung function decline in men (FEV1 and FVC) was 
more strongly associated with a low SES, while for women decline was associated 
with marital status (Johannessen et al., 2010). Unmarried females were observed to 
have a smaller decline in FEV1 and FVC than married and widowed females, an 
effect not seen in men. Conversely, a low educational level did not affect lung 
function decline in men, but was significantly associated with FEV1 decline in 
females in a larger study (Tabak et al., 2009). A smaller cross-sectional study 
(Trupin et al., 2010) found that FEV1 was lower in those with high school education 
or less vs. some college education (p = 0.05). 
With one exception (Trupin et al., 2010), all studies in this sub-group use self-
reported data on socio-economic factors. Trupin et al. (2010) used telephone 
interviews to acquire this data. 
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2. Environmental factors and lung function 
Sub-category: distance of home from roadway 
Table 4.6 summarises information on the factor(s) allocated to this sub-category. 
Table 4.6: Summary of studies, distance of home from roadway and lung 
function 
Exposure 
/ factor 
Type of 
study 
Sample 
size 
Measure 
(exposure) 
Measure 
(outcome) 
Results / 
significance 
Distance 
of home 
from 
roadway 
Cross-
sectional 
(Trupin et al., 
2010) 
n=176 Mapped by 
researchers 
Lung 
function 
change in 
asthmatics, 
FEV1 
Significant increase 
proportionate with 
increase in distance 
from roadway (p = 
0.001) 
Cohort 
(Balmes et 
al., 2009) 
n=176 Mapped by 
researchers 
Lung 
function 
change in 
asthmatics, 
FEV1 
Significant increase 
proportionate with 
increase in distance 
from roadway (p = 
0.04); sig. increase 
proportionate with 
increase in distance 
from major roadway (p 
= 0.02) 
Cross-
sectional 
(Kan et al., 
2007) 
n=15792 Mapped by 
researchers 
Lung 
function 
decline, 
FEV1, FVC 
Significant decline in 
FVC in females 
(p=0.030); no sig. 
decline for males 
 
All studies considered here investigated the effects of air pollution resulting from 
traffic exhaust by categorising the distance of the home from the nearest major road.  
A gender difference was observed in a cross-sectional study with a large population 
of >15000 (Kan et al., 2007), with distance from major road of <150m associated 
with a significant reduction in FVC in women (-24.2mL, p = 0.030), but not in men (p 
= 0.548). Reduction in FEV1 was not significant for women or men (p = 0.099 and p 
= 0.693, respectively). 
In studies on two similar populations of asthmatics, FEV1 measured as percentage-
of-predicted (%pred) was shown to significantly increase in proportion with home 
distance from roadway in two studies (p = 0.001 [Trupin et al., 2010]; p = 0.04 
[Balmes et al., 2009]). Balmes et al. (2009) also found a significant increase 
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associated with distance from major roadway, defined as interstate or state highways 
(p = 0.02).  
 
Sub-category: childhood respiratory illness 
Table 4.7 summarises information on the factor(s) allocated to this sub-category. 
Table 4.7: Summary of studies, childhood respiratory illness and lung function 
Exposure 
/ factor 
Type of 
study 
Sample 
size 
Measure 
(exposure) 
Measure 
(outcome) 
Results / 
significance 
Childhood 
respiratory 
illness 
Cohort 
(Johnston, 
Strachan & 
Anderson, 
1998) 
n=1392 Historical Lung function 
decline, 
FEV1, FVC 
Pneumonia associated 
with significant FEV1 
decline (p = 0.006) and 
FVC decline (p = 0.001);  
whooping cough 
associated with 
significant FVC decline 
(p = 0.04) 
 
Only one study (Johnston et al., 1998) investigating the effects of contracting a lung 
condition such as pneumonia or whooping cough (pertussis) during childhood on 
lung function in adulthood was retrieved. Pneumonia was associated with a 
reduction in adult FEV1 (p = 0.006) and FVC (p = 0.001), and whooping cough a 
reduction in FVC (p = 0.04) (Johnston et al., 1998). No significant reduction in FEV1 
was associated with whooping cough. Recall bias is an issue with this factor 
however, as these results presume that the historical diagnoses of these diseases 
are accurate. 
 
3. Occupation and lung function 
Occupational exposures that can potentially lead to a reduction in lung function in the 
employee are many and varied, from a hypersensitivity reaction leading to 
occupational asthma (Baran & Teul, 2007; Hoy et al., 2007), to the irritant effect of 
the agent on lung tissue (Johnsen et al., 2008; Moshammer et al., 2007). 
 
Sub-category: respirable dust / coal dust 
Table 4.8 summarises information on the factor(s) allocated to this sub-category. 
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Table 4.8: Summary of studies, exposure to respirable dust / coal dust and lung function 
Exposure / 
factor 
Type of study Sample 
size 
Measure 
(exposure) 
Measure 
(outcome) 
Results / significance 
Respirable 
dust (silica / 
ceramic / 
cement) 
Cohort (Bakke, 
Ulvestad, Stewart & 
Eduard, 2004) 
n=651 Personal 
exposure 
sampling 
Lung function 
decline, FEV1, FVC 
Decline in FVC, silica dust (p = <0.001); decline in FEV1, 
NO2 exhaust (p = <0.001) 
Cross-sectional (Cowie 
et al., 2001) 
n=774 Historical / 
exposure 
estimates 
Lung function 
decline, FEV1, FVC 
Decline in FEV1 and FVC in male smokers (p = <0.05);                   
decline in FEV1 and FVC in females (p = <0.05) 
Cross-sectional (Noor, 
Yap, Zolkepli & Faridah, 
2000) 
n=132 Measured Lung function 
decline, FEV1, FVC 
Decline in FEV1 in 30-40 year old employees (p = <0.05) 
Cross-sectional 
(Jaakkola, Sripaiboonkij 
& Jaakkola, 2011) 
n=308 Self-reported Lung function 
decline, FEV1, FVC 
Decline in FEV1 (p = 0.01) and FVC (p = 0.005) 
associated with silica dust 
Brown coal 
dust 
Retro cohort 
(Finocchiaro, Lark, 
Keating, Ugoni & 
Abramson, 1997) 
n=448 Classified by 
occupation 
Lung function 
decline, FEV1 
Significant decline only in mixed vs. high exposure 
groups (p = 0.008) 
Cohort (Carta, Aru, 
Barbieri, Avataneo & 
Casula, 1996) 
n=909 Personal 
exposure 
sampling 
Lung function 
decline, FEV1 
Significant decline, p-value not stated 
Cross-sectional (Lewis, 
Bennett, Richards & 
Britton, 1996) 
n=1853 Classified by 
occupation 
Lung function 
decline, FEV1 
Decline in FEV1 (p = <0.001) 
 
 
Page | 77  
 
A number of studies investigated the effects of dust inhalation in the construction and 
mining industries. A six-year cohort study on 651 tunnel construction personnel 
(Bakke et al., 2004) found a significant reduction in FVC associated with exposure to 
α-quartz (silica) dust (p = <0.001). The most powerful association with FEV1 decline 
was not with respirable dust, however, but with exposure to the nitrogen dioxide (p = 
<0.001) resulting from blasting and machinery exhausts. Silica dust was also 
observed, in the form of tile dust in a ceramic tile facility, to affect FEV1 (p = 0.01) 
and FVC (p = 0.005), with a larger adverse effect in current smokers (Jaakkola et al., 
2011). Exposure data was self-reported, however, and so exposure levels were not 
measured or estimated. 
Ceramic fibres and respirable dust were associated with a reduction in FEV1 and 
FVC (p = <0.05) (Cowie et al., 2001) in men, but this was only seen in current 
smokers. Women also experienced a significant decline in FEV1 and FVC (p = 
<0.05), but this group was not separated into smokers and non-smokers, and so 
smoking cannot be ruled out as a confounding factor. 
Cement dust exposure was not associated with a significant reduction in FEV1 or 
FVC using data from the entire study population (n = 132) of cement factory 
employees (Noor et al., 2000). Selecting only employees 30-40 years old, however 
(n = 77), showed a reduction in FEV1 in non-smoking employees (-0.30L, p = <0.05) 
and smoking employees (-0.27L, p = <0.05), compared to non-smoking controls. No 
significant decline was observed in FVC. There were also significant declines 
associated with high dust exposure vs. low exposure in FEV1 (-0.35L, p = <0.05) and 
FVC (-0.22L, p = <0.05). 
 
Exposure to brown coal dust from mining was investigated for a possible association 
with lung function in three studies. The smallest of the three studies, an Australian 
retrospective cohort study (n = 448, Finocchiaro et al., 1997), did not find a 
significant decline in FEV1 comparing low exposure to high exposure groups. A 
decline in FEV1 was observed, but was only significant (p = 0.008) in mixed vs. high 
exposure groups. Smoking was also shown to have a significant effect on FEV1 (p = 
0.02) in comparison to non-smoking. 
A larger Italian study (n = 909, Carta et al., 1996) found that the difference in FEV1 
decline between exposure groups was significant after adjusting for smoking (p-
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value not stated), although absolute spirometric values are not shown, and the data 
generally is not presented with clarity. There is also the lack of a true control group 
with no dust exposure in this and the study by Finocchiaro et al. (1997). 
The largest of the three studies was a British cross-sectional study (n = 1853, Lewis 
et al., 1996) using a control group from outside the mining industry. A significant 
decline in FEV1 was found after adjusting for smoking (-155mL, p = <0.001). When 
data were refined to participants aged 45 years and under, a greater decline was 
observed (-251mL, p = <0.001). 
 
Sub-category: farming / laboratory animals 
Table 4.9 summarises information on the factor(s) allocated to this sub-category. 
Table 4.9: Summary of studies, exposure to farming / laboratory animals and 
lung function 
Exposure 
/ factor 
Type of 
study 
Sample 
size 
Measure 
(exposure) 
Measure 
(outcome) 
Results / 
significance 
Farming Cohort (Venier 
et al., 2006) 
n=215 Self-reported Lung 
function 
decline, 
FEV1, VC 
Significant decline in 
FEV1 (p = <0.05) and 
VC (p = 0.01) 
associated with 
traditional vs. modern 
farming methods and 
equipment 
Laboratory 
animals 
Retro cohort 
(Portengen, 
Hollander, 
Doekes, de 
Meer & 
Heederik, 2003) 
n=319 Historical Lung 
function 
decline, 
FEV1, FVC 
Significant decline in 
FEV1 (p = <0.05) and 
FVC (p = <0.01) only 
in subjects with 
existing sensitization 
 
The modernisation of dairy farming methods was investigated for its effect on lung 
function decline (Venier et al., 2006), testing the hypothesis that advanced methods 
and improved ventilation may result in significantly improved spirometric values. The 
authors cite micro-organisms within stored hay as the significant exposure for small 
dairy farmers. FEV1 annual decline and vital capacity (VC) were reduced in 
traditional farm workers in comparison to those using modern techniques and 
equipment (p = < 0.05 and < 0.01, respectively). 
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Working with laboratory animals was associated with a significant decline in lung 
function only in individuals with an existing sensitisation to the animal they work with 
(Portengen et al., 2003). Mean annual decline of FEV1 and FVC in these subjects 
was -83mL/y (p = <0.05) and -148mL/y (p = <0.01), respectively. 
 
Sub-category: second-hand smoke (SHS) 
Table 4.10 summarises information on the factor(s) allocated to this sub-category. 
Table 4.10: Summary of studies, exposure to second-hand smoke (SHS) and 
lung function 
Exposure 
/ factor 
Type of 
study 
Sample 
size 
Measure 
(exposure) 
Measure 
(outcome) 
Results / 
significance 
Second-
hand 
smoke 
Randomised 
controlled 
study (Flouris 
et al., 2009) 
n=16 1 hour’s 
controlled 
exposure 
Lung 
function 
decline, 
FEV1 
Significant immediate 
decline (p = <0.05), 
return to baseline after 
3 hours post-exposure 
Cross-
sectional 
(Janson et al., 
2001) 
n=7882 Structured 
interview 
Lung 
function 
decline, 
FEV1 
Significant decline 
when exposed ≥8 
hours/day (p = 0.01) 
 
Second-hand smoke (SHS) was included in this section as this is considered to be 
an occupational exposure, rather than a direct lifestyle choice such as personal 
smoking.  
One hour’s exposure to SHS was observed (Flouris et al., 2009) to reduce FEV1 with 
immediate testing (0.5L reduction from pre-exposure measurements, p = <0.05), but 
with a return to baseline at 3 hours following exposure. Another study (Janson et al., 
2001) showed that SHS had a significant negative effect on FEV1 only if exposure 
was ≥8 hours/day (p = 0.01), otherwise there was no significant association with lung 
function. 
 
4. Physical factors and lung function 
Sub-category: upper body segment (UBS) / sitting height (SiH) 
Table 4.11 summarises information on the factor(s) allocated to this sub-category. 
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Table 4.11: Summary of studies, upper body segment (UBS) / sitting height 
(SiH) and lung function 
Factor Type of 
study 
Sample 
size 
Measure 
(exposure) 
Measure 
(outcome) 
Results / 
significance 
UBS 
and/or 
SiH 
Cross-
sectional 
(Whitrow & 
Harding, 
2007) 
n=3294 Measured 
(UBS) 
Effect of factor 
on racial 
differences in 
lung function 
(FEV1, FVC) 
UBS shown to account 
for 41-51% of racial 
difference in 
adolescents (Black 
African/Caribbean vs. 
white) 
Cross-
sectional 
(Harik-Khan, 
Muller & Wise, 
2004) 
n=1462 Measured 
(SiH) 
Effect of factor 
on racial 
differences in 
lung function 
(FEV1, FVC) 
SiH shown to account 
for 42-53% of racial 
difference in children 
(African-American vs. 
white American) 
Cross-
sectional 
(Harik-Khan, 
Fleg, Muller & 
Wise, 2001b) 
n=1242 Measured 
(SiH) 
Effect of factor 
on racial 
differences in 
lung function 
(FEV1, FVC) 
SiH shown to account 
for 35-39% of racial 
difference (African-
American vs. white 
American) 
 
The racial difference in lung function (Quanjer et al., 1993; Collen et al., 2010) may 
be related to a variance in trunk size (Hsi, Hsu and Jenkins, 1983; Hankinson, 
Odencrantz and Fedan, 1999); this can be explored through body compartmentation, 
measuring certain physical characteristics and investigating these as associative 
factors. Body compartmentation measurements include standing height (SH), sitting 
height (SiH), femur leg length (LL), and upper body segmentation (UBS). 
In a cross-sectional study on African-Americans and white Americans, (Harik-Khan 
et al., 2001b) replacing SH with SiH for regression analyses was observed to 
account for 35-39% of the racial difference in FEV1 and FVC. SiH was also shown to 
be a more important predictor of difference than socio-economic factors such as 
education level (2-4.7% reduction in difference) and poverty index (2.5-7.5%). A 
similar study comparing African-American and white American children (Harik-Khan 
et al., 2004) found that SiH accounted for 42-53% of the racial difference in FEV1 
and FVC. 
A study in UK adolescents (Whitrow & Harding, 2007) also supported these results, 
observing that upper body segment (UBS) – a measurement analogous to SiH – 
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again accounted for a greater amount of the racial difference in FEV1 and FVC than 
other physical measurements and socio-economic measures.  
 
Sub-category: low birth weight (LBW) and lung function 
Table 4.12 summarises information on the factor(s) allocated to this sub-category. 
Table 4.12: Summary of studies, low birth weight (LBW) and lung function 
Factor Type of 
study 
Sample 
size 
Measure 
(exposure) 
Measure 
(outcome) 
Results / 
significance 
LBW Cohort (Hoo 
et al., 2004) 
n=80 Measured Effect of factor (vs. 
appropriate for 
gestation birth 
weight) on infant 
lung function 
(FEV0.4) 
Significant reduction 
of 9% (95% CI 2–
16%,    p = <0.05) 
Retro cohort 
(Laerum et 
al., 2004) 
n=1683 Historical Effect of factor (vs. 
appropriate for 
gestation birth 
weight) on adult lung 
function 
(FEV1%pred, 
FVC%pred) 
No significant effect 
observed after 
adjustment for 
confounders 
Cohort 
(Edwards, 
Osman, 
Godden, 
Campbell & 
Douglas, 
2003) 
n=323 Historical Effect of factor (vs. 
appropriate for 
gestation birth 
weight) on adult lung 
function (FEV1, FVC) 
Positive association 
with birth weight          
(p = 0.01) 
 
Low birth weight (LBW) may be associated with reduced adult lung function due to 
the effects on lung development and growth (Stick, 2000; Stein et al., 1997; 
Shaheen, Sterne, Tucker, Florey, 1998). This was shown to have an effect on lung 
function in both infants and adults. LBW was associated with 9%, 8% and 4% 
reductions in FEV0.4 , FEF75% and FVC, respectively, in infants aged ~9 months (Hoo 
et al., 2004). A study measuring lung function in 381 adults aged 45-50 years 
(Edwards et al., 2003) with LBW found that both FEV1 and FVC show a positive 
association with birth weight, i.e. lung function increases with birth weight (adjusted p 
= 0.01 for trend). 
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A larger (n = 1683) historical cohort study on 1683 adults (Laerum et al., 2004) 
showed an initial associated decline, but after adjusting for confounders such as BMI 
and smoking, no significant effects were seen on FEV1(%pred) or FVC(%pred). 
 
Conclusions 
The factors identified from this review are summarised in table 4.13. 
The purpose of this review was to inform the development of data collection sheets, 
by examining existing research to identify factors which are observed to influence 
lung function.  
The following information was selected for inclusion on the data collection sheets, 
based on the evidence from previous research of an association with lung function: 
• smoking habits (age of initiation was not seen to be relevant so this was not 
included on the sheet) (Vollmer et al., 2000; Downs et al., 2005; Belousova et al., 
1997; Jaakkola et al., 1991; Wang et al., 2009; Clennell et al., 2008; Urrutia et al., 
2005; Apostol et al., 2002) 
• socio-economic status (educational level, household income, marital status) 
(Adedoyin et al., 2010; Raju et al., 2005; Johannessen et al., 2010; Tabak et al., 
2009; Trupin et al., 2010) 
• distance from nearest major road of family home (defined as the nearest regularly-
used main road or ‘A-road’) (Kan et al., 2007; Trupin et al., 2010; Balmes et al., 
2009) 
• reported history of childhood respiratory illness (e.g. pneumonia, whooping cough) 
(Johnston et al., 1998) 
• previous occupation (any work involving exposure to respiratory irritants or 
sensitisers) (Baran & Teul, 2007; Hoy et al., 2007; Johnsen et al., 2008; Moshammer 
et al., 2007; Bakke et al., 2004; Jaakkola et al., 2011; Cowie et al., 2001; Noor et al., 
2000; Lewis et al., 1996; Venier et al., 2006; Portengen et al., 2003; Delclos et al., 
2006) 
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Table 4.13: Summary of factors identified as associated with lung function 
Factor Lung function 
measure 
Evidence of 
effect? 
Comments 
Smoking FEV1, FVC, 
PEFR, FEF25-75% 
Yes • effect is dosage-related (Urrutia et al., 2005) 
• greater decline in women; women quitters recover faster (Downs et al., 2005) 
• initiation age not significant (Apostol et al., 2002) 
Weight-related factors FEV1, FVC Yes • body mass index not significant in women (Wood et al., 2010) 
Socio-economic status FEV1, FVC, PEF Yes • marital status only significant in women (Johannessen et al., 2010) 
Distance from (major) roads FEV1, FVC Yes • more important factor for asthmatics (Trupin et al., 2010; Balmes et al., 2009) 
Childhood respiratory illness FEV1, FVC Yes  
Occupational dust exposure FEV1, FVC Yes • significant results for construction, mining, silica & cement dust (Bakke et al., 
2004; Carta et al., 1996; Cowie et al., 2001; Finocchiaro et al., 1997; Jaakkola 
et al., 2011; Lewis et al., 1996; Noor et al., 2000) 
Farming exposure FEV1, VC Yes  
Lab. animals exposure FEV1, FVC Yes • only significant with existing sensitisation (Portengen et al., 2003) 
Second-hand smoke FEV1 Mixed • significant if exposure ≥ 8 hours/day (Janson et al., 2001)  
• significant short-term effects (Flouris et al., 2009) 
Sitting height / Upper body 
segment 
FEV1, FVC Yes  
Low birth weight FEV1, FEV0.4, 
FVC, FEF 
Mixed  
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• birth weight (Stick, 2000; Stein et al., 1997; Shaheen et al., 1998; Hoo et al., 2004; 
Edwards et al., 2003). 
 
The following measurements were taken during the spirometric assessment 
appointment with each participant, as previous research has provided supporting 
evidence of an association with lung function: 
• weight and height of the participant, to calculate body mass index (Wang et al., 
2009; Marcon et al., 2009; Stenius-Aarniala et al., 2000; Wood et al., 2010; Harik-
Khan et al., 2001a) 
• sitting height and upper body segment (Hsi, Hsu and Jenkins, 1983; Hankinson, 
Odencrantz and Fedan, 1999; Harik-Khan et al., 2001b; Harik-Khan et al., 2004; 
Whitrow & Harding, 2007). 
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Existing questionnaires 
Occupational health questionnaires 
Questionnaires already in use for occupational health relating to respiratory issues 
are summarised in table 4.14 below and the following text. 
 
Table 4.14: Questions asked relating to respiratory health on existing 
occupational health questionnaires 
Subject of question Category Document reference Validation 
Previous chest disease / 
illness 
Medical / 
symptoms 
Serco Occupational Health, 2010;  
Medical Research Council, 1986 
N/S* 
Yes 
History of allergy / 
asthma symptoms 
Medical / 
symptoms 
Serco Occupational Health, 2010;  
Wieslander, Norback, Janson & 
Edling, 1997;  
Delclos et al., 2006 
N/S 
Yes 
                
Yes 
Chest problems, e.g. 
breathlessness, wheeze, 
cough 
Medical / 
symptoms 
Health & Safety Executive, n.d.[a];  
Wieslander et al., 1997; 
Medical Research Council, 1986 
N/S 
Yes 
Yes 
Interruption of sleep Medical / 
symptoms 
Medical Research Council, 1986 Yes 
Exposure in previous 
job(s) 
Employment Serco Occupational Health, 2010;  
Delclos et al., 2006; 
Medical Research Council, 1986 
N/S 
Yes 
Yes 
Chest problems in 
relation to previous job 
Employment Health & Safety Executive, n.d.[a] N/S 
Smoking status Lifestyle Serco Occupational Health, 2010;  
Medical Research Council, 1986 
N/S 
Yes 
Exercise habits - type 
and frequency 
Physical 
activity 
Serco Occupational Health, 2010 N/S 
Non-occupational 
exposure 
Additional 
information 
Delclos et al., 2006 Yes 
*not stated 
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The majority of questions regarding respiratory health concern existing symptoms 
and problems (Serco Occupational Health, 2010; Wieslander et al., 1997; Delclos et 
al., 2006; Health and Safety Executive, n.d.[a]; Medical Research Council, 1986). 
These range from simple yes/no questions (example 1, below) to requests for more 
detailed information (example 2, below). 
Example 1: 
“Have you had a chest disease at any time e.g. asthma, bronchitis, pleurisy, tuberculosis? 
Do you have any allergies or allergic conditions, e.g. hay fever…?” (Serco Occupational 
Health, 2010) 
 
Example 2: 
“Do you feel shortness of breath when you walk fast on flat land or slight inclines? 
Have you felt wheezing in the chest during the night during the last two years?” (Wieslander 
et al., 1997) 
 
Questions on previous chest disease/illness (e.g. example 1, above) (Serco 
Occupational Health, 2010; Medical Research Council, 1986) do not specifically ask 
about childhood respiratory illnesses such as pneumonia and pertussis (whooping 
cough), when there is some evidence that such illnesses can adversely affect adult 
lung function (Johnston et al., 1998). 
Information on previous occupational exposure is also requested. The user is asked 
to declare if they have ever worked with specific substances, e.g. asbestos, 
isocyanates or wood dust (Serco Occupational Health, 2010; Medical Research 
Council, 1986). The questionnaire used by Delclos et al. (2006) for health service 
workers is particularly exhaustive in this regard, with a checklist of dozens of 
substances, including ammonia, gluteraldehyde, acetaldehyde, chloramines, 
formaldehyde, nitric oxide, toluene and pesticides. Delclos et al. (2006) also ask 
about non-occupational exposure, through metalworking and woodworking hobbies, 
for example. 
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Only one questionnaire (Serco Occupational Health, 2010) requests information on 
exercise habits (example 3, below): 
Example 3: 
“Do you take any form of regular physical exercise?” (Serco Occupational Health, 2010) 
 
There is evidence that reduction in weight is associated with an improvement in lung 
function (Wang et al., 2009; Marcon et al., 2009; Jubber, 2004; Wood et al., 2010), 
suggesting further exploration of this area; it should be noted, however, that Serco 
(2010) do request height and weight, from which body mass index (BMI) can be 
calculated. 
 
Smoking details are requested on the Serco and Medical Research Council 
questionnaires (Serco Occupational Health, 2010; Medical Research Council, 1986) 
with questions asked to ascertain quantity smoked per day, and time since quitting 
for ex-smokers. The Medical Research Council questionnaire additionally asks the 
following (example 4): 
Example 4: 
“How old were you when you started smoking regularly? 
Do you smoke any other forms of tobacco?” (Medical Research Council, 1986) 
 
It should be noted, however, that age of smoking initiation does not tend to be a 
significant factor, as this is usually confounded by current smoking status (Apostol et 
al., 2002). 
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Non-occupational health questionnaires 
Existing respiratory questionnaires not used for occupational health purposes are 
summarised in table 4.15 below and the following text. 
 
Table 4.15: Questions asked relating to respiratory health on non-
occupational health questionnaires 
Subject of question Category Document reference Validation 
Asthma symptoms:  
limitation of regular activities / 
interruption of sleep; 
breathlessness, wheeze, 
cough 
Medical / 
symptoms 
QualityMetric 
Incorporated, 2002;  
Asthma UK, 2010 
Yes 
N/S 
Asthma - frequency of inhaler 
use 
Medical / 
symptoms 
QualityMetric 
Incorporated, 2002;  
Asthma UK, 2010 
Yes 
N/S 
Asthma history / history of 
allergy 
Medical / 
symptoms 
Asthma UK, 2010 N/S 
Asthma / chronic obstructive 
pulmonary disease / other lung 
disease Yes/No 
Medical / 
symptoms 
Stanford University, 2008 Yes 
Chest problems, e.g. 
breathlessness, wheeze, 
cough 
Medical / 
symptoms 
British Lung Foundation, 
2011;  
Stanford University, 2008; 
Yawn et al., 2010; 
Jones, Quirk & 
Baveystock, 1991 
N/S 
Yes 
Yes 
Yes 
Chest problems in relation to 
limitation of regular activities 
Medical / 
symptoms 
Jones et al., 1991 Yes 
Chest problems in relation to 
employment 
Employment Jones et al., 1991 Yes 
Smoking status Lifestyle British Lung Foundation, 
2011; 
 Yawn et al., 2010 
N/S 
Yes 
Exercise habits - type and 
frequency 
Physical 
activity 
Stanford University, 2008 Yes 
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As with occupational questionnaires, existing symptoms and problems comprise the 
majority of questions; it should be noted, however, that many non-occupational 
questionnaires are tailored to existing sufferers (QualityMetric Incorporated, 2002; 
Asthma UK, 2010). For example, the Asthma Control Test (QualityMetric 
Incorporated, 2002) uses a scoring system to rate the user’s control of existing 
asthma symptoms (example 5, below). 
Example 5: 
“During the past 4 weeks, how often did your asthma symptoms (wheezing, coughing, chest 
tightness, shortness of breath) wake you up at night or earlier than usual in the morning? 
o 4 or more times a week 
o 2-3 nights a week 
o Once a week 
o Once or twice 
o Not at all” (QualityMetric Incorporated, 2002) 
 
The use of a 5-point response scale is of interest here. A study evaluating the use of 
a questionnaire as a diagnostic tool for chronic obstructive pulmonary disease 
(COPD) (Hanania et al., 2010) found that such 5-point scaled responses were 
significantly more accurate than yes/no answers at predicting airflow obstruction 
(p=<0.05).  
The Stanford Questionnaire (Stanford University, 2008) uses both yes/no and 
multiple scaled responses (examples 6 & 7, below). 
Example 6: 
“Please indicate below which chronic condition(s) you have: 
 Asthma 
 Emphysema or COPD” (Stanford University, 2008) 
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Example 7: 
“In general, would you say your health is: 
(Circle one) 
Excellent……….………1 
Very good……………..2 
Good…………………..3 
Fair…………………….4 
Poor…………….……..5”  (Stanford University, 2008) 
 
Example 6 presumes that the user is aware of an existing condition, and is not 
intended to predict the future development of such a condition; example 7, 
meanwhile, is so generalised as to be functionally meaningless. This questionnaire 
also asks the user to rate their shortness of breath over the previous two weeks on a 
scale from 0 (no shortness of breath) to 10 (severe shortness of breath). A more 
effective line of questioning would ascertain the specific activities that leave the user 
breathless (example 2, above, example 8, below). 
Example 8: 
“Do you experience shortness of breath upon physical exertion (walking up a flight of stairs 
or walking up an incline without stopping to rest)?” (Yawn et al., 2010) 
 
The St. George’s Respiratory Questionnaire (Jones et al., 1991) is particularly 
exhaustive in this area, listing a wide variety of activities in relation to 
breathlessness, coughing and wheezing.  
Smoking details (quantity and duration) are requested on the questionnaire 
developed by Yawn et al. (2010). The British Lung Foundation questionnaire (British 
Lung Foundation, 2011) merely asks if the user is a smoker, non-smoker or ex-
smoker.  
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Reviews 
A research report was conducted by the Institute of Occupational Medicine on behalf 
of the Health and Safety Executive (Miller, Graham, Creely, Cowie & Soutar, 2003) 
to examine questionnaire predictors for occupational asthma. The findings are 
summarised in table 4.16. 
Table 4.16: Questionnaire predictors of occupational asthma identified by 
Miller et al. (2003) 
Subject of question Category Document reference 
Asthma history (childhood)* Medical / 
symptoms 
Miller et al., 2003 
Asthma symptoms, e.g. 
breathlessness, wheeze, cough 
Medical / 
symptoms 
Miller et al., 2003 
Exposure in previous job(s) to 
allergen(s) or irritant/reactive 
chemicals* 
Employment Miller et al., 2003 
Previous occupation Employment Miller et al., 2003 
Smoking status Lifestyle Miller et al., 2003 
*questions or further details additional to those listed in tables 4.14 and 4.15 are marked in bold text 
 
The report by Miller et al. (2003) concluded that in terms of occupational asthma, 
there are no agreed standards as to which predictive questions are most effective. 
The factors found to be most strongly associated with clinically-assessed 
occupational asthma were previous occupational exposure to allergens or irritant 
reactive chemicals, and childhood asthma. Many questionnaires request asthma 
history, but Miller et al. (2003) specifically highlight the importance of asthma in 
childhood.  
For previous occupational exposure, a checklist can be provided on a questionnaire 
in the style of that used by Delclos et al. (2006), ensuring that substances with 
known respiratory hazards (review, chapter 1, section 1.2) are included. 
Other relevant factors not otherwise observed on existing questionnaires, but 
identified from the literature review previously in this section, were childhood 
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respiratory disease, socio-economic status, distance of home from nearest major 
road, and birth weight. 
Data collection sheet construction 
For any questionnaire-type document to be effective in its purpose, it must be clear 
and straightforward, sensibly organised, and the questions must be structured in the 
appropriate manner to acquire the desired information (Peterson, 2000, pp.13-27, 
101-102).  
The factors identified from the literature review and existing questionnaires were 
arranged by theme into sections (table 4.17). 
A brief introductory paragraph was included at the beginning of the sheet to state its 
purpose, provide confidentiality assurance, and to request that the participant 
answers all questions (Peterson, 2000, pp.102-106; Gillham, 2007, pp.37-39). 
With the exception of birth weight, questions were structured as closed-end 
questions, limiting responses to a defined set of options. This was done to ensure 
meaningful responses and so facilitate statistical analysis, and also for ease of 
completion by participants (Bradburn, Seymour & Wansink, 2004, pp.151-152; 
Peterson, 2000, pp.38-39).  
For certain questions rating scale responses were used. For example, ‘exercise 
habits’ was arranged as a 5-point scale, with option 1 (never exercise) as the ‘worst’ 
option, and option 5 (exercise every day) as the ‘best’. A Likert-type scale such as 
this, limited to 5 points for simplicity, was the most effective way of acquiring 
meaningful and useful data for this type of question (Peterson, 2000, p.75; Gillham, 
2007, pp.31-32; Hanania et al., 2010). All 5-point sets of responses were constructed 
in this way, ‘negative’ at option 1 to ‘positive’ at option 5. 
Groupings of the questions into sections is summarised in table 4.17; the completed 
data collection sheet is included in the appendix (appendix entry 5). 
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Table 4.17: Grouping of questions asked on data collection sheet 
Section 1: Personal information Name, date-of-birth, gender 
Birth weight 
Exercise habits (1-5 scale) 
Section 2: Socio-economic 
information 
Marital status 
Educational level 
Household income (1-5 scale) 
Distance of home from major road (1-5 scale) 
Section 3: Smoking history Smoking status 
Section 4: Asthma & other 
chest conditions 
Asthma & allergies, personal and family history 
Other chest problems, personal and family history 
Childhood chest illness 
Symptoms:                   Breathlessness (1-5 scale) 
                                              Wheezing (1-5 scale) 
                                               Coughing (1-5 scale) 
                Limitation of regular activities (1-5 scale) 
                              Interruption of sleep (1-5 scale) 
Section 5: Previous 
occupational exposure 
List of relevant substances 
Previous employment, list of relevant industries 
Section 6: Previous non-
occupational exposure 
List of hobbies involving relevant substances 
 
The completed data collection sheet was piloted during August 2011. Six individuals 
from CPL Aromas were selected, ensuring variance in department, role, age and 
gender. The individuals were asked to complete the sheet with no prior explanation 
as to the questions asked or the purpose of the sheet. The completed sheets were 
returned to the researcher and checked, with all sheets correctly completed. The 
individuals were invited to comment on ease-of-completion, order and structure, and 
suggested improvements; feedback received was exclusively positive, and no 
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improvements to the sheet were necessary. Individuals were also asked to measure 
the time taken to complete the sheet; times ranged from 8 to 15 minutes. 
The completed and piloted data collection sheet was distributed to study participants 
during phase 3 of recruitment, detailed earlier in this chapter.  
 
4.3 Data collection (questionnaire development phase 2) 
The purpose of phase 2 (figure 4.1) was to collect the spirometric data, demographic 
data and physical data from the study participants. 
Spirometric data 
Spirometric assessments were performed as detailed in chapter 2; FEV1 pre-shift 
measurements were used. 
Demographic data 
Completed data collection sheets were handed to the researcher during the pre-shift 
spirometric appointments.  
Physical data 
Physical data was measured and recorded by the researcher during the pre-shift 
spirometric appointments. Height was measured using a stadiometer; participants 
were asked to remove shoes and caps. Weight was measured using a digital scale; 
participants were asked to remove shoes and protective clothing such as high-
visibility vests and jackets. Sitting height (SiH) was also measured using the 
stadiometer and a standard stool, and upper body segment (UBS) calculated from 
this (UBS = SiH minus stool height). Body mass index (BMI) was calculated from 
standing height and weight (BMI = weight[kg] / height[m]2). 
Spirometric data and physical data were recorded on a results form, which the 
participant was asked to sign (appendix entry 14). 
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4.4 Data exploration (questionnaire development phase 3) 
Phase 3 (figure 4.1) involved the analysis of each demographic and physical factor 
for any effect on the spirometric outcome measures. Those factors observed to have 
an effect were selected for progression to phase 4. 
The statistical package Predictive Analytics SoftWare Statistics (PASW [Predictive 
Analytics SoftWare] Statistics version 18.0 for Windows, release 18.0.0 [July 30, 
2009]) was used for all statistical calculations. Demographic and physical data were 
added to the spirometric data contained on the electronic PASW data file created for 
part 1. 
Statistical analysis was used to analyse the effects of each predictor variable on the 
spirometric outcome measurements. Pre-shift (baseline) FEV1 measurements 
(%predicted) were used as the dependent variable. Building the model for statistical 
analysis is summarised in figure 4.2. 
Item reduction occurred in two stages: first, the exclusion of predictor variables 
where frequency of endorsement had resulted in an incomplete spread of responses 
(for example, variables with 1-5 responses where only responses 4 and 5 were 
given); these variables were excluded from further analysis. 
Simple linear regression was performed for the remaining predictor variables. For the 
second stage of item reduction, similar predictors were checked for correlation using 
Pearson correlation for continuous predictors, and chi-square test for categorical 
variables; where correlation was significant between two similar predictors (p = 
<0.05), one predictor was selected as the most relevant based on effect size, and 
the other was seen as redundant and was excluded. All remaining significant* 
predictors were then fitted in a multiple linear regression model to give adjusted 
values. The unstandardised coefficient (B) was taken as a measure of effect size 
(Hosmer & Lemeshow, 2001, pp.3-30, pp.32-42). 
*Statistical significance for progression to the multiple linear regression model was 
set at p = <0.2, as recommended by Hosmer and Lemeshow (2001, p.88, pp.106-
118), Menard (2001, pp.64-66) and Montgomery, Peck and Vining (2006, pp.281-
283. 
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Predictor variables Outcome variable 
Simple linear regression 
Variable excluded 
Figure 4.2: Building the model for statistical analysis using simple and multiple linear regression 
Report unadjusted B 
Report adjusted B 
Multiple linear regression 
Incomplete spread 
of responses 
Yes               No 
Effect size from simple linear regression significant at 
p = <0.2 level? 
Yes                                No 
Similar predictor variables? 
Yes                                                                       No 
Correlation check 
Continuous predictors:  
Correlation coefficient 
(Pearson r) 
Categorical 
predictors:  
Chi-square 
Correlation significant at p = <0.05 level? 
Yes                                               No 
Select one variable, exclude 
one (from each correlated pair) Variable excluded 
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4.5 Questionnaire construction (questionnaire development phase 4) 
Factors selected from phase 3 for progression to phase 4 (figure 4.1) were 
thematically organised, allocated an appropriate weighting, and used to construct the 
final questionnaire. 
 
A weighting score was then allocated to each variable response, based on: 
• unstandardised coefficient (B) (adjusted where appropriate) 
• distance from lowest or highest observed values (continuous variables) 
• distance from reference category (categorical variables) 
• direct of effect on FEV1 (positive or negative). 
 
The questions relating to the remaining variables were organised into groups and 
collated as the final questionnaire, using the data collection sheet (appendix entry 5) 
as a template.  
Chapter 5 will present the results of phases 3 and 4 of questionnaire development. 
 
Summary 
This chapter has detailed the methodology behind the development of the data 
collection sheet, and how the information acquired will be used alongside spirometric 
data to develop a predictive pre-placement questionnaire. The development of this 
final questionnaire – phases 3 and 4 of the development process outlined above – 
will be reported in chapter 5. 
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Chapter 5 Results, part 2 (questionnaire development) 
The aim of this chapter is to complete development of the predictive pre-placement 
questionnaire. 
This will be achieved by: 
● reporting the results of data exploration (phase 3 of questionnaire development);  
● reporting the results of questionnaire construction (phase 4 of questionnaire 
development); 
● performing internal validity checks on the finished questionnaire and associated 
weighting system. 
 
5.1 Data exploration (questionnaire development phase 3) 
Phase 3 involved the analysis of each variable for effect size on the outcome 
measure, pre-shift FEV1. The stages of data exploration were performed as 
described in chapter 4. 
The first stage of item reduction resulted in the exclusion of 6 variables, as shown in 
table 5.1. 
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Table 5.1: Item reduction: incomplete responses 
Variable excluded Frequency of endorsement 
Breathlessness (scale 1-5) 1: 
0 
2: 
0 
3: 
11.6% 
4: 
26.8% 
5: 
61.6% 
Wheezing (scale 1-5) 1: 
0 
2: 
0 
3: 
2.7% 
4: 
3.6% 
5: 
93.8% 
Limitation of activities (scale 1-5) 1: 
0 
2: 
0 
3: 
0 
4: 
10.7% 
5: 
89.3% 
Interruption of sleep (scale 1-5) 1: 
0 
2: 
0 
3: 
4.5% 
4: 
5.4% 
5: 
90.2% 
Personal non-asthmatic chest problem 
Yes/No 
Yes: 
2.7% 
No: 
97.3% 
Family history, non-asthmatic chest 
problem Yes/No 
Yes: 
5.4% 
No: 
94.6% 
 
The frequency of endorsement for these variables shows an incomplete spread of 
responses, and so there is insufficient variance in the responses to support a 
meaningful analysis of the data. These variables were therefore excluded from 
further analysis. 
Simple linear regression was then performed for each remaining variable, to show 
effect size using the unstandardised coefficient (B), as shown in table 5.2. 
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Table 5.2: Linear regression showing effect size of predictor variables on pre-
shift FEV1 measurements 
 
Variable 
Unadjusted (simple linear regression) 
B (95%CI) p-value 
Birth weight, kg 1.10 (-5.53 – 7.72) 0.741 
Smoking status -2.06 (-5.22 – 1.09) 0.198 
Upper body segment (UBS), m 23.53 (-41.91 – 88.97) 0.478 
Body mass index, by group 1.43 (-2.12 – 4.99) 0.426 
Marital status 5.12 (0.05 – 10.19) 0.048 
Educational level -1.18 (-3.97 – 1.61) 0.403 
Exercise frequency (scale 1-5) -1.96 (-4.36 – 0.44) 0.108 
Household income (scale 1-5) -2.17 (-5.87 – 1.52) 0.247 
Distance of home from major road 
(scale 1-5) 
0.88 (-1.51 – 3.27) 0.466 
Coughing (scale 1-5) 1.46 (-1.26 – 4.19) 0.288 
Personal history of asthma Yes/No 4.28 (-5.56 – 14.11) 0.391 
Family history of asthma Yes/No 0.88 (-5.06 – 6.82) 0.769 
Childhood history of asthma Yes/No -1.14 (-8.62 – 6.33) 0.762 
Personal history of hayfever Yes/No 0.47 (-5.98 – 6.91) 0.886 
Family history of hayfever Yes/No -1.79 (-7.30 – 3.71) 0.520 
Childhood respiratory illness Yes/No 1.05 (-8.82 – 10.91) 0.833 
Previous occupational exposure to at 
least 1 of chemicals listed Yes/No 
-4.02 (-9.49 – 1.44) 0.147 
Previous employment in at least 1 of 
listed jobs Yes/No 
0.58 (-4.93 – 6.10) 0.835 
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Further item reduction was performed by checking similar predictor variables for 
correlation; all relevant variables were categorical, so chi-square tests were used. 
Where correlation was significant (p = <0.05), one predictor was selected as the 
most relevant based on effect size, and the other was seen as redundant and was 
excluded. This resulted in the exclusion of a further 3 variables, as shown in table 
5.3.  
Table 5.3: Item reduction: correlation check and item redundancy 
Variables Chi-square (p-value) Variable selected 
Personal history of asthma 
Yes/No vs. 
Childhood history of asthma 
Yes/No 
12.39 (<0.001) Personal history of asthma 
Yes/No 
Personal history of hayfever 
Yes/No vs. 
Family history of hayfever 
Yes/No 
23.56 (<0.001) Personal history of hayfever 
Yes/No 
Previous occupational 
exposure to at least 1 of 
chemicals listed Yes/No vs. 
Previous employment in at 
least 1 of listed jobs Yes/No 
9.00 (0.003) Previous employment in at 
least 1 of listed jobs Yes/No 
 
All remaining predictors that reached the level of significance recommended by 
Hosmer and Lemeshow (2001, p.88, pp.106-118), Menard (2001, pp.64-66) and 
Montgomery et al (2006, pp.281-283. for regression model building (p = <0.2) were 
then fitted in a multiple linear regression model to give adjusted values (table 5.4). 
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Table 5.4: Linear regression showing effect size of predictor variables on pre-
shift FEV1 measurements (including adjusted figures) 
 
Variable 
Unadjusted (simple linear 
regression) 
Adjusted* (multiple linear 
regression) 
B (95%CI) p-value B (95%CI) p-value 
Birth weight, kg 1.10 (-5.53 – 7.72) 0.741  
Smoking status -2.06 (-5.22 – 1.09) 0.198 -2.18 (-5.38 – 1.02) 0.180 
Upper body 
segment (UBS), m 
23.53 (-41.91 – 88.97) 0.478  
Body mass index, 
by group 
1.43 (-2.12 – 4.99) 0.426  
Marital status 5.12 (0.05 – 10.19) 0.048 3.73 (-1.55 – 9.02) 0.164 
Educational level -1.18 (-3.97 – 1.61) 0.403  
Exercise frequency 
(scale 1-5) 
-1.96 (-4.36 – 0.44) 0.108 -1.80 (-4.31 – 0.70) 0.156 
Household income 
(scale 1-5) 
-2.17 (-5.87 – 1.52) 0.247  
Distance of home 
from major road 
(scale 1-5) 
0.88 (-1.51 – 3.27) 0.466  
Coughing (scale 1-
5) 
1.46 (-1.26 – 4.19) 0.288  
Personal history of 
asthma Yes/No 
4.28 (-5.56 – 14.11) 0.391  
Family history of 
asthma Yes/No 
0.88 (-5.06 – 6.82) 0.769  
Personal history of 
hayfever Yes/No 
0.47 (-5.98 – 6.91) 0.886  
Childhood 
respiratory illness 
Yes/No 
1.05 (-8.82 – 10.91) 0.833  
Previous 
employment in at 
least 1 of listed 
jobs Yes/No 
0.58 (-4.93 – 6.10) 0.835  
*Adjusted for smoking status, marital status and exercise frequency 
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The variables and associated effect sizes (B) as shown in table 5.4 were selected for 
progression to phase 4. 
 
5.2 Questionnaire construction (questionnaire development phase 4) 
The weightings allocated to each variable response score are shown in table 5.5 
(continuous variables) and table 5.6 (categorical variables), along with the maximum 
possible score for each variable. 
Table 5.5: Weighting system allocating scores to continuous variables 
Variable Mean (lowest 
value, highest 
value) 
Effect 
direction* 
Score Maximum 
possible 
score+ 
Birth weight, kg 3.25 (0.82, 5.06) Positive For each kg 
below highest 
observed value, 
score 1.10 
4.24 x 1.10 = 
4.66 
Upper body 
segment, m 
0.87 (0.77, 0.96) Positive For each m below 
highest observed 
value, score 
23.53 
0.19 x 23.53 = 
4.47 
*Effect on pre-shift FEV1 measurements 
+Based on lowest value 
 
The maximum possible score for continuous variables was calculated using the 
unstandardised coefficient (B), the direction of effect (on FEV1), and the lowest and 
highest observed values. For example, for birth weight, the effect direction is 
positive, so that FEV1 increases as birth weight increases. The highest observed 
value was 5.06kg, so for each unit (kg) below this value, the value of B should be 
added to the score. The lowest observed value was 0.82kg, and so the maximum 
possible score was calculated thus:  
Maximum score (for birth weight) = (highest – lowest values) x B 
                                                     = (5.06kg – 0.82kg) x 1.10 
                                                     = 4.24 x 1.10 = 4.66. 
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Table 5.6: Weighting system allocating scores to categorical variables 
Variable Reference 
category 
Effect 
direction* 
Score Maximum 
score+ 
Smoking status Non-smoker Negative Non-smoker: 0       
Former smoker: 2.18 
Smoker: 4.36 
4.36 
Body mass index, by 
group 
Normal 
weight 
Positive Normal weight: 2.86 
Overweight: 1.43   
Obese: 0 
2.86 
Marital status Single Positive Single: 7.46          
Married: 3.73      
Divorced/Widowed: 0 
7.46 
Educational level GCSE or 
equivalent 
Negative GCSE equiv.: 0              
A-level equiv.: 1.18 
Degree equiv.: 2.36  
Post-grad: 3.54 
3.54 
Exercise frequency 
(scale 1-5) 
Response 1 
(lowest) 
Negative 1: 0 2: 1.80 3: 3.60 7.20 
4: 5.40 5: 7.20  
Household income 
(scale 1-5) 
Response 1 
(lowest) 
Negative 1: 0 2: 2.17 3: 4.34 8.68 
4: 6.51 5: 8.68  
Distance of home from 
major road (scale 1-5) 
Response 1 
(lowest) 
Positive 1: 3.52 2: 2.64 3: 1.76 3.52 
4: 0.88 5: 0  
Coughing (scale 1-5) Response 1 
(worst 
symptom) 
Positive 1: 5.84 2: 4.38 3: 2.92 5.84 
4: 1.46 5: 0  
Personal history of 
asthma Y/N 
Yes Positive Yes: 4.28 No: 0 4.28 
Family history of 
asthma Y/N 
Yes Positive Yes: 0.88 No: 0 0.88 
Personal history of 
hayfever Y/N 
Yes Positive Yes: 0.47 No: 0 0.47 
Childhood respiratory 
illness Y/N 
Yes Positive Yes: 1.05 No: 0 1.05 
Previous employment 
in 1 of listed jobs Y/N 
Yes Positive Yes: 0.58 No: 0 0.58 
*Effect on pre-shift FEV1 measurements 
+Based on lowest response value 
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The maximum possible score for categorical variables was calculated using the 
unstandardised coefficient (B), the direction of effect (on FEV1), and distance from 
the reference category. 
For example, for smoking status, the effect direction is negative, so that FEV1 would 
be expected to decrease from non-smoker to former smoker to smoker. Non-smoker 
is therefore the reference category; for each unit away from the reference category, 
the unstandardised coefficient (B) should be scored. The maximum score would be 
for smoker, and would be calculated thus: 
Maximum score (for smoking status) = distance from reference category x B 
                                                           = 2 x 2.18 
                                                           = 4.36. 
 
The total maximum score (the ‘worst’ score in terms of expected FEV1 performance) 
for all variables is as follows: 
• maximum score, continuous variables = 9.13 
• maximum score, categorical variables = 50.72 
• total maximum score = 9.13 + 50.72 = 59.85. 
Each participant’s scores should be totalled, and the total score then converted into 
a percentage of the maximum possible score. 
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The questions relating to the remaining variables were organised into groups as 
follows, and the final questionnaire was constructed, using the data collection sheet 
developed for phase 1 (appendix entry 5) as a template.  
• Personal Information 
- birth weight, kg 
- upper body segment (measure height, sitting height and stool height) 
- body mass index, by group (measure height and weight) 
- smoking status 
- exercise frequency (scale 1-5) 
• Socio-economic information 
- marital status 
- educational level 
- household income (scale 1-5) 
- distance of home from major road (scale 1-5) 
• Symptoms and history 
- coughing (scale 1-5) 
- personal history of asthma Y/N 
- family history of asthma Y/N 
- personal history of hayfever Y/N 
- childhood respiratory illness Y/N 
- previous employment in 1 of listed jobs Y/N 
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The final questionnaire is included in the appendix (appendix entry 16), along with a 
scoring guide for the assessor (appendix entry 17). 
5.3 Internal validity checks 
The questionnaires were completed using data from 5 randomly selected study 
participants. Scores were calculated and compared to the FEV1 pre-shift 
measurements (table 5.7). 
Table 5.7: Questionnaire scores of randomly-selected study participants 
compared to FEV1 pre-shift measurements 
Participant code Questionnaire 
score 
% of maximum 
possible score 
FEV1 pre-shift, 
%predicted* 
055 23.3 38.9 92.4 
010 23.1 38.6 88.8 
104 23.7 39.6 76.6 
052 24.1 40.3 73.1 
102 33.0 55.1 67.6 
*Shown in descending order of FEV1 pre-shift measurements 
 
The questionnaire scores correlate well with FEV1 measurements. Based on these 
findings, a questionnaire score of ≥ 40.0% corresponds well with FEV1 measurement 
of <80%predicted, regarded as the lower limit of ‘normal’ in the interpretation of lung 
function measurements (Celli et al., 2004; Pellegrino et al., 2005). 
As a further validity check, the questionnaires were piloted by 4 new employees at 
the researcher’s workplace; these individuals did not take part in the original 
research study. Spirometry measurements were performed using the study protocol 
outlined in chapter 2.  
Questionnaire scores were calculated and compared to FEV1 pre-shift 
measurements (table 5.8).  
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 Table 5.8: Questionnaire scores of new employees compared to FEV1 pre-shift 
measurements 
Questionnaire score % of maximum possible 
score 
FEV1 pre-shift, 
%predicted* 
18.8 31.4 110.0 
30.0 50.1 104.6 
35.2 58.8 96.2 
37.8 63.2 89.7 
*Shown in descending order of FEV1 pre-shift measurements 
 
Again the questionnaire scores correlate well with FEV1 measurements. As the 
questionnaire score increases, the FEV1 measurement (%pred) decreases. The 
suggested threshold of a questionnaire score ≥ 40.0% of the maximum does not 
apply here, however, suggesting that although correlation is good, further testing and 
validation is necessary to establish the appropriate threshold for the questionnaire 
score to suggest an FEV1 of <80%predicted. 
This is encouraging for the future validation of the questionnaire, and suggests that 
this may indeed be a useful tool for occupational health screening. 
 
Summary 
This chapter has concluded the phases of questionnaire development, leading to the 
completed questionnaire as included in the appendix (appendix entry 16). Internal 
validity checks have thus far supported the questionnaire as a useful screening tool 
for employees within the fragrance industry. The results of both parts of the study will 
be further discussed and summarised in chapter 6. 
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Chapter 6 Final discussion 
The aim of this chapter is to further discuss the findings of both parts of the study, in 
the context of current practice and the implications for future practice. 
This will be achieved by: 
● discussing the results of the controlled research study (part 1) in the context of 
current health and safety legislation and practice;  
● summarising the implications of part 1 for future practice; 
● discussing the predictive questionnaire developed for part 2, and its potential for 
future use; 
● summarising the limitations of both parts of the study; 
● summarising future research arising from this study. 
 
● 6.1 Introduction 
This thesis set out to investigate occupational respiratory exposure within the 
fragrance industry and its effects on lung function from two perspectives: firstly, with 
a controlled study comparing spirometric results between ‘exposed’ and ‘control’ 
groups; and secondly, from an occupational health perspective, with the 
development of a pre-placement questionnaire. 
The research study was a novel investigation in terms of setting, background and 
population; occupational studies using spirometry to assess the effects of exposure 
are common in other industries (Baran & Teul, 2007; Bello et al., 2009; Fishwick et 
al., 2004; Ghasemkhani et al., 2006; Hashemi et al., 2010; Johnsen et al., 2008; 
Kezunovic, 2008; Kogevinas et al., 2007; Moshammer et al., 2007; Osman & Pala, 
2009; Rylander & Carvalheiro, 2006; Suuronen et al., 2008), but within the fragrance 
industry no meaningful previous attempt has been made to use this type of study to 
assess employees. (The exceptions are two Russian studies published too long ago 
to be of any current relevance [Galperina et al., 1986; Xuev, 1964]. The annual 
updating of usage restrictions and prohibitions within the industry [RIFM Expert 
Panel, 2011], combined with the development of strict health and safety procedures 
prescribed and enforced by legislation [Home Office, 1974; Home Office, 2002], 
mean that these studies are not relevant to current occupational exposure.) This 
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research study can therefore be seen as the first step in the development of a body 
of work focussing on employees within the fragrance industry.  
The pre-placement questionnaire was developed to address the concerns of Madan 
and Williams (2010, 2012) and others (Mahmud et al., 2010; Hulshof et al., 1999) 
that many occupational health questionnaires are not fit-for-purpose and do not 
provide any meaningful information that can be used effectively by occupational 
health practitioners. These concerns are particularly relevant in the UK with the 
introduction of the Equality Act 2010 (Home Office, 2010), prohibiting the employer 
from requesting health-related information prior to an offer of employment being 
made. In this context, the questionnaire can function as an effective tool within the 
fragrance industry. It should be seen as a tool that is intended for the benefit of both 
employer and employee.  
 
● 6.2 Discussion, part 1 
The results of the study conducted to answer the research question have shown that 
no significant effects on lung function were observed resulting from occupational 
exposure within the fragrance industry. This is in contrast to research conducted in 
other industries, where respiratory effects of occupational exposure were observed 
(Fishwick et al., 2004; Hashemi et al., 2010; Johnsen et al., 2008; Osman & Pala, 
2009; Rylander & Carvalheiro, 2006). The lack of previous research within the 
fragrance industry – an advantage in terms of justifying the need for this research – 
is in this context a disadvantage, as there are simply no directly comparable studies 
within industry. The specific challenge for this study, then, is in relating its findings to 
current guidelines and practice, the principles of establishing a safe, healthy working 
environment set out by the Health and Safety Executive (Health & Safety Executive, 
2012, pp.5-8), and placing it as the beginning of a body of work on occupational 
exposure within the industry.  
The Health and Safety Executive (HSE) is the public body responsible for regulating 
and enforcing all matters pertaining to occupational health and safety in Great Britain 
(Health & Safety Executive, 2012; Home Office, 1974). Their core aim is summarised 
below: 
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“Our mission is the prevention of death, injury and ill health to those at work and 
those affected by work activities.” (Health & Safety Executive, 2012, p.7.) 
The HSE also runs campaigns and programmes targeted at specific areas, such as 
the Disease Reduction Programme. The aims of this programme are to reduce 
incidence of occupational asthma, and to develop risk reduction measures for work-
related respiratory conditions (Health & Safety Executive, 2008).  
In terms of the legal requirements set out by UK legislation, the UK fragrance 
industry conforms to the statutes and guidelines set out in the Health and Safety at 
Work Act 1974 (Home Office, 1974) to ensure that the workplace is as safe as is 
practicably possible, and risks are assessed and either eliminated, reduced or 
managed. This is supported by the study findings, whereby a lack of significant effect 
on lung function suggests that protective measures in the workplace are sufficient in 
managing the risks posed by occupational exposure. The findings could also be 
used to support budgetary justification of the maintenance and upkeep of facilities 
and equipment and the supply of appropriate personal protective equipment – the 
results show that the budget allocated to health and safety has a clear benefit in 
preventing ill health. 
Research within industry on occupational exposure and health (and resulting 
improvements to practice or guidelines) not only conforms to the general mission 
statement above, but also to specific initiatives such as the Disease Reduction 
Programme. Such research is also relevant to one of the HSE’s stated key 
objectives from their most recent Annual Report: 
“Clarifying ownership of risk and improving compliance: 
Motivate others in the health and safety system to address their responsibilities in a 
common sense and proportionate manner and contribute to improving health and 
safety performance.” (Health & Safety Executive, 2012, p.16.) 
The research study conducted here can be seen as extremely pertinent to this 
objective; by initiating, funding and supporting this research, the UK industry has 
proved willing to take ‘ownership’ of respiratory issues in relation to occupational 
exposure, and take further steps to ensure employees’ occupational health beyond 
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what is prescribed by law. The preparation for the research has also shown how 
straightforward it can be to establish, maintain and run a spirometric health 
surveillance system in the workplace, in line with the principles set out in Regulation 
11 of the COSHH Regulations (Home Office, 2002). This can be achieved in-house 
with minimal equipment and training costs, and the workload handled by a small 
number of willing personnel in addition to their usual duties. This will be a 
recommendation for industry arising from this research. In relation to this, the HSE 
has prepared a number of freely available industry-specific guideline documents 
advising on COSHH; for example, for the woodworking industry (Health & Safety 
Executive, n.d.[b]). There is no such specific guidance for the fragrance industry. A 
guidance document endorsed by the HSE providing specific guidance for the 
industry would be of great value, and this will also be a recommendation arising from 
the research – this will be formally suggested to the HSE. Such a document could be 
prepared by collaboration with health and safety representatives from UK fragrance 
companies, in the spirit of co-operation fostered by this study. 
The lack of similar industry-specific research makes it all the more imperative that 
the work of this study is continued, both in terms of a direct follow-up and in 
expanding the study. Repeating the study with the same cohort of individuals would 
allow the assessment of any changes to lung function over time, and would be of 
great interest, although there is a danger that loss-to-follow-up may leave the sample 
size too small to generate statistically relevant results or introduce attrition bias 
(Crombie & Davies, 1996, p.118). The study could also be expanded to include the 
fragrance companies who declined to participate. The successful completion of this 
initial research and dissemination of results may help to convince these companies 
to take part in future research. There is also the possibility that overseas divisions 
could be supported to conduct similar research, and so contribute to a global data-
set. Larger studies conducted in this way would provide a greater sample size and 
so increase the statistical power of any findings. Such future research could be seen 
as continuing the work of this study, and building up a body of work specific to this 
industry.  
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● 6.3 Discussion, part 2 
The questionnaire developed for part 2 is intended to function as a score based 
predictive tool used in conjunction with a questionnaire for employees within the 
fragrance industry, by providing a numerical score that is predictive for potential 
respiratory problems. The need for such a tool has increased in recent years with the 
passing of the Equality Act 2010, with the result that employers are no longer able to 
request health-related information prior to a formal offer of employment (Home 
Office, 2010). Any pre-placement procedure must therefore be effective in terms of 
assessing the needs of the employee, and must also be conducted rapidly. 
Occupational health screening questionnaires are, however, of little benefit in 
providing concrete, useful information to the employer in terms of predicting adverse 
health outcomes and/or assessing employees’ needs (Madan & Williams, 2010; 
Madan & Williams, 2012; Mahmud et al., 2010; Hulshof et al., 1999). 
Madan and Williams (2012) conclude that: 
“There is little evidence that pre-employment health screening by questionnaire is 
effective in determining future health or occupational outcomes for prospective 
employees.” (Madan & Williams, 2012.) 
The challenge, then, lay in developing a screening questionnaire that is effective, 
and provides a clear result that can be used in predicting occupational outcomes and 
so aid in the pre-placement assessment of employees. The questionnaire (appendix 
entry 16) was informed by the literature and existing questionnaires before being 
developed and finalised from the study data. An accumulated score is calculated 
from the responses, with a higher score expected to predict a lower FEV1 
performance.  
Two internal validity checks on the final questionnaire showed a correlation between 
questionnaire score and FEV1, with a high score correlating with reduced FEV1 
results.   
Interestingly, there was disparity in terms of establishing a threshold point for 
potential respiratory issues. The first check suggested that a score threshold of 
≥40.0% of maximum predicts an FEV1 of <80%predicted. The second check, 
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conducted with new employee data, found that the score threshold would be >60% 
of maximum before FEV1 <80%predicted is approached. These were conducted with 
a small number of people, however (check 1 n = 5, check 2 n = 4), and were 
intended as a rapid initial check on the functionality of the questionnaire, and to show 
that score does negatively correlate with FEV1. Further external validation is 
necessary to establish the threshold score relating to FEV1 <80%predicted before 
the questionnaire can be made available for widespread use.  
The questionnaire will be externally validated using spirometric results from 
fragrance industry employees not involved with the original research. This will be 
achieved by visiting the companies that declined to take part, and using the results of 
both parts of the study and the clear benefits offered by the questionnaire to justify 
their involvement with the validation process. External validation does not form part 
of this thesis, and is part of the suggested future research. 
Following external validation, the questionnaire would be offered to all fragrance 
companies within the UK. It should be given to any new employees for completion 
following an offer of employment. A score calculated as above the threshold point 
would be predictive of potential respiratory issues. Responses of the employer to 
such a score may include:  
● a more detailed risk assessment;  
● a specific risk assessment relating to respiratory exposure;  
● increased protective measures made available to the employee;  
● periodic scheduled appointments with occupational health / health and safety / 
human resources;  
● and/or spirometric assessments (more frequent if these are already in place). 
 
In this way the questionnaire may provide a predictive tool which could be used to 
fulfil the need identified by Madan and Williams (2010, 2012) for an effective 
predictive tool that provides useful information to the employer for the benefit of both 
employer and employee. As an industry-specific tool, generated from data 
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representative of UK fragrance industry employees, a limitation of the questionnaire 
is that it is only valid for use in that industry. The process used to develop the 
questionnaire, however, could be used as a model to develop similar tools in other 
areas. For example, if the research conducted for part 1 was followed up and 
extended to represent the global fragrance industry, regional questionnaires could be 
developed alongside this. This model could also be followed in other industries 
where chemical use or dust presents an occupational exposure hazard, and 
questionnaires developed specific to those industries. 
 
6.4 Implications in the field and recommendations for future practice 
Based on the results of this study, health and safety measures in place within the 
fragrance industry are sufficient but must be maintained as a minimum. Although no 
significant respiratory effects resulting from occupational exposure were found in this 
study, occupational risks do exist in the fragrance industry, and so the industry would 
benefit from further research. Future research with a larger sample size would give 
confidence that the results reported here give a representative view of employees in 
the industry, and that sufficient protective measures are in place. 
A COSHH guide specific to the fragrance industry should be prepared and made 
available via the HSE. This will be suggested to the HSE. The guide could be 
prepared as a collaborative effort within the UK industry and endorsed by the HSE. 
Spirometric occupational health surveillance is of great benefit to staff and 
employers. Where this does not take place, this should be implemented as a matter 
of priority. Providing this service in-house is straightforward and inexpensive; 
guidance will be offered where necessary on the process of setting up and 
maintaining such a service.  
The challenge of effectively assessing employees’ occupational needs whilst 
complying with the Equality Act 2010 (Home Office, 2010) can be met with the use of 
a pre-placement questionnaire, albeit one that is specifically designed and created to 
yield useful information, rather than a generic form. The questionnaire developed 
here is an example of this. Once externally validated, the questionnaire will function 
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as a predictive tool for potential lung function issues in employees of the fragrance 
industry, aiding in the pre-placement and risk assessment processes. The wider 
implications of this, taking into account the conclusions of Madan and Williams 
(2010, 2012) that many occupational health questionnaires are not useful or 
effective, are that specific tools such as this should be the standard method of pre-
placement assessment, where feasible. Where a specific risk or hazard is evident in 
a workplace, and health-related information can be effectively used to support risk 
management for the employee, a tool designed to gather that information can be 
more effective than a generic form. It is critical, however, for the potential cost 
implications of implementing any such tool to be defined as part of the development 
and/or validation process. Further to this, the development model used to generate 
the questionnaire can be followed in other global regions of the industry and/or other 
industries with occupational respiratory hazards, thus creating tools that are specific 
to the region or to a particular industry.  
 
● 6.5 Limitations of the study 
The two chief limitations of the research study concern sample size and the limited 
population represented by the participants. 
The sample size of 112 was sufficient to meet the minimum sample required for 
statistical analysis (108). Although this does compare favourably with some studies 
in other industries (n = 100, Hashemi et al., 2010; n = 82, Rylander & Carvalheiro, 
2006; n = 75, Fishwick et al., 2004), many studies which found significant effects 
using spirometry had significantly larger populations (n = 656, Osman & Pala, 2009; 
n = 3924, Johnsen et al., 2008). It must be acknowledged that a larger sample size 
for this study may have, in theory, been necessary in order to observe any effects of 
occupational exposure, if such effects exist, or to eliminate any concerns in this area. 
The sample size was the result of the lack of participation of certain UK fragrance 
companies during the recruitment process. Whilst this was disappointing, it was not 
expected that all invited companies would agree to participate. The offer to 
participate in follow-up research studies will be supported by the work undertaken 
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thus far, and it is hoped that this will result in a larger study population being 
available. 
The other chief limitation of the study is that the results are representative of the 
study population – UK fragrance industry employees – and should not be 
extrapolated to represent other global regions. This was the intention of the study 
design, however, to conduct the research at sites within the UK, as a global study 
would have been impractical at this stage in terms of budgetary and time constraints. 
As has been stated previously, this work can be followed up using the study 
methodology to conduct similar research in other global locations. 
An additional limitation is that no exposure monitoring was conducted at the sites 
visited for data collection, as analysis of personal exposure data did not form part of 
the research methodology. The collection of personal exposure monitoring data will 
be investigated for feasibility in further studies.  
The existing limitations of the predictive questionnaire tool are that it remains to be 
externally validated within industry, and that a threshold score corresponding to 
FEV1 <80%predicted has not yet been established. External validation will provide 
further support of its effectiveness, and also allow a threshold score to be defined. 
The questionnaire is also limited in that it is representative of the UK fragrance 
industry population, although this is its intended purpose. 
Finally, as has been discussed above, an issue with the research study is that there 
are no directly comparable studies conducted within industry to compare these 
results to. Strictly speaking, this is not a limitation of the study itself, rather a 
limitation of the available literature, and this research aims to begin the process of 
filling this knowledge gap. This can be seen as the greatest strength of this research, 
a truly novel piece of work in an under-investigated area, breaking ground in the 
fragrance industry and produced with the willing co-operation of parties that have 
long been competitors. This research is indeed the beginning of a body of work 
focussed on the industry, and will be continued and expanded with the ongoing 
collaborative support of the industry. 
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● 6.6 Overall conclusions 
No significant effects of occupational respiratory exposure on the spirometric 
performance of the study population were observed. The study population was 
representative of employees of the UK fragrance industry. This suggests that 
protective measures in place in the fragrance industry are sufficient in minimising 
occupational risk to respiratory health, and so are effective in preventing reduction of 
employees’ lung function during working hours. This conforms to the requirements of 
health and safety legislation and to the stated aims of the Health and Safety 
Executive, and such protective measures must be maintained as a minimum. It 
would be useful, however, to replicate this study with a larger population. A larger 
future study using the same methodology would determine if sample size was truly a 
limitation of this study. 
The potential confounding factors adjusted for using statistical analysis were: 
smoking status; body mass index; personal history of respiratory problems; and 
family history of respiratory problems. These factors were not observed to 
significantly affect the outcome measurements. A larger future study may also allow 
further exploration of the effects of these potential confounders, particularly smoking 
status. 
Using spirometric, physical and demographic data from this study population, a pre-
placement occupational health questionnaire was developed as a predictive tool for 
potential lung function problems in fragrance industry employees. External validation 
and determination of the threshold score representing an FEV1 of ≤80% is required 
before the questionnaire can be released for widespread use. Once validated, the 
questionnaire can be used as an effective tool to provide meaningful and useful 
information as part of a pre-placement assessment. This tool may provide the means 
to comply with relevant legislation prohibiting health-related questions prior to the 
offer of employment, while ensuring that the needs of the employee are known and 
can be met. The development model used to create the questionnaire could be 
followed to generate region-specific or industry-specific questionnaires. 
Occupational exposure within the fragrance industry is an unexplored area for 
research. The lack of previously published research in this area may be due to 
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concerns of the employers that any negative findings would expose them to litigation, 
compensation claims or enforcement notices. This may also be a factor in the 
decision of some companies to decline to participate in the study. The reverse is the 
case, however; participation in studies such as this demonstrates that companies are 
actively supporting occupational research, and that they are attentive to employees’ 
occupational health needs. Engaging in cross-industry collaboration to support the 
finding of definitive research results leaves companies in a far stronger position of 
defence. This is a particularly salient point when considering that a great deal of 
similar research has been carried out in other industries. 
This study is the first step in a novel area of research. The research can – and 
should – be followed-up and expanded upon. 
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● 6.7 Future dissemination 
Disseminated material arising from the research was listed in the dissemination list 
(page xi). Articles yet to be published and future presentations are listed below. 
___________________________________________________________________ 
● Chemical exposure and lung function in the fragrance industry: a multi-site 
cross-sectional study. 
Article, submitted for publication to Occupational Medicine.  
 
___________________________________________________________________ 
● The development of a pre-placement occupational health questionnaire that 
is predictive for potential lung function problems, for use within the UK 
fragrance industry. 
Article, to be submitted for publication. 
___________________________________________________________________ 
● The validation of a pre-placement occupational health questionnaire that is 
predictive for potential lung function problems, for use within the UK fragrance 
industry. 
Article, to be submitted for publication. 
___________________________________________________________________ 
● Chemical exposure and lung function in the fragrance industry: a multi-site 
cross-sectional study. 
Presentation, to be given to:  
International Fragrance Association United Kingdom (IFRA-UK) Executive 
Committee, London; UK fragrance companies. 
___________________________________________________________________ 
● The development, validation and use of a pre-placement occupational 
health questionnaire that is predictive for potential lung function problems, for 
use within the UK fragrance industry. 
Presentation, to be given to:  
International Fragrance Association United Kingdom (IFRA-UK) Executive 
Committee, London; UK fragrance companies. 
___________________________________________________________________ 
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● 6.8 Future studies 
Future areas of research arising from this study and the discussion of the findings 
are summarised below: 
● participants of the research study could be directly followed-up at a later date using 
the same data collection and analysis methodology (Monson, 1990, p.61, pp.144-
147), in order to investigate changes to lung function over time (this would be 
considered as a cohort study, albeit with a relatively small population); 
● regional studies could be conducted globally using the same research 
methodology, to give results representative of the region; 
● following completion of further global regional studies, a global meta-study could 
compare and/or combine results from those regional studies; 
● a multi-industry study directly comparing relative risk of lung function effects from 
occupational exposure within the fragrance industry to that in other industries, in the 
style of the research conducted by Kogevinas et al. (2007), would be of interest; 
● dermatological effects of occupational exposure within the fragrance industry also 
remain unexplored, this is another potential area for future research; 
● development of a COSHH guidance document endorsed by the HSE providing 
specific guidance for the fragrance industry; 
● advice and guidance to other parties as necessary on the benefits of an in-house 
spirometry assessment service and the procedure and requirements for establishing 
such a service (this could be via informal consultation or the creation of a guidance 
document); 
● validation of the predictive questionnaire within the fragrance industry is necessary 
before its subsequent use in pre-placement assessments; 
● further global region-specific questionnaires could be developed, following the 
questionnaire development methodology used here as a model. 
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Summary 
This chapter has summarised the findings of both parts of the study, placing them in 
the context of current practice and considering the implications for future practice. 
Limitations of the study were acknowledged, and future research ideas arising from 
these findings were proposed. 
Chapter 7 will begin with an assessment of the objectives outlined in chapter 1 and 
how these have been fulfilled, and will then be dedicated to personal and 
professional reflection, including an evaluation of progress towards the professional 
doctorate and the significant developmental steps that have occurred throughout the 
process. 
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Chapter 7 Reflection 
The aim of this chapter is to revisit the objectives outlined in chapter 1, and to give a 
reflective account of personal and professional development throughout the course. 
This will be achieved by: 
● assessing the work undertaken against the defined objectives, and identifying any 
future work arising;  
● reflecting on previous learning prior to the course; 
● presenting a SWAIN analysis conducted at the beginning of the course; 
● considering critical events in the context of strengths and weaknesses identified 
and/or addressed; 
● conducting an up-to-date SWAIN analysis. 
 
● 7.1 Assessment of objectives 
The work undertaken in planning, undertaking and reporting the results of the study 
was assessed against each formal objective outlined in chapter 1. 
Objective 1 
Professional training and experience: 
To gain formal training in spirometric testing and interpretation, and experience at 
conducting spirometric testing in the workplace. 
Achieved by: Links:  
● receiving formal training; ● appendix entry 3 
● running spirometric health 
surveillance programme in the 
workplace. 
● appendix entry 4 
 
Tasks remaining / follow-up:  
● continue with workplace spirometric assessments;  
● keep up-to-date with developments in spirometric equipment, testing and/or 
interpretation via relevant literature, network of contacts, and refresher courses 
where appropriate. 
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Objective 2 
To answer the research question: 
In fragrance industry employees, is occupational respiratory exposure to chemicals 
linked to a statistically significant change in lung function as measured using 
spirometry? 
Achieved by: Links:  
● designing an appropriate research 
methodology; 
● chapter 2, research methodology 
● conducting the study according to 
the methodology; 
● chapter 3, results (part 1) 
● reporting and discussing the results 
of the study. 
● chapter 3, results (part 1) 
● chapter 6, section 6.2, discussion (part 1) 
 
Tasks remaining / follow-up:  
● dissemination of results through published articles and presentations (see 
objective 5). 
 
Objective 3 
Statistical analysis: 
To undertake statistical analysis on data collected to explore the relationship between 
chemical exposure and lung function. 
Achieved by: Links:  
● consulting with a statistician to 
ascertain the most appropriate 
methods of analysis; 
● chapter 2, section 2.8, statistical analysis 
● performing analysis and reporting 
results. 
● chapter 3, results (part 1) 
 
Tasks remaining / follow-up: none. 
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Objective 4 
Predictive questionnaire: 
To develop a predictive pre-placement screening questionnaire using spirometric data 
obtained and demographic information from pre-assessment data collection sheets. 
Sub-objective: 
To critically evaluate existing evidence on factors potentially associated with reduction in 
lung function (to inform the development of pre-assessment data collection sheets). 
Achieved by: Links:  
● clearly defining the phased 
development process; 
● chapter 4, questionnaire development 
methodology 
● conducting a literature review; 
● reviewing existing questionnaires; 
● developing an appropriate data 
collection sheet informed by the 
literature; 
● chapter 4, literature review and review of 
existing questionnaires 
● appendix entry 5 (data collection sheet) 
● performing data analysis using 
appropriate methods; 
● developing the final questionnaire 
and accompanying scoring guide. 
● chapter 5, results (part 2) 
● appendix entry 16 (final questionnaire) 
● appendix entry 17 (scoring guide) 
 
Tasks remaining / follow-up:  
● external validation of questionnaire; 
● release of questionnaire to industry and support for its use where appropriate. 
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Objective 5 
Dissemination: 
To disseminate results via industry seminars/presentations and reports, and preparation of 
article(s) for publication. 
Achieved by: Links:  
● delivering presentations to industry 
and associated organisations; 
● Dissemination list (page xi) 
● submitting an article for publication; ● Dissemination list (page xi) 
Dix, G.R. (2012). Assessing the impact of journals: 
A review of journals in the field of respiratory 
research, in the context of industrial occupational 
health. Occ Health [at Work], 8(5), 30-33. 
● preparing a summary report and 
poster to participating companies; 
● Dissemination list (page xi) 
● poster presentation outside industry 
(European Respiratory Society Annual 
Congress). 
● Dissemination list (page xi) 
● appendix entry 18 
 
Tasks remaining / follow-up: (also see chapter 6, section 6.7, future dissemination) 
● articles for journal publication:  
Chemical exposure and lung function in the fragrance industry: a multi-site 
cross-sectional study; 
The development of a pre-placement occupational health questionnaire that is 
predictive for potential lung function problems, for use within the UK fragrance 
industry; 
The validation of a pre-placement occupational health questionnaire that is 
predictive for potential lung function problems, for use within the UK fragrance 
industry; 
● presentations to be developed:  
Chemical exposure and lung function in the fragrance industry: a multi-site 
cross-sectional study; 
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The development, validation and use of a pre-placement occupational health 
questionnaire that is predictive for potential lung function problems, for use 
within the UK fragrance industry. 
 
Objective 6 
Professional implications: 
To explore the implications of research findings for industry via: 
preparation of guidelines/recommendations as appropriate; 
making the predictive questionnaire available within the fragrance industry; 
suggestion of future research ideas arising from the research findings. 
Achieved by: Links:  
● reporting and discussing the 
results of the study and their 
implications; 
● chapter 3, results (part 1) 
● chapter 6, section 6.2, discussion (part 1) 
● chapter 6, section 6.4, implications in the 
field and recommendations for future practice 
● discussing the potential use, 
value and limitations of the final 
questionnaire; 
● chapter 6, section 6.3, discussion (part 2) 
● chapter 6, section 6.4, implications in the 
field and recommendations for future practice 
● suggesting future ideas for 
research following and expanding 
this work. 
● chapter 6, section 6.8, future studies 
 
Tasks remaining / follow-up: (also see chapter 6, section 6.8, future studies) 
● development of a COSHH guidance document endorsed by the HSE providing 
specific guidance for the fragrance industry; 
● advice and guidance to other parties as necessary on the benefits of an in-house 
spirometry assessment service and the procedure and requirements for establishing 
such a service; 
 ● validation of the predictive questionnaire, followed by its dissemination throughout 
the fragrance industry. 
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● 7.2 Professional and personal reflection 
Introduction 
A key element of the professional doctorate programme is a reflective account of the 
professional and personal development that has occurred throughout the course. 
Reflection on the experiences underpinning that development allows the 
consolidation of what has been learnt, and enables further development from future 
experiential learning (Kolb, 1984, pp.27-29, p.38; Moon, 1999, p.21, p.161). In this 
way, learning is seen as an ongoing process with its own values and impact, rather 
than merely a necessary step towards a defined outcome (Kolb, 1984, pp.26-29).  
This reflective account begins with a consideration of learning and experiences prior 
to undertaking the professional doctorate and a SWAIN analysis (strengths, 
weaknesses, aspirations, interests and needs [Hall & Marsh, 2000, p.34, pp.46-47; 
O’Neill & Pennington, 1992, pp.35-41; UK Centre for Bioscience, 2010, pp.10-11]) 
conducted at this point in time. SWAIN analysis was preferred over alternatives such 
as SWOT analysis (strengths, weaknesses, opportunities, threats [Johnson, Scholes 
& Whittington, 2008, p.119, pp.569-570; Mullins, 2007, pp.545-546]) as I felt this 
would facilitate a more comprehensive evaluation of personal attributes and lead to 
the clear identification of ‘needs’ in order to achieve aspirations and identify and/or 
overcome weaknesses. In this way, SWAIN can be truly effective in using reflection 
as a mechanism towards further self-development (Moon, 1999, p.77). 
Components of the SWAIN analysis will then be considered in more detail, reflecting 
on the changes resulting from experiential learning during the course of the 
doctorate programme. A current SWAIN analysis conducted as I approach the end of 
the professional doctorate will then be used to demonstrate the developmental 
changes that have occurred.  
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Previous learning  
To be effective, any assessment of personal development requirements must include 
a consideration of previous learning experiences, and what the individual has taken 
forward from those experiences (Boud, Keogh & Walker, 1985, p.7).  
 
Academic learning 
My academic qualifications prior to beginning the professional doctorate were an 
honours degree (BSc Hons Biology) from the Open University, and a post-graduate 
diploma (PGDip Medical Toxicology) from Cardiff University. Both of these courses 
were undertaken via distance learning. The advantage of this format was being able 
to work full-time whilst studying. Undertaking these qualifications developed the 
following personal attributes, which I would consider to be strengths: 
● adaptability – the modular structure of the Open University courses led to an 
overlap of subjects at times, requiring the ability to switch between subjects while 
ensuring sufficient attention was given to each. 
● organising and prioritising workloads – periods of high workloads caused by 
overlap of Open University courses required the prioritisation of tasks and 
assignments. To achieve this, I would ‘break up’ the workloads into sections and 
assign each a time-bound deadline based on priority. This system worked well and 
so was also used when undertaking the post-graduate diploma. 
● remote / independent working – both courses were undertaken as a distance 
learner, which promoted the development of self-organisation strategies as in the 
example above. Support was available in both cases, but this was barely used, as I 
did not feel that responses were timely, and I preferred to overcome any obstacles 
through my own investigation and comprehension. These periods developed and 
cemented my inclination for self-reliance and a determination to achieve things 
without outside assistance.  
The successful completion of these qualifications gave me a tremendous sense of 
achievement and self-satisfaction. I felt rewarded, and somewhat vindicated, as 
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these experiences proved to me that hard work unquestionably leads to rewards. 
This is a basic personal principle that I have carried forward. 
One of the strengths identified, however, had the potential to become a self-limiting 
factor, and so must be considered as a weakness: 
● reluctance to involve / depend on others – while self-reliance had served me well 
to this point, I realised this was also a weakness which could impact my progression 
through the professional doctorate course. The course would involve developing 
doctoral level skills which were completely new to me, such as complicated statistical 
analysis methods, writing for publication, and formally reviewing published literature. 
It was likely that I would need support throughout the course, and so I resolved to 
actively minimise the effects of this personality trait by seeking support and 
interacting as much as possible with my study group and tutors/supervisors. 
 
Work-based learning 
I had been employed in the Regulatory department at CPL Aromas for almost three 
years when I began the professional doctorate course. Intensive learning had been 
required on the regulations and directives relevant to fragrance production, sale and 
use and their practical implementation using specialised software. Working in 
Regulatory requires a balance of short-, mid- and long-term priority tasks, the 
priorities of which change frequently. This work-based learning therefore supported 
the strengths of adaptability, and organising and prioritising workloads. The 
management structure in the department is relatively informal and flexible, and I am 
generally left to manage my own workload; this is my preferred way of working, and 
has further supported the strength of independent working. On reflection, however, 
this has also supported the weakness of a reluctance to involve / depend on others; 
this is unlikely to become an issue in the working environment, but as mentioned 
above, it was a weakness that needed to be actively worked on during the 
professional doctorate course.  
It is notable that, prior to the professional doctorate course, academic and work-
based learning were not integrated in any way, and any effects they had on personal 
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development occurred separately from each other, even when those effects were 
similar. The professional doctorate course was selected as one of its underlying 
principles is its relevance to, and interaction with, the student’s workplace. This 
would therefore enable true experiential learning, by linking academic and work-
based learning to achieve personal development (Kolb, 1984, p.4). 
 
SWAIN analysis 1 
Table 7.1 presents a SWAIN analysis conducted prior to beginning the professional 
doctorate, identifying the strengths, weaknesses, aspirations and interests relevant 
to the successful completion of the course. The final section, ‘needs’, outlines the 
actions necessary to build on strengths, overcome or minimise weaknesses, achieve 
aspirations and stimulate interests. 
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Table 7.1: SWAIN analysis, prior to undertaking the professional doctorate 
STRENGTHS  WEAKNESSES 
● adaptability 
● prioritising / organising workloads 
● remote / independent working 
● broad knowledge base 
● drive and ambition for progression 
● work ethic, professionalism 
● reluctance to involve and/or depend on others 
● lack of experience writing and studying at 
doctoral level 
● lack of experience delivering presentations 
● limited understanding and experience of formal 
statistical analysis methods 
● lack of specialised knowledge and competency 
in area of research interest 
ASPIRATIONS INTERESTS 
● professional development 
● increased professional recognition and respect 
in industry 
● academic development to doctoral level 
● development of specialised knowledge base 
● chemical industry 
● employee health and well-being 
● respiratory exposure, lung function / spirometry 
NEEDS 
● to conceive, plan and undertake a research project relevant to the workplace, interests, and 
academic requirements 
● to have support from employer: study days, time allowed for planning and conducting research 
● to select appropriate first supervisor; foster good relations through tutorials / progress updates, 
discussion of problems and successes, asking for assistance when required 
● to ask for assistance / support from tutors when required 
● to foster good relations with peer group through regular contact; ask for and offer support when 
needed 
● to gain experience of statistical analysis methods and understanding of which methods are 
appropriate for different data manipulation requirements 
● to gain experience delivering presentations 
● to gain experience writing and reviewing at doctoral level, via progression through doctorate unit 
assignments 
● to successfully write, submit and publish research article(s) in an appropriate journal 
● to undertake formal spirometry training and gain experience in conducting and interpreting 
spirometric tests. 
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The following sections reflect on the points identified in the SWAIN analysis above, 
and examine the progression from this initial analysis to one conducted as I 
approach the end of the professional doctorate process.  
 
Critical events and effects on strengths and weaknesses 
The first SWAIN analysis (table 7.1) identified personal strengths that would be 
necessary for progression through the professional doctorate course, and 
weaknesses that needed to be addressed. The ‘needs’ in table 7.1 were designed 
not only to aid general progression through the course, but also to minimise or 
eliminate specific weaknesses identified. Thus weaknesses can be addressed with 
experiential learning and reflection on critical ‘events’, either by being transformed 
through experience into strengths, or by a lessening of their effects. This 
development planning and reflection was conducted with Kolb’s reflective learning 
cycle (Kolb, 1984, pp.20-22) in mind, whereby reflection on concrete experience 
leads to new ideas and concepts which can be used to inform further experiences 
and further reflection, and so on. 
Relevant events are given below with a brief commentary on their effects on 
personal development. 
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● Event: Presentations (see dissemination list, page xi) 
- research proposal presentations to university peer group and tutors (x2) 
- research proposal presentations to industry (x2) 
- presentation of preliminary results to industry-associated bodies (x2) 
- poster presentation, European Respiratory Society 
Prior to the course, I had no experience writing or delivering presentations. This lack 
of experience was clear from the feedback received after giving the first presentation 
to the study group and tutors (22/01/2010), suggesting that I appeared nervous and 
did not engage with the audience effectively (appendix entry 19). Between this and 
the second presentation (11/02/2011), I had delivered several presentations as 
training material at work. This experience, combined with an increased subject 
knowledge and being more comfortable among the study group, gave me the 
confidence to deliver the second presentation much more effectively, and this was 
reflected in the feedback, which was greatly improved (appendix entry 20). 
Subsequent presentations – proposing my planned research and delivering 
preliminary results – built upon this experience, and I now feel I can count 
presentation skills as a strength. Of particular satisfaction was being personally 
invited to New Jersey, USA, to present the results of the study to the Research 
Institute for Fragrance Materials (RIFM); the audience was relatively hostile, and the 
presentation essentially became a defence of my research, which I was able to deal 
with without losing confidence or becoming nervous. I would not have been able to 
deal with such an experience prior to the course. 
 
Attribute affected: Transformed to: 
Lack of experience presenting (W)* Presentation skills (S)* 
*S = strength; W = weakness 
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● Event: Statistical analysis 
- statistics assignment for unit 2, Advanced Research Techniques 
- statistical analysis on research study results 
- statistical analysis for questionnaire development 
Formal methods of statistical analysis were unfamiliar to me prior to the course, and I 
anticipated that such methods would be required in the analysis of my research data. 
Unit 2 of the course, Advanced Research Techniques, gave me the opportunity to 
learn the various methods of statistical analysis and to practice using those methods 
on the sample data sets provided. For the assignments for this unit, we were given 
the choice of completing either quantitative or qualitative analysis to an advanced 
‘specialist’ level; although I had enjoyed the qualitative component of the unit, I 
selected the former, as I felt this would be of more value to me later during the 
research phase of the course.  
Although I felt competent in using statistical methods in analysing my research data, 
I felt that the advice of a statistician was required to be certain of the appropriate 
methods to use, and I had several consultations with the University of Portsmouth 
statistician, Dr. Reuben Ogollah. My prior experience gave me the confidence to 
discuss my requirements with Reuben without having to cover the basics, and to use 
his advice to come to a considered conclusion as to the appropriate methods to use. 
 
Attribute affected: Transformed to: 
Lack of statistical analysis knowledge (W)* Competence with statistical analysis 
methods (S)* 
*S = strength; W = weakness 
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● Event: Writing for publication (see dissemination list, page xi) 
- acceptance of an article for journal publication 
Writing succinctly to the standard required at doctoral level was not only necessary 
for the course unit assignments, but also useful for the preparation of articles for 
journal publication. An expectation of the professional doctorate course is the writing 
up of results for publication in an appropriate journal, so this was a weakness that 
had to be addressed. Completion of the unit assignments, and guidance and 
feedback on writing, helped me build these skills and gain confidence in this area. I 
was particularly pleased with an assignment written for unit 3, Publication and 
Dissemination, and I took the advice of both Dr. Isobel Ryder and Prof. Graham Mills 
who both suggested that I should submit the piece as an article for journal 
publication. The article was a journal review, focussing on how a journal’s 
effectiveness in disseminating results and information can be measured, with 
particular emphasis on dissemination into the industrial occupational health field. 
This was published in the journal Occupational Health [at Work] (see dissemination 
list, page xi).  
Publishing this article felt like a definitive step forward for me, and shows that the 
experience writing unit assignments has had a clear developmental effect on my 
writing skills. I now look forward to writing up my research results as articles for 
publication. 
 
Attribute affected: Transformed to: 
Lack of experience writing at doctoral level 
(W)* 
Writing at an appropriate level (S)* 
*S = strength; W = weakness 
 
 
 
Page | 137  
 
● Event: Spirometry training and experience 
- formal training in spirometric assessment and interpretation 
- experience in performing spirometric tests in the workplace 
In addition to developing the skills and confidence to perform spirometric testing, 
formal training and substantial subsequent experience in conducting workplace 
health surveillance testing has stimulated the development of specialised knowledge 
in this area. This is turn has increased the professional respect I receive in the 
workplace, and it is rewarding to know that employees trust me with confidential 
information and are keen to follow my advice. The confidence gained from 
conducting tests and overseeing the health surveillance programme was of critical 
importance during the data collection phase of my research, when I visited unfamiliar 
sites and tested new people; I was able to put these participants at ease and ensure 
good test performances, due to my previous experiences.  
 
Attribute affected: Transformed to: 
Lack of specialised knowledge (W)* Specialised knowledge base & competency 
in spirometric testing (S)* 
*S = strength; W = weakness 
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● Event: Conducting research study 
- planning a feasible research study 
- data collection 
- reporting of results 
The successful completion of this ‘event’ encompasses the development and 
utilisation of all the strengths mentioned previously. Although the research study was 
not conducted with the aim of addressing any single identified weakness, the 
weaknesses given above did need to be addressed for the research to be 
successfully conducted and reported.  
This has led to the development of a strength that was not the result of a weakness 
identified in table 7.1 and subsequently transformed. The research study was the 
result of a great deal of planning and pre-emptive measures (spirometry experience, 
for example), and almost 3 years have passed between the initial proposal (quarter 
1, 2010), and the writing up and submission of this thesis (quarter 4, 2012). As a 
result, I can now count planning long-term projects as a strength. 
 
Attribute affected: Strength developed: 
________ Planning long-term projects (S)* 
*S = strength 
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● Event: Study group days and tutorials 
- formal and informal study days with peer group 
- regular communication with peer group 
- tutorials with first supervisor and regular contact for support and advice 
A critical weakness arising from the first SWAIN analysis was my reluctance to 
involve or depend on others. Although this relates to a strength – independent 
working – I was aware that this may have become a liability during the professional 
doctorate course, as it was almost certain that I would need some form of support. 
Taking advantage of the formal study sessions, I gradually became friends with 
others in the study group, and this greatly assisted my progression through the 
course. I feel fortunate to be a member of a group with similar interests and needs, 
although our professional interests are often very different. I have felt truly 
comfortable with the group, both face-to-face and via remote contact. It is testament 
to the strength of our peer bond that if I ask a question or ask for support via email, I 
know that someone will respond swiftly. I have found this network of support to be 
invaluable, both directly (for example, proof-reading of my draft work) and indirectly, 
knowing that others in the group are undertaking similar tasks and are under similar 
pressures. I hope to remain in contact with members of the group long after the 
course has been completed. 
The support I have received from Dr. Isobel Ryder has also been critical to my 
progress through the course, both as a unit tutor and as a first supervisor for my 
research. I have come to rely on Dr. Ryder in many ways, and I have made a 
conscious effort to accept this and not to be hesitant in accepting the support 
offered. It was Dr. Ryder who facilitated my entry onto the professional doctorate 
course, and she has been an ever-present source of support since.  
I do feel that I still have a preference for independent working, but I realise that this is 
a strength I only have to make use of when it is necessary; it is not necessarily the 
default state of working, as I had previously thought. Due to my experiences on the 
course, I can now truly appreciate the value of support from others, and how this can 
enrich professional development and learning experiences.  
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Attribute affected: Transformed to: 
Remote / independent working (S)* 
 
 
Reluctance to involve / depend on others 
(W)* 
Remote / independent working when 
necessary (S) 
Preference for independent working (W) 
Appreciation of support from others (S) 
*S = strength; W = weakness 
 
● Additional: new weaknesses identified from current reflection 
Reflection on all the above factors and the general progression through the doctorate 
course has led me to become aware of further weaknesses, which could be 
addressed through future experiential learning.  
Drive and ambition was identified as a strength in the first SWAIN analysis. I have 
long considered this to be a positive attribute which has fuelled my determination to 
complete every task I set out to achieve. For example, at the beginning of the 
research planning process (quarter 1, 2011), I planned out in detail each step of the 
process, culminating in the submission of this thesis and the subsequent 
presentation and viva voce. I remain on course with the time-bound steps of this 
timeline (appendix entry 21). This is in line with my long-held belief that a decision to 
undertake a task must inevitably lead to the completion of that task. On reflection, 
however, this suggests an unwillingness to even consider the possibility of failure, 
and this unwillingness leads to a lack of contingency planning in case of unforeseen 
obstacles and events. I believe the root of this to be a general fear of failure, which I 
have only now become aware of due to my reflection on the whole doctorate process 
and the development that has occurred as a result. In terms of addressing this in the 
future, I will be sure to consider the effects of unforeseen events on projects and 
tasks, and to clearly outline contingency plans, even when this does not feel 
necessary. I believe it is also necessary for me to come to terms with the idea that 
failure can itself be a learning process, and can provide valuable material for 
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personal reflection and further development. For example, the first presentation to 
the study group did not go well, but this provided the opportunity to develop and 
improve my skills in this area for future presentations.  
 
Attribute: Led to: 
Drive and ambition (S)* Fear of failure (W)* 
Lack of contingency planning (W) 
*S = strength; W = weakness 
 
Table 7.2 summarises how weaknesses identified in the first SWAIN analysis were 
acted upon in order to eliminate them or minimise their effects on further personal 
development. This leads to a second SWAIN analysis, with new strengths and 
weaknesses relevant to my current situation, and new needs and aspirations to take 
forward. 
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Table 7.2: Elimination or minimisation of weaknesses identified from SWAIN 
analysis 
From SWAIN analysis 1 From SWAIN analysis 2 
Remote / 
independent 
working (S*) 
Reluctance to 
involve / depend on 
others (W*) 
→ 
Support from first 
supervisor (N*) 
Support from tutors (N) 
Support from peer group 
(N) 
→ 
Remote / independent 
working when necessary 
(S) 
Preference for 
independent working (W) 
Appreciation of support 
from others (S) 
Lack of experience 
writing at doctoral 
level (W) 
→ 
Experience writing / 
reviewing at doctoral level 
(N) 
Write and publish research 
article(s) (N) 
→ 
Writing at an appropriate 
level (S) 
Lack of experience 
presenting (W) → 
Experience delivering 
presentations (N) → 
Presentation skills (S) 
Lack of statistical 
analysis knowledge 
(W) 
→ 
Experience of statistical 
analysis methods (N) → 
Competence with 
statistical analysis 
methods (S) 
Lack of specialised 
knowledge (W) → 
Development of specialised 
knowledge base (A*) 
Broad knowledge base (S) 
Spirometry training and 
experience (N) 
Plan and undertake 
research project (N) 
→ 
Specialised knowledge 
base and competency in 
spirometric testing (S) 
Drive and ambition 
(S) 
 
→ 
 Fear of failure (W) 
Lack of contingency 
planning (W) 
  Plan and undertake 
research project (N) → 
Planning long-term 
projects (S) 
*S = strength; W = weakness; A = aspiration; N = need 
 
SWAIN analysis 2 
Table 7.3 presents a SWAIN analysis, conducted as I approach the end of the 
professional doctorate process. 
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Table 7.3: SWAIN analysis, following completion of the professional doctorate 
STRENGTHS WEAKNESSES 
● adaptability 
● prioritising / organising workloads 
● remote / independent working when necessary 
● appreciation of the value of support from others 
● broad knowledge base 
● specialised knowledge in occupational 
respiratory issues and competency in conducting 
and interpreting spirometric tests 
● writing at a level suitable for doctoral work and 
for publication 
● presentation skills 
● ability to use appropriate statistical analysis 
methods for data manipulation 
● drive and ambition for progression 
● work ethic, professionalism 
● planning large / long-term projects 
● preference for independent working 
● fear of failure / unwillingness to contemplate 
failure 
● determination and drive can blind to potential 
failures, and over-ride the need for contingency 
planning 
 
ASPIRATIONS INTERESTS 
● professional development 
● maintain specialised knowledge base 
● conduct further research 
● publish further research 
● increased professional recognition through 
dissemination 
● chemical industry 
● employee health and well-being 
● respiratory exposure, lung function / spirometry 
● further investigation / follow-up of occupational 
health / exposure issues 
NEEDS 
● to conceive, plan and undertake further research projects, with appropriate contingency planning 
● to have support from employer: time allowed for planning and conducting research 
● to successfully write, submit and publish research article(s) in an appropriate journal 
● to keep up-to-date with developments in spirometric equipment, testing and/or interpretation via 
relevant literature, network of contacts, and refresher courses where appropriate. 
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Conclusion 
Reflection on the professional doctorate process and its developmental effects has 
demonstrated how powerful learning can be as an instrument for personal change. I 
have undergone true experiential learning throughout this course, and can now 
understand the value of an integrative approach, linking academic learning, work-
based learning and personal development in such a way that one could not occur 
without the others. Strengths and weaknesses have been identified and addressed, 
with future needs clearly defined in order to meet aspirations and interests. The most 
important weaknesses in terms of personal development were not those 
weaknesses arising from a lack of experience, but deep-rooted personality attributes 
that, if left unaddressed, could limit further development and progress. One of those 
weaknesses (reluctance to involve others) was minimised, and the other, yet to be 
addressed (fear of failure), was discovered directly as a result of this reflective 
account. 
This course has been a challenging experience, in terms of academic and integrative 
learning and practical issues such as time constraints, and yet with challenge comes 
reward. This process has enabled me to undergo significant developments both 
professionally and personally. I have achieved significant goals up to this point – 
publication of my work, conducting original research – and what I have learnt as a 
professional doctorate student will stay with me as I continue to progress further and 
achieve future goals. 
 
Summary 
This chapter has revisited the objectives defined in chapter 1 and assessed the work 
undertaken against those objectives, outlining any future work necessary to achieve 
them or to follow up the research carried out. 
This chapter has also given a reflective account of personal and professional 
development throughout the course, and identified weaknesses remaining to be 
addressed and future needs to be fulfilled.  
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Entry 4: CPL Aromas’ Health Surveillance programme 
Entry 5: Data collection sheet 
Entry 6: CPL Aromas’ spirometry protocol 
Entry 7: Email from Dr. Reuben Ogollah (28/07/2011), re: sample size 
Entry 8: Ethical approval, SHSSW Research Ethics Committee 
Entry 9: Information sheet for employees 
Entry 10: Informed consent form 
Entry 11: Confidentiality agreement 
Entry 12: Invitation letter to companies 
Entry 13: Acceptance form for the employer 
Entry 14: Spirometry results form 
Entry 15: Health and safety procedure, Cresylic acid 
Entry 16: Pre-placement questionnaire 
Entry 17: Pre-placement questionnaire, scoring guide 
Entry 18: Poster presentation, European Respiratory Society, September 2012 
Entry 19: Presentation feedback, January 2010 
Entry 20: Presentation feedback, February 2011 
Entry 21: Professional Doctorate study timeline 
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